Impact of biopolymer matrices on relaxometric properties of MRI contrast agents and their application to Nanotechnology by Ponsiglione, Alfonso Maria
  
 
 
 
 
 
University of Naples Federico II 
 
 
 
Department of Chemical, Materials and Production Engineering 
 
Ph.D. thesis in 
INDUSTRIAL PRODUCT AND PROCESS ENGINEERING 
XXXI cycle 
 
 
IMPACT OF BIOPOLYMER MATRICES ON RELAXOMETRIC 
PROPERTIES OF MRI CONTRAST AGENTS AND THEIR 
APPLICATION TO NANOTECHNOLOGY 
 
 
Supervisors: Candidate: 
Paolo Antonio Netti 
Professor of Biomaterials and Tissue Engineering 
Alfonso Maria Ponsiglione 
MSc in Biomedical Engineering 
Enza Torino 
Researcher in Bioengineering 
 
 
Ph.D. program coordinator:  
Giuseppe Mensitieri 
Professor of Materials Science and Engineering 
 
  
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
IMPACT OF BIOPOLYMER MATRICES ON 
RELAXOMETRIC PROPERTIES OF MRI 
CONTRAST AGENTS AND THEIR APPLICATION 
TO NANOTECHNOLOGY 
 
  
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
TABLE OF CONTENTS 
 
 
 
 
ABSTRACT .......................................................................................................................... 1 
STRUCTURE OF THE THESIS AND IMPLEMENTATION STRATEGY ................................... 5 
CHAPTER 1. STATE OF THE ART ................................................................................... 10 
1.1. Nanomedicine .................................................................................................... 10 
1.1.1. Nanoparticles for Therapy .................................................................................. 12 
1.1.2. Nanoparticles for Diagnostics ............................................................................. 14 
1.2. Magnetic Resonance Imaging ........................................................................... 15 
1.3. Contrast agents for MRI .................................................................................... 16 
1.3.1. Advantages in using contrast agents ................................................................... 16 
1.3.2. Physics of contrast agents ................................................................................... 16 
1.3.3. Contrast agents limitations.................................................................................. 17 
1.4. Polymers and contrast agents ............................................................................ 18 
1.4.1. Advantages in combining polymers and contrast agents .................................... 18 
1.4.2. Literature overview ............................................................................................. 19 
1.5. The need for new polymer-based contrast agents.............................................. 22 
1.6. Chapter 1 references .......................................................................................... 22 
  
 
 
 
 
 
CHAPTER 2. AIM OF THE WORK ................................................................................... 30 
2.1. Aim .................................................................................................................... 30 
2.2. Chapter 2 references .......................................................................................... 32 
CHAPTER 3. IMPACT OF BIOPOLYMERS ON RELAXOMETRIC PROPERTIES OF 
CONTRAST AGENTS: DEFINITION OF HYDRODENTICITY ........................ 35 
3.1. Summary of the chapter ..................................................................................... 35 
3.2. Introduction ....................................................................................................... 36 
3.3. Materials and Methods ...................................................................................... 38 
3.3.1. Materials ............................................................................................................. 38 
3.3.2. Sample preparation ............................................................................................. 38 
3.3.3. Isothermal Titration Calorimetry ........................................................................ 38 
3.3.4. Relaxometric measurement ................................................................................. 39 
3.3.1. NMR Spectroscopy ............................................................................................. 39 
3.3.1. Water Self-Diffusion Coefficient ........................................................................ 40 
3.3.2. Differential Scanning Calorimetry ...................................................................... 40 
3.4. Results ............................................................................................................... 41 
3.4.1. Changes in polymer conformation induced by a Gd-based contrast agent ......... 41 
3.4.2. NMR study of DTPA interactions and water mobility in polymer solution ....... 45 
3.4.3. Water dynamics within hydrated polymer matrix containing Gd-DTPA ........... 49 
3.4.4. Relaxation times, rates and relaxivity of the polymer matrix ............................. 50 
3.5. Theoretical interpretation of the enhanced Relaxivity ....................................... 56 
3.6. Theory of the Gado-mesh formation ................................................................. 59 
3.7. Conclusion ......................................................................................................... 61 
3.8. Chapter 3 references .......................................................................................... 62 
CHAPTER 4. APPLICATION OF THE HYDRODENTICITY TO THE DESIGN OF 
NANOSTRUCTURES FOR ENHANCED MRI ................................................ 69 
4.1. Summary of the chapter ..................................................................................... 69 
4.2. Introduction ....................................................................................................... 70 
  
 
 
 
 
 
4.3. High pressure homogenization to produce polymer nanoparticles based on 
Hydrodenticity ............................................................................................................. 71 
4.3.1. Study of emulsion stability ................................................................................. 71 
4.3.2. Preparation of DVS-crosslinked nanoparticles with and without CA ................. 72 
4.3.3. Purification and characterization of HA-NPs ..................................................... 73 
4.3.4. Relaxivity studies................................................................................................ 74 
4.3.5. Modelling of NMR dispersion: NMRD profile .................................................. 76 
4.3.6. Discussion ........................................................................................................... 78 
4.4. Microfluidic flow focusing approach to produce polymer nanoparticles based on 
Hydrodenticity ............................................................................................................. 79 
4.4.1. Preparation of crosslinked Hyaluronic Acid Nanoparticles (cHANPs) .............. 79 
4.4.2. Swelling behaviour and hydrogel structural parameters of cHANPs.................. 80 
4.4.3. In vitro relaxometric properties .......................................................................... 82 
4.4.4. Discussion ........................................................................................................... 85 
4.5. Microfluidic flow focusing approach to produce coacervated chitosan-hyaluronic 
acid nanoparticles based on Hydrodenticity ................................................................ 88 
4.5.1. Nanoparticles’ production through hydrodynamic flow focusing ...................... 90 
4.5.2. Comparison between batch and microfluidic system: effect of chitosan 
concentration ...................................................................................................... 91 
4.5.3. Concentration effect at FR2 = 0.5 ....................................................................... 92 
4.5.4. Flow rate effect at TPP = 0.003% and TPP = 0.012% ........................................ 93 
4.5.5. Morphological trend of NPs ............................................................................... 95 
4.5.6. Gd-DTPA encapsulation ..................................................................................... 96 
4.5.1. Fluorophore encapsulation .................................................................................. 97 
4.5.2. Discussion ........................................................................................................... 98 
4.6. Microfluidic flow focusing approach to produce chitosan-loaded liposome 
nanostructures based on Hydrodenticity .................................................................... 101 
4.6.1. liposomes and MRI ........................................................................................... 102 
4.6.2. Literature review: liposomes and polymersomes for enhanced MRI contrast .. 104 
4.6.3. Chitosan-loaded liposome nanostructures ........................................................ 118 
4.6.4. Effect of chitosan concentration ....................................................................... 119 
4.6.5. Effect of acetic acid concentration .................................................................... 120 
4.6.6. Flow rates optimization .................................................................................... 121 
4.6.7. Gd-DTPA encapsulation ................................................................................... 122 
4.6.8. Discussion ......................................................................................................... 124 
  
 
 
 
 
 
4.7. Chapter 4 references ........................................................................................ 125 
CHAPTER 5. CONCLUSION AND FUTURE OUTLOOK ................................................... 132 
5.1. Contribution to the fundamental understanding and applications ................... 132 
5.2. Draft of a preliminary model for the study of polymer contrast agents .......... 136 
5.3. Future activities ............................................................................................... 137 
APPENDIX: SUPPORTING INFORMATION AND NANOSTRUCUTRES’ SYNTHESIS ........ 139 
 
 
  
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
FIGURES LIST 
 
 
 
 
Figure 1.1 Schematic illustration of EPR effect. Image adapted from 4: Yu, X.; Trase, I.; Ren, M.; 
Duval, K.; Guo, X.; Chen, Z., Design of Nanoparticle-Based Carriers for Targeted Drug 
Delivery. 2016; Vol. 2016, p 1-15. ................................................................................. 12 
Figure 3.1 Thermograms (heat flow versus time) of Gd-DTPA into aqueous solution of HA at 0.6 % 
w/v. Temperature and stirring rate have been kept constant at 25 °C and 200 rpm, 
respectively, for each sample. ........................................................................................ 42 
Figure 3.2 Titration curves of Gd-DTPA into aqueous polymer solutions at 25 °C. Calorimetric traces 
(heat flow against time) for (A) 0.3% w/v HA, (B) 0.5% w/v HA and (C) 0.7% w/v HA. 
In (D) it is reported the normalized enthalpy vs Gd-DTPA/HA molar ratio for Gd-DTPA 
in 0.3% w/v HA (red circles), in 0.5% w/v HA (blue triangles) and in 0.7% w/v HA 
(magenta diamonds). The curves were shifted vertically for clarity; y-offset were set at 2 
(red circles), 0 (blue triangles) and -10 (magenta diamonds). ........................................ 43 
Figure 3.3 (A) 1H NMR spectrum and chemical structure of DTPA; (B) 1H NMR spectrum and 
chemical structure of DTPA; (C–I) 1H NMR spectra of DTPA/HA solutions at different 
molar ratios, from DTPA/HA = 2 to DTPA/HA = 100. Characteristic peaks of DTPA and 
HA are highlighted in blue and red respectively. ........................................................... 46 
Figure 3.4 (A) Normalized time dependent water self-diffusion coefficient in 0.1% w/v HA (squares), 
1% w/v HA (triangles), 2% w/v HA (flipped triangles), 3% w/v HA (diamonds). (B) 
Normalized time dependent water self-diffusion coefficient in 1% w/v HA (triangles), 5 
μM Gd-DTPA in 1% w/v HA (flipped triangles) and 30 μM Gd-DTPA in 1% w/v HA 
(stars). ............................................................................................................................ 47 
  
 
 
 
 
 
Figure 3.5 Stejskal Tanner Plot is used for calculating water self-diffusion coefficient of: (1) distilled 
water; (2) 0.25 % w/v HA solution with 5 μL DVS 8 hours after the crosslinking reaction; 
(3) 5 % w/v HA solution with 40 μL DVS 8 hours after the crosslinking reaction........ 48 
Figure 3.6 (A) DSC thermograms of HA at different concentrations (0.3, 0.5 and 0.7% w/v). (B) 
Melting (Tm) and crystallization (Tc) temperatures for free Gd-DTPA in water and HA 
solutions with and without CA. ...................................................................................... 50 
Figure 3.7 a) Longitudinal relaxation rate as a function of Gd-DTPA concentration and b) 
longitudinal relaxation time distribution for: (1) Gd-DTPA in distilled water; (2) Gd-
DTPA in 0.3 % w/v HA solution; (3) Gd-DTPA in 0.5 % w/v HA solution; (4) Gd-DTPA 
in 0.3 % w/v HA crosslinked with DVS (HA:DVS = 1:8); (5) Gd-DTPA in 0.5 % w/v 
HA crosslinked with DVS (HA:DVS = 1:8). Linear regression is applied to each set of 
data reported in a). ......................................................................................................... 51 
Figure 3.8 Increment in longitudinal relaxation rate, R1, at different contrast agent concentrations 
(from 0 to 1 mM) for: free Gd-DTPA in water (black squares); Gd-DTPA in 0.5% w/v 
HA solution (blue filled triangles); Gd-DTPA in 0.5% w/v HA crosslinked with DVS 
(blue empty triangles). The R1 increment is calculated in percentage with respect to the 
corresponding R1 of Gd-DTPA in water. A fast increment in R1 is observed until a Gd-
DTPA concentration equal to 300 µM. For higher Gd-DTPA concentrations, the R1 
increment reaches a plateau. .......................................................................................... 53 
Figure 3.9 Formation mechanism affects hydrogel network structure: schematic representation of: 
formation of a hydrogel of hyaluronic acid in water (top); complex HA-Gd-DTPA 
structure (middle); crosslinked hydrogel network containing the contrast agent (bottom).
 ....................................................................................................................................... 55 
Figure 3.10 Relaxation enhancement induced by water-mediated HA/Gd-DTPA interactions. ....... 58 
Figure 4.1 (A) Relaxivity values r1 determined at magnetic field strengths of 3T for different set of 
HA-NPs with respect to free Gd-DTPA in water. (B) Longitudinal relaxation rate (1/T1) 
versus Gd-DTPA concentration for free Gd-DTPA in water and for HA-NPs at different 
polymer concentrations loaded with Gd-DTPA. (C) T1-weighted images of Gd-DTPA, 
unloaded (used as control) and HA-NPs at different polymer concentrations loaded with 
Gd-DTPA. All samples are imaged at 3T, 25°C, using standard spin echo (SE) sequence. 
(D) Distribution of longitudinal relaxation times of (T1) of 200 μM Gd-DTPA in water 
(squares), unloaded 0.25% HA-NPs (circles) and 0.25% HA-NPs loaded with 200 μM 
Gd-DTPA (triangles). ..................................................................................................... 75 
  
 
 
 
 
 
Figure 4.2 NMRD profiles showing relaxivity of Gd-DTPA in water (squares), unloaded 0.25% HA-
NPs (circles), Gd-loaded 0.25% HA-NPs at 25°C (triangles) and 37°C (flipped triangles).
 ....................................................................................................................................... 77 
Figure 4.3 Swelling behaviour and hydrogel parameters of cHANPs. (a) Swelling ratio of of Gd-
DTPA loaded cHANPs versus time at different DVS concentrations obtained according 
to the first (DVS in middle channel) or the second crosslinking scenario (DVS in side 
channels). (b) and (c) Swelling ratio (-●-) and mesh size (-■-) of Gd-DTPA loaded 
cHANPs versus crosslink density after 48 hours in water. d) and e) FE-SEM images of 
Gd-DTPA loaded cHANPs in water at 0.8% DVS (middle channel) and 4% DVS (side 
channels), respectively. (f) 15° C tilted FE-SEM image of Gd-DTPA loaded cHANPs at 
4%. ................................................................................................................................. 81 
Figure 4.4 In vitro MRI and effect of the Hydrodenticity. (a) Longitudinal relaxation rate (1/T1) 
versus Gd-DTPA concentration for (-▲-) free Gd-DTPA in water and for Gd-DTPA 
loaded cHANPs at different crosslink densities (-●- 7.6*10-4 and -■- 4.6*10-4 mol/cm3), 
showing a relaxivity of 3.9 mM-1s-1, 14.09 mM-1s-1 and 48.97 mM-1s-1 respectively. (b) 
Longitudinal relaxation time distribution for cHANPs at different crosslink densities. (c) 
Bar chart of longitudinal relaxivity (gray columns) and mesh size (blue columns) values 
for cHANPs at different crosslink densities. (d) Mesh size versus crosslink density (-■-) 
and corresponding relaxivity values (-▲-) along with a graphical representation of 
cHANPs’ polymer network at different mesh size values. ............................................. 83 
Figure 4.5 Hydrodenticity to enhance relaxivity. Schematic illustration of an improved diagnostic 
window in which it is possible to obtain a medical device for clinical use in the MRI field 
able to overcome the limitations related to the use of commercial CAs such as low 
relaxivity, limited acquisition time and reduced tissue specificity. ................................ 87 
Figure 4.6 Representation of hydrodynamic flow focusing within microfluidic chip. Middle and side 
streams include two different polymers that leads to NPs formation through an ionotropic 
gelation via CS-TPP crosslinking followed by HA-CS complex coacervation. ............ 91 
Figure 4.7 a) Tests carried out from Callawaert studies in batch with a 6 to 1 CS: HA ratio and flow 
rate ratio equal to 0.5 using compounds concentrations 1/400 compared to Callawaert 
ones (CS 2.5 mg/mL; HA 0.8 mg/mL; TPP 1.2 mg/mL). b) CS= 0.05 mg/mL. c) CS = 
0.1 mg/mL. d) CS=0.2 mg/mL. SEM images reveal that, changing CS concentration but 
using the same flow rate and CS: HA ratio, obtained coacervate shows a considerable 
size and polydispersity reduction when CS concentration grows. ................................. 92 
Figure 4.8 a) graphic trend of NPs size for different CS: HA ratio shows a higher standard deviation 
at 3.125 due to double NPs population development. Independently of high or low flow 
  
 
 
 
 
 
rates, size grows when CS: HA increase although starting nuclei are different. b) SEM 
images CS: HA = 1.56 c) SEM images CS: HA =3.125. ............................................... 93 
Figure 4.9 a) NPs size trend evaluated at three different FR2 (0.05, 0.2 and 0.4) depending on TPP 
concentration (0.012 or 0.003%). b) Histogram that compare NPs size at both high and 
low flow rates at different TPP concentration with a flow rate ratio equal to 0.4. c) SEM 
images at different TPP concentration and flow rate. .................................................... 94 
Figure 4.10 NPs morphological characterization at a) TEM and b) SEM for different CS: HA ratio, 
flow rate ratio and flow rate conditions. Low flow rates allow to modulate morphology 
and obtain different structure as full core, co-precipitates or core-shell. On the other hand, 
higher flow rates use leads to NPs with a mainly core-shell morphological structure. .. 96 
Figure 4.11 Longitudinal relaxation time distribution. Comparison between water and Gd-loaded 
NPs. ................................................................................................................................ 97 
Figure 4.12 Calibration straight line for NPs in the range 0-200 pmol/mL ...................................... 98 
Figure 4.13 Schemes of core-encapsulated gadolinium chelate (CE-Gd) liposomes, surface-
conjugated gadolinium chelate (SC-Gd) liposomes and liposomes containing both 
encapsulated and conjugated gadolinium chelates (Dual-Gd) and T1 relaxation rates (R1) 
of liposomal-Gd formulations for different lipid concentrations. [Adapted from 33: Zhou 
Z, Lu ZR. Gadolinium‐based contrast agents for magnetic resonance cancer imaging. 
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2013;5(1):1-
18.] ............................................................................................................................... 103 
Figure 4.14 a) TEM image and size distribution of chitosan-liposomes obtained at 65% EtOH + 35% 
water in the side channels; b) TEM image and size distribution of chitosan-liposomes 
obtained at 80% + 20% water EtOH in the side channels. ........................................... 119 
Figure 4.15 TEM image and size distribution of chitosan-liposomes obtained at 0 mg/ml (a), 0.1 
mg/ml (b) and 0.375 mg/ml (c) chitosan concentration. .............................................. 120 
Figure 4.16 a) TEM image and size distribution of chitosan-liposomes obtained at 1% acetic acid; b) 
TEM image and size distribution of chitosan-liposomes obtained at 10% acetic acid. 121 
Figure 4.17 a) TEM image and size distribution of chitosan-liposomes obtained with a flow rate in 
the middle channel equal to 1 µL/min; b) TEM image and size distribution of chitosan-
liposomes obtained with a flow rate in the middle channel equal to 3 µL/min; ........... 122 
Figure 4.18 a) TEM image and size distribution of chitosan-liposomes obtained with a flow rate in 
the middle channel equal to 1 µL/min; b) TEM image and size distribution of Gd-loaded 
  
 
 
 
 
 
chitosan-liposomes obtained with a flow rate in the middle channel equal to 1 µL/min.
 ..................................................................................................................................... 123 
Figure 4.19 a) TEM image and size distribution of chitosan-liposomes obtained with a flow rate in 
the middle channel equal to 3 µL/min; b) TEM image and size distribution of Gd-loaded 
chitosan-liposomes obtained with a flow rate in the middle channel equal to 3 µL/min.
 ..................................................................................................................................... 123 
Figure 5.1 Graphical representation of the increased relaxivity obtained by tuning the hydrogel 
composition. ................................................................................................................. 133 
Figure 5.2 Schematic representation of the Gado-Mesh. ................................................................ 134 
Figure 5.3 Nanostructures for enhanced MRI developed starting from the concept of Hydrodenticity.
 ..................................................................................................................................... 135 
Figure 5.4 MatLab simulations of NMRD profiles for different types of contrast agents. ............. 136 
 
 
  
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
TABLES LIST 
 
 
 
 
Table 3.1 Range of water self-diffusion coefficients, D, measured for: (1) distilled water; (2) Gd-
DTPA solutions at different Gd-DTPA concentrations; (3) 0.25 and 5 % w/v HA 
hydrogel solutions at varying crosslinking degrees, i.e. different DVS concentrations. 49 
Table 3.2 Relaxivity enhancement for the investigated polymer/CA systems. ................................. 52 
Table 4.1 Literature review about liposomes for MRI .................................................................... 116 
Table 4.2 Longitudinal relaxation time (T1). ................................................................................... 124 
Table 4.3 Longitudinal relaxation time (T1) after dialysis. ............................................................. 124 
 
 
  
  
 
 
 
 
 
 
 
  
 
 
 
 
 
1 
 
 
ABSTRACT 
 
 
 
 
Magnetic Resonance Imaging (MRI) represents the first-line diagnostic imaging 
modality for numerous indications. It is a clinically well-established, non-invasive 
technique providing three dimensional whole body anatomical and functional 
imaging. It takes advantage of the magnetic properties of water protons present in 
the body and their tissue-dependent behaviour. High magnetic fields (1.5 T and 
above) are clinically favoured because of their higher signal-to-noise ratio, capability 
for MR spectroscopy, and other forms of functional MRI, high speed imaging, and 
high resolution imaging. 
Signal intensity in MRI is related to the relaxation rate of in vivo water protons and 
can be enhanced by the administration of a contrast agent (CA) prior to scanning. 
These CAs utilize paramagnetic metal ions and enhance the contrast in an MR image 
by positively influencing the relaxation rates of water protons in the immediate 
surroundings of the tissue in which they localize. Among different CAs, Gadolinium 
contrast medium is used in up to 30% of MRI scans and the most clinically-used 
MRI. However, Gadolinium (Gd), like most of the clinically-used CAs, is 
characterized by a relaxivity well below its theoretical limit, lacks in tissue 
specificity and, in addition, it causes heavy allergic effects and serious 
nephrotoxicity. 
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In this framework, Port et al. have reported that the rigidification of MRI CAs, 
obtained through covalent or non-covalent binding to macromolecules, could be 
favourable to an increase in relaxivity of the metal-chelate. Later, Decuzzi et al. have 
proved that it is possible to modify through the geometrical confinement the 
magnetic properties of MRI CAs by controlling their characteristic correlation times 
without the chemical modification of the chelate structure. Furthermore, Courant et 
al. have highlighted the capability of combined hydrogels to boost the relaxivity of 
Gd-based CAs. 
Despite several experimental studies addressed in this field, a comprehensive 
knowledge of the mechanisms involved in the relaxation enhancement due to the 
entrapment of CAs in polymer-based architectures is still missing. In particular, the 
role played by the water at the interface between polymer chains and MRI CAs has 
not been fully investigated and could lead to the availability of tailored models that 
accurately describe these novel complex systems. 
 
In this work, we aim to demonstrate that a more in-depth knowledge about the 
interference between macromolecules and MRI CAs and an understanding of their 
physicochemical properties can significantly to impact in the design strategies of the 
nanostructures and, consequently, to overcome the limitations of clinically used MRI 
CAs, particularly linked to the low relaxivity. In this perspective, it is of primary 
importance to study the main phenomena involved in the formation of polymer 
matrices and how their properties can influence the relaxivity of MRI CAs. 
For this reason, we proposed a general strategy based on formation of 
nanostructures for boosting the efficacy of commercial Gd-based CAs by using FDA 
approved biopolymers, providing also tissue specificity and reduced nephrotoxicity. 
Indeed, we want to take advantage not only by the use of nanotechnologies for 
enhanced MRI but only by their capability to reach a specific target and to 
accumulate only in the site of interest. 
 
The implemented strategy has consisted in the control of the relaxometric 
properties by tuning the water dynamics, the physicochemical interactions and, 
therefore, the polymer conformation. 
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Effectively, we primary investigated, in bulk, the impact of hydrogel solutions on 
the relaxometric properties of commercial CAs, highlighting the key role of hydrogel 
structural parameters (mesh size and crosslink density) in the relaxation 
enhancement. In this part, chemical and thermodynamic interactions involved in the 
complexation between biopolymers and CAs have been investigated through 
Isothermal Titration Calorimetry. Furthermore, characterizations of water dynamics 
and mobility and measurement of the relaxometric properties in hydrogel solutions 
containing CAs have been carried out by NMR and Time-Domain relaxometer. 
 
The main outputs were summarized in a concept called Hydrodenticity and defined 
as the equilibrium between the water osmotic pressure, the elastodynamic forces of 
the polymer chains and the hydration degree of the CA which is able to increase the 
relaxivity of the CA itself. Indeed, hydrogel nanostructures made of hydrophilic 
polymer chains held together by chemical or physical crosslinking, have the ability 
to swell in water, forming elastic gels that retain a large quantity of fluid in their 
mesh-like structures. The presence of hydrophilic polymer interfaces and the control 
of water behaviour in hydrogels play a fundamental role in the relaxation 
enhancement of the Gadolinium-based CAs by influencing the characteristic 
correlation times defined by the theory of Solomon and Bloembergen. 
Then, starting from the acquired knowledge, we moved to observe the role of 
Hydrodenticity in the design of biopolymer nanostructures for enhanced MRI.  
 
For the nanostructures’ synthesis, we used two different processing techniques: (1) 
High Pressure Homogenization; (2) Microfluidic Flow Focusing. These techniques 
were selected because of their ability to control process parameters enabling the 
tuning of the interaction between the biopolymers and the CA. Indeed, by easily 
adjusting concentrations, pressure of the Homogenizer and/or flow rates of the 
Microfluidic platform, we can modulate the crosslinking degree of the 
nanostructures and tune their hydrophilicity, size, shape and surface charge, 
impacting on the relaxometric properties. 
These approaches allow us to load MRI CAs into functional nanostructures and 
obtain nanocarries with tunable relaxometric properties. 
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The powerful aspect and the novelty of our approach lies in the definition of 
Hydrodenticity and in its application to several architectures, biopolymers, lipids and 
mixture of them., preserving the main properties of nanoparticles for drug delivery. 
As future perspective, the nanostructures can also be engineered to carry more than 
one agent, accumulate in specific tissues or to act as probes for simultaneous 
diagnosis and therapy (theranostic or multimodal imaging agents), thereby 
facilitating targeted treatments and precision medicine. 
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STRUCTURE OF THE THESIS AND 
IMPLEMENTATION STRATEGY 
 
 
 
 
  
 
 
 
 
 
6 
 
The PhD Thesis is structured as follows: 
1. CHAPTER 1: State of the Art. We examined the literature about contrast 
agents for MRI with specific focus on their mechanisms of action, on their 
efficacy, i.e. the relaxivity, and on the strategies currently used by 
researchers and industries to improve the performances of the already used 
contrast agents. In this perspective, the crucial role of hydrogel matrices in 
enhancing the relaxometric properties of Gd-based CAs has been widely 
recognised. However, despite the considerable efforts made towards the 
improvement of GdCAs through macromolecules and hydrogel 
nanostructures, a fundamental understanding of the energetic and 
thermodynamic contribution capable to boost the efficacy of the CAs by 
using hydrogels, which could potentially become advanced nanostructure 
for MRI, is still missing. Besides, only few strategies to produce 
biocompatible nanostructures with enhanced relaxivity using biopolymers 
are available. 
 
2. CHAPTER 2: Aim of the Work. In this section, the aim of the Thesis is 
presented and contextualized in light of the already presented State of the 
Art. 
 
3. CHAPTER 3: Interaction between biopolymers and contrast agents: 
definition of the Hydrodenticity. In this section, we investigate changes 
in the relaxivity of Gd-DTPA in different biopolymer solutions (hyaluronic 
acid was chosen as a model biopolymer) by varying both the polymer 
concentration used and the structure of the polymer matrix (crosslinked and 
non-crosslinked). We show isothermal calorimetry and NMR 
measurements performed to characterize the thermodynamic properties and 
diffusion behaviour of the polymer/Gd-DTPA solutions. We identify the 
best conditions that boost CAs’ relaxivity and understand how to tune 
polymer structures to reach these favourable conditions. We point out that 
the balanced water-mediated interplay between hydrophilic biopolymers 
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and CAs is significant in determining both the arrangement of the polymer 
chains in solution and the CA’s relaxivity. On the basis of this theoretical 
considerations, the concept of Hydrodenticity, defined as the equilibrium 
between elastodynamic forces of the hydrogel network and the water 
osmotic pressure and hydration degree of the CA responsible for the 
relaxivity enhancement, is introduced and discussed. The fundamental 
thermodynamic concepts here highlighted can be transferred to the nano-
scale and applied to develop high effective MRI nanoprobes. 
 
4. CHAPTER 4: Application of the Hydrodenticity to the design of 
nanostructures for enhanced MRI. 
a. Nanostructures by High Pressure Homogenization. Using the 
acquired knowledge on the interactions between biopolymers and 
MRI CAs, we bring it to the nano-scale. We use the high pressure 
homogenization to synthetize crosslinked hyaluronic acid 
nanoparticles entrapping the Gd-DTPA. The obtained formulation 
showed an increase in the relaxivity far higher than what was 
expected from the experiments in bulk systems. The structure-
function relationships nanoparticles is studied through the 
Inductively coupled plasma mass spectrometry (ICP-MS) to test the 
loading capability and through the Fast Field Cycling NMR 
relaxometry to measure the nuclear magnetic relaxation dispersion 
(NMRD) profiles and test the relaxivity of the nanostructures in the 
high magnetic field region. Scanning and Transmission Electron 
Microscopy (SEM and TEM) along with Dynamic Light Scattering 
(DLS) are also used to carry out the morphological and structural 
characterization. 
b. Nanostructures by Microfluidics. To better tune the 
nanostructure’s characteristics, a microfluidic platform is used to 
produce the nanoparticles. Three different types of nanostructures 
are designed and synthesized: (1) crosslinked HA nanohydrogels; 
(2) HA-CS coacervated nanoparticles; (3) hybrid polymer-lipid 
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nanostructures. We show that by varying the composition of the 
nanostructures and its structural properties it is possible to tune the 
relaxivity of the overall system. The microfluidic platform allows a 
fine and continuous control over the nanostructures’ characteristics 
by changing the process parameters. NMR and ICP-MS are used to 
test the relaxometric properties of the nanoparticles. Scanning and 
Transmission Electron Microscopy (SEM and TEM) along with 
Dynamic Light Scattering (DLS) are also used to carry out the 
morphological and structural characterization. 
 
5. CHAPTER 5: Conclusion and future outlook. The achieved results 
demonstrate that the relaxivity of Gd-based CAs varies in presence of 
polymer matrices. The relaxivity can be tuned by controlling the 
concentration, composition and structural properties polymer networks. 
This capability is enhanced at the nano-scale. Therefore, Gd-loaded 
nanoarchitectures can perform differently in terms of relaxivity by tailoring 
their structural parameters. A draft of a preliminary predictive model that 
describes the polymer-CA systems is implemented and it is today under 
development. Such a model could provide a versatile and helpful tool to 
study, control and properly design new structures obtained through the 
combination of polymers and metal-chelates, paving the way to the 
implementation of a library containing different biopolymer-CAs 
combinations with improved relaxometric properties and potentially 
leading to a new generation of nanostructured CAs. 
 
6. APPENDIX: Supporting Information and Synthesis of the 
nanostructures. In this section, the materials and methods adopted to 
synthesize the nanostructures presented in Chapter 4 are presented. In 
addition, all the supporting figures, tables and data are also available in this 
section. 
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1.1. NANOMEDICINE 
In the field of material science, the prefix “nano” is used to describe materials that 
have structural components smaller than 1 µm in at least one dimension. At the 
nanometer scale, materials are comparable to atoms and molecules. The creation and 
utilization of these materials in the biotechnology take the name of 
nanobiotechnology and its application to the medicine field is called nanomedicine 
1. Nanomaterials for medicine have a number of applications in several disciplines, 
such as oncology, cardiology and neurology, because pathological and physiological 
processes occur at level of cells 1,2. 
In particular, nanoparticles (NPs) have proved to be new promising nano-scaled 
structures for improved detection, treatment and prevention of several diseases. 
Indeed, NPs have novel physicochemical properties with a considerable impact on 
delivery of drugs and agent, from the molecular to the systemic level. NPs’ properties 
influence their behaviour in vivo and consequently their therapeutic and/or diagnostic 
efficacy. For this reason, it is crucial in the design of NPs to know what the main 
characteristics of a NP are: 
 Size 
 Surface properties (charge and functionalization) 
 Shape 
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 Composition 
 Purity 
 Stability 
 Biological environment (for example pH) where NPs need to be applied. 
Surface charge and shape of nanoparticles are crucial in extravasation, in interstitial 
transport and in targeting, while size affects circulation time in bloodstream, in renal 
clearance and can be optimized for each tumour. All these properties play an active 
role from determining circulation of NPs in the bloodstream to modulating cellular 
responses 3. 
NPs’ design and production present some issues that still need to be overcome. The 
first problem concerns the size distribution of the NPs; indeed, high polydispersity 
can compromise the pharmacokinetics and the efficacy of the treatment. 
Furthermore, NPs need to be biocompatible and low toxic in vivo. In addition, 
sterility conditions must be preserved through all the production process 4. 
To understand better NPs’ advantages, it is important to know those differences 
between tumour and normal tissues that can influence the delivery of diagnostic or 
therapeutic agents. In fact, during their travel toward the target, NPs flow in the 
bloodstream, overcome vessel walls and penetrate through interstitial space to reach 
target cells. 
In tumour tissues, these aspects become abnormal: tortuous and leaky vessels, 
heterogeneous blood flow, lack of functional lymphatic vessels, vascular 
hyperpermeability owing to vessel walls irregular structure, a uniformly elevated 
interstitial fluid pressure (IFP) that reduces pressure gradients across vessel wall and 
so convective transport, a dense ECM with high collagen-fibres concentration that 
hinders diffusion (Figure 2.1) All these issues can be resolved using engineered 
nanoparticles 5,6. 
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Figure 1.1 Schematic illustration of EPR effect. Image adapted from 4: Yu, X.; Trase, I.; Ren, M.; 
Duval, K.; Guo, X.; Chen, Z., Design of Nanoparticle-Based Carriers for Targeted Drug Delivery. 
2016; Vol. 2016, p 1-15. 
To obtain a desirable effect, it is necessary the overpassing  a series of obstacles 
which can reduce bioavailability and therapeutic or diagnostic efficacy. 
Macrophages and monocytes of the reticuloendothelial system (RES) are highly 
efficient at removing NPs through opsonization. Digestive enzymes and low pH 
contribute to the rapid degradation of NPs, while renal system rapidly filter NPs with 
diameter under 10 nm. Therefore, it is important to understand all factor affecting 
biodistribution to develop successful nanostructured drug delivery systems. 
 
1.1.1. NANOPARTICLES FOR THERAPY 
Therapeutic NPs are used for different goals: among them, targeting and adhesion 
into atherosclerotic lesions within the cardiovascular system, heart therapy thanks to 
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target antigen characteristic of infarcted myocardium, treatments of lung diseases 
through the circulation and/or respiratory tract and many others but the main and 
most widespread applications are related to cancer therapy 7. In fact, cancer cells can 
through a genetic mutation that lead them to grow uncontrollably. The aim of 
therapeutic agents is to bring a sufficient drug payload to kill cancer cells but, at the 
same time, preserve normal tissues 5,6. Current treatments like radiotherapy or 
chemotherapy are not able to damage specifically only target cancer cells and lead 
to undesirable side effects. 
Many chemotherapeutic drugs, such as paclitaxel or doxorubicin, can be loaded 
into NPs and it is possible to modify NPs’ properties to use them through three 
different targeting modalities: 
 Passive targeting: use natural properties and processes to drive therapeutic 
agents to the target site. The most used is EPR effect that is influenced mainly 
by the size. Increased permeability and insufficient lymphatic drainage lead 
to therapeutic accumulation. Passive targeting requires a NPs circulation time 
of at least 6 hours NPs between 100-200 nm accumulate in tumour target 
through leaky tumour vessels. The surface charge of the NPs is another 
fundamental property. Negative charged NPs circulate longer in the 
bloodstream but they are less taken up by cancer cells compared to positively 
charged NPs 4,8–10. 
 Active Targeting: receptor-specific ligands on NPs surface can promote drug 
delivery toward diseased cells or tissue. High accumulation at the diseased 
site and uptake selectivity can be achieved using ligands that bind with 
overexpressed molecules on cancer cell. Antibodies are most employed 
because of their high specificity and availability; small molecules like folic 
acid can be used for their small size, stability and reproducibility 4,8–10. 
 Physical Targeting: external stimuli like magnetic fields, temperature or 
radiation can be used to drive NPs until target cancer cells. It is even possible 
the use NPs as means to convert external energy to heat and so kill cancer 
cells 4. 
To understand and predict how the dynamics and behaviour of NPs vary according 
to their physicochemical properties during their route through the bloodstream, 
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theoretical and mathematical models can be used (continuum, molecular and 
stochastic modelling) 4,8–10. 
 
1.1.2. NANOPARTICLES FOR DIAGNOSTICS 
Diagnostic agents allow obtaining images about a specific investigated body area 
to achieve information on tissues’ condition. 
The goal of using NPs to deliver diagnostic agents is the increase of specificity, i.e. 
the ability to concentrate the agent only in the target site, preserving surrounding 
tissues and allowing better diagnosis. 
Some of the main diagnostic modalities are examined in the following paragraphs. 
A special attention will be given to the Magnetic Resonance Imaging (MRI), which 
is the main focus of this thesis. 
1.1.2.1. Optical imaging 
Optical imaging uses visible light as vehicle for medical investigation. It mainly 
uses photons and their interaction with matter to obtain detailed images of organs 
and tissues. 
Optical imaging significantly reduces patient exposure to radiation by using non-
ionizing radiation, which includes visible, ultraviolet, and infrared light. It is 
particularly effective for soft tissue and permits to investigate different properties 
using different light colors. 
Near-infrared imaging (NIR) is highly used because NIR light penetrates deeper 
into and out tissues than other wavelengths of visible spectrum. NIR used contrast 
agents as organic agents suffer from rapid photobleaching, instability, biological and 
chemical degradation and tend to aggregate. 
These aspects lead to reduce emission signals and often confined agents in 
untargeted tissues. NP-based agents have strong stable signal in the NIR region, 
increased lifetime, lower degradation and cytotoxic effect. 
Examples of NPs for NIR imaging are semiconductor quantum dots, gold 
nanoshells and dye encapsulating nanoparticles 11. 
Chapter 1. State of the Art 
 
 
 
 
 
 
15 
1.1.2.2. PET 
Positron emission tomography (PET) is a nuclear medicine technique that provides 
functional information through positron emitting radionuclides employment. 
Positron is a particle with the same mass and charge of electron but different sign. 
Collision between positron and electron causes a reaction called “annihilation” that 
leads to formation of two 511 kV gamma radiations with an angle of 180° between 
them. In a narrow temporal window around 10 nanoseconds, PET scintillation 
crystals measure line that link two detectors including in coincidence event. 
This line is called Line of Response (LOR) and identify annihilation. PET permits 
tracer distribution visualization in body but limitation is given by absence of 
anatomical information. Employed radionuclides are natural radioactive isotopes as 
carbon-11, oxygen-15 or fluorine-18 like elements that constitute biological matter. 
Therefore, they can be bound to molecules to form radioactive tracer and to study 
directly biological and physiological processes. 
Advantages of using NPs for PET lie in the possibility to use targeting ligands, alter 
pharmacokinetics and increase PET radionuclides quantity and type 12. 
 
1.2. MAGNETIC RESONANCE IMAGING 
The Magnetic Resonance Imaging (MRI) represents the first-line diagnostic 
imaging modality for numerous indications. During the past 30 years, it has emerged 
as an established technique for preclinical imaging and clinical diagnosis 13–15. 
It is a clinically well-established, non-invasive technique providing three-
dimensional whole body anatomical and functional imaging 16,17 by using the 
magnetic properties of water protons present in the body and their tissue-dependent 
behavior. High magnetic fields (1.5 T and above) are clinically favoured because of 
their higher signal-to-noise ratio, capability for MR spectroscopy 18, and other forms 
of functional MRI, high-speed imaging, and high-resolution imaging. 
Although MRI enables visualization of tissues at high spatial resolution without 
using ionizing radiation or invasive procedures 19, it is largely limited because it lacks 
the proper sensitivity, which is significantly lower than other imaging modalities, 
such as PET/SPECT 20–23. Performances of MRI examinations can be improved by 
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using Contrast Agents (CAs), which allow differentiating tissue types that would 
otherwise be indistinct 24–26. 
 
1.3. CONTRAST AGENTS FOR MRI 
1.3.1. ADVANTAGES IN USING CONTRAST AGENTS 
MRI Performances of the CAs are well-described by the “ relaxivity”, defined as 
the rate of change in longitudinal or transverse relaxation times of the water protons 
per mM concentration of metal ions and determining the enhancement of the image 
contrast 27. 
The presence of the CA causes a significant increase in the relaxation rate of the 
water proton nearby paramagnetic ions, thereby adding details to the anatomical 
resolution. Thanks to its very high magnetic moment, Gadolinium (Gd) is the most 
frequently used metal ion for MRI. 
However, owing to the toxicity of free Gd ions 21, which can induce nephrogenic 
system fibrosis (NSF), Gd-chelates, such as Gd-DTPA (Magnevist, Schering AG) 28, 
are commonly used in contrast-enhanced examinations 20,26,29. 
 
1.3.2. PHYSICS OF CONTRAST AGENTS 
Starting from the Solomon–Bloembergen–Morgan (SBM) theory 30, the physics of 
CAs is described by a set of physicochemical parameters characterizing the 
fluctuating magnetic dipole created by the paramagnetic ion. In  detail, according to 
the SBM model, the metal complex can be viewed as having separate coordination 
spheres 31: the Inner Sphere (IS), which consists of water molecules directly 
coordinated to the metal ion, and the Outer Sphere (OS), which is a less organized 
structure consisting of bulk water molecules diffusing in the near environment of the 
metal complex. 
In some cases, a Second Sphere (SS) contribution is taken into account, which is 
related to water molecules hydrogen bonded to the metal complex 32. Each of the 
coordination mentioned above spheres has its characteristic parameters. IS 
parameters include the number of labile water molecules coordinated to the metal 
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ion (q), the residence time of the coordinated water molecule (τM), which in turn 
determines the rate of the coordinated water molecule exchanging with the bulk, and 
the rotational correlation time (τR), which is how quickly the contrast agent is 
tumbling in solution. Conversely, OS parameters include the translational diffusional 
time (τD), which represent the diffusion of water molecules in the bulk near to the 
Gd complex. 
 
1.3.3. CONTRAST AGENTS LIMITATIONS 
Currently, more than 35% of all clinical MRI scans utilize the injection of clinically 
approved Gd-based CAs (GdCAs) intravenously 19,20. 
Despite this widespread use, most of the clinically-used CAs are characterized by 
poor effectiveness in the high magnetic fields region (3 T and above), mainly limited 
by their concentration (mM) and relaxivity (r1, mM
−1s−1), which is clinically favored 
because of its higher signal-to-noise ratio and high-resolution imaging. MRI CAs 
also lack of tissue specificity and can cause heavy allergic effects, serious 
nephrotoxicity 33–35. 
Some concerns arise also from long scan time and rapid renal clearance, which 
significantly reduce the time window for clinical imaging acquisitions 34,36,37. 
Furthermore, McDonald et al. 38 have recently reported results about intracranial Gd 
deposition after repeated intravenous administration of CAs even if these signal 
intensity changes are not specific and can be seen with several other pathologic 
conditions. 
In these perspectives, the possibility to have a CAs that could work at low 
concentration but without giving over its signal intensity and, therefore, positive 
contrast effect is of great interest. 
Furthermore, the poor relaxivity of commercially available CAs, much below its 
theoretically maximal value required to obtain an accurate diagnosis at safe 
administration dosage 39 has led to to a growing interest in studying different types 
of Gd derivatives and to the development of novel macromolecules conjugating CAs 
13,40–47. 
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1.4. POLYMERS AND CONTRAST AGENTS 
1.4.1. ADVANTAGES IN COMBINING POLYMERS AND CONTRAST AGENTS 
As previously reported in the SBM theory, characteristic parameters of the metal 
chelate can be physically or chemically tuned and are of primary importance in the 
design of new CAs 48. In particular, the Gd-chelator determines the number of 
coordinated water molecules (q) and the water exchange rate (kex), which is the 
inverse of the residence time τM. Moreover, decreased τD and τR, which can be 
obtained, for instance, through the binding of the metal chelate with large 
macromolecules, generally yield increased relaxation rates at low magnetic fields 
(<1.5 T) 35. 
It is already known that molecular motion, size, rigidity and possible binding 
between Gd-chelates and other macromolecules may induce changes in relaxivity 34. 
Furthermore, polymer architecture and properties can strongly affect the MRI 
enhancement 49–51. Among them, crosslinked hydrophilic biopolymers networks 
(hydrogels) have been investigated because of their biocompatibility, 
biodegradability, low immunogenicity, low toxicity, prolonged circulation time 52 
and, not least, high affinity to water and swelling properties 50,53–56. 
Several studies, indeed, have demonstrated that the polymer architecture plays a 
crucial role on different parameters, such as the water exchange time and the 
rotational correlation time, thereby influencing the CA’s relaxivity 49. In particular, 
polymer properties, such as the rigidity, strongly affects the MRI enhancement 50. 
Internal rigidification, obtained for example by ionic interactions 57,58, can retard 
rotational motion of the complex and enhance the relaxivity more than flexible 
polymers 52,59. 
Crosslinked polymers, like nanogels and hydrogels, have significant applicability 
to the design of switchable CAs, because an increasing of the crosslinking degree 
can induce relaxivity enhancement by restricting molecular tumbling while 
maintaining the switching property 60 and allowing facile access of water throughout 
the structure, which is a key feature in the development of MRI contrast agents 61,62. 
In details, hydrogels 53,56,63,64 show these three-dimensional networks, made of 
hydrophilic polymer chains held together by chemical or physical crosslinking, they 
are glassy in the dry state but have the ability to swell in water, forming elastic gels 
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that retain a large quantity of fluid in their mesh-like structures 65. The presence of 
hydrophilic polymer interfaces and the control of water behaviour in hydrogels play 
a fundamental role in the relaxation enhancement of the Gadolinium-based contrast 
agents by influencing the characteristic correlation times defined by the theory of 
Solomon and Bloembergen 30. 
 
1.4.2. LITERATURE OVERVIEW 
The extensive research on nano-engineered systems and polymer-based 
nanocomposites 54,55,66–74 has led to significant advances also in the field of MRI 
50,52,72,75–77. In particular, some recent studies have shown that nanoconstructs can 
improve CAs’ relaxivity and many efforts have been devoted to the development of 
polymer-based carriers for MRI CAs with particular reference to Gadolinium (Gd) 
chelates, which are the most commonly clinically used agents 49,75,78–82. 
As reported by Port et al. 51, rigidification of Gd-based CAs would be favourable 
to an increase in the relaxivity of the metal chelate since the presence of the ligand 
around the Gd ion induces a shortening of the residence lifetime of the inner-sphere 
water molecules (τM) 51,83,84. In addition, they hypothesized that the presence of a 
rigid coordination cage of a chelate should limit its intramolecular conformational 
motions, which distorts the ligand field at the metal centre due to solvent molecules 
collisions, thus influencing the electronic relaxation times (τS1 and τS2) 51. To assess 
the rigidification strategy, Port synthetized a constrained derivative of Gd-PCTA12, 
Gd-cyclo-PCTA12, in which one ethylene bridge connecting two nitrogen atoms of 
the triamine block is replaced by a cyclohexylene bridge, and the impact of 
rigidification was studied by comparing the physicochemical and relaxometric 
properties of both gadolinium MRI contrast agents, Gd-PCTA12 and Gd-cyclo-
PCTA12. 
Other experimental approaches studied by Decuzzi et al. 27,85,86 proved that 
geometrical confinement could limit the mobility of water molecules and thereby 
enhance the relaxation response of Gd-based CAs without its chemical modification. 
In particular, they observed that nanometric pores of silica microparticles increase 
the rotational correlation time (τR) of Gd-DTPA (inner-sphere effect), which cannot 
tumble freely being adsorbed on the walls of the 100 nm pores. At the same time, it 
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also increases the diffusion correlation time (τD) for water molecules (outer-sphere 
effect), which are geometrically confined and forced to interact longer with Gd-
DTPA adsorbed to the inner pore surface 27. Through the confinement strategy, a 
poor increment of the relaxivity can be obtained without modifying the chemical 
structure of the CA. 
As advancement of the geometrical confinement, in some more recent works, 
Courant et al. 80 and Callewaert et al. 87, showed that biocompatible hydrophilic 
hydrogels can be exploited to produce high water content nanoparticles (NPs) 
encapsulating the metal chelate. Inside the hydrogel, which creates a favourable 
aqueous environment for Gd-based CAs 52,75,88–90, the rotational motion of the 
encapsulated CA (Gd-DOTP, Gd-DOTA and Gd-DTPA) is restricted and its 
magnetic properties are amplified. 
Courant et al. 80 developed a polymeric system based on the integration of Gd-
chelates (Gd-DOTA) into nanoparticles to improve the relaxivity for MRI 
applications. Because of its hydrophilic nature, the encapsulation of (Gd-DOTA) was 
made in a hydrophilic and biocompatible polymer matrix obtained by interaction of 
chitosan (CH) 89 and hyaluronic acid (HA) 52,75,88 that forms a favourable aqueous 
environment for Gd-based CAs. Furthermore, inside the hydrogel, CA rotational 
motion is restricted and the magnetic properties of the encapsulated CA are 
amplified, without modification of chemical structure of chelate. 
Callewaert et al. 87 showed that Gd-loaded CH nanohydrogel relaxivities can be 
tuned according to the Gd-based CA and the hydrogel matrix composition. They 
observed that, since the crosslinking degree could limit water access and mobility 
inside the nanogels, this can be counterbalanced by the association of a second 
hydrophilic polymer (HA) to constitute high-water content nanoparticles. 
In our recently published works 90,91, we have initially analysed the impact that 
hydrophilic biopolymer networks have on the relaxivity of Gd-based CAs and 
explained the role of the water in the interaction between polymers and metal 
chelates. This concept, called “Hydrodenticity”, has been the subject of further 
investigations as reported by Russo et al. 92. In a still previous work published by 
Russo and co-worker 93, crosslinked Hyaluronic Acid NanoParticles (cHANPs) 
containing a Gd chelate (Gd-DTPA), are synthesized through a microfluidic platform 
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that allows a high degree of control over particle synthesis, enabling the production 
of monodisperse particles as small as 35 nm for MRI applications. The relaxivity 
(r1) achieved with the cHANPs is 12-times higher than Gd-DTPA. Within cHANPs, 
the properties of Hydrodenticity can be modulated to obtain desired mesh size, 
crosslink density, hydrophilicity and loading capability, as reported by Russo et al. 
92,94. Moreover, they proved that an increase of the crosslinking degree of biopolymer 
can induce the enhancement of relaxivity by restricting molecular tumbling while 
maintaining the switching property and allowing easy access of water throughout the 
structure, which is a key feature in MRI CAs. 
The possibility to adopt a unique platform to tune the hydrogel structural 
parameters and, consequently, increase the relaxivity of a metal chelate without any 
chemical modification, could have a great impact on the clinical outcome. In fact, 
thanks to their improved relaxometric properties, cHANPs could ensure a brighter 
contrast with a lower amount of metal chelate, thus enabling the potential reduction 
of the administration dosage as approved for clinical use. 
In a further work 95, we reported an efficient way to produce Hybrid Core-Shell 
(HyCoS) NPs composed of a Chitosan core and a shell of Hyaluronic Acid (HA) 
with improved relaxometric properties (up to 5-times than the commercial CA). 
Subsequently, the same nanosystem is used to develop a new nanoprobe for 
simultaneous Positron Emission Tomagraphy (PET)/MRI acquisitions as reported in 
our more recent publication 96. 
Based on the above reported works, it has been finally demonstrated that the 
polymer architecture affects some characteristic parameters of the metal chelate and 
tunes its relaxometric properties 30,49,80,81,85,92. 
Moreover, it is clear that crosslinked biopolymers can have a significant role to 
overcome the limitations of clinically relevant CAs without their chemical 
modification and as a compound in the design of advanced nanostructures with 
improved safety profile and switchable relaxometric properties. 
Indeed, it is known that the functional properties as well as the swelling behaviour 
of hydrogels are influenced by the hydration degree, which can be likely modulated 
by changing the chemical composition of the system 50,53–56,97,98. 
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1.5. THE NEED FOR NEW POLYMER-BASED CONTRAST AGENTS 
In this perspective, we believe that a more in-depth knowledge about the 
interference between macromolecules and MRI CAs and an understanding of their 
physicochemical properties is necessary to impact in the design strategies of the 
nanostructures and, consequently, to overcome the limitations of clinically used MRI 
CAs, particularly linked to the low relaxivity. To this aim, it is crucial to study the 
main phenomena involved in the formation of polymer matrices and how their 
properties can influence the relaxivity of MRI CAs is performed. 
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2.1. AIM 
Magnetic Resonance Imaging (MRI) is a promising technology in biomedical 
research and clinical diagnosis and provides high spatial resolution without the use 
of ionizing radiation 16,17. Contrast Agents (CAs) are metal ions injected prior MRI 
scanning in the human body to enhance the signal intensity and improve the contrast 
between healthy and pathological tissues 26,34,99,100. Among them, the most 
extensively used CAs in the clinical practice are paramagnetic gadolinium (Gd) 
chelates 101. Despite their widespread use, these Gd-based CAs are limited by low 
sensitivity 49,91,93; therefore, large amount of these paramagnetic agents need to be 
used in order to obtain an appropriate diagnostic contrast 31,102. In many cases, the 
exposure to Gd-based MRI CAs in patients with compromised renal function is 
associated with Nephrogenic Systemic Fibrosis (NSF) 103, a systemic disease that 
can lead to death 104–106. Moreover, recent studies in humans conducted by 
McDonald, Kanda and coworkers 38,107 have revealed that these compounds are 
retained in some tissues (i.e. kidneys, bone, skin and brain) also in healthy subjects. 
In this framework, the opportunity to develop a safer and more effective probe for 
MRI 108,109 starting by clinical approved CAs is a significant and valuable challenge 
110–112. 
Despite several experimental studies addressed in the field of MRI CAs, a 
comprehensive knowledge of the mechanisms involved in the relaxation 
enhancement due to the entrapment of CAs in polymer-based architectures is still 
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missing. In particular, the role played by the water at the interface between polymer 
chains and MRI CAs has not been fully investigated and could lead to the availability 
of tailored models that accurately describe these novel complex systems. 
The Thesis presents a study of the interactions involved in polymer-hydrogel-based 
CAs’ solutions, aiming at understanding the key role of the water as mediating agent 
that acts at the interface between the polymer and the metal-chelate and determines 
both the polymer conformation and the relaxation enhancement. 
The first aim is to investigate the thermodynamic properties of different 
combinations of hydrogels and Cas for Magnetic Resonance Imaging (MRI), to 
understand how the polymer structure can impact on the relaxometric properties of 
the metal chelate. As result of the study, we introduced the novel concept of 
Hyrodenticity, describing the equilibrium, occurring in hydrogel entrapping Gd-
based CAs, between water osmotic pressure, elastodynamic of polymer chains and 
hydration degree of the CA able to enhance its relaxivity. 
Then, we applied the concept of Hydrodenticity to design nanostructures and 
investigate the impact of different nano-architectures on the efficacy of CAs for MRI 
highlighting the key role of hydrogel structural parameters (mesh size and crosslink 
density) in the enhancement of the relaxometric properties of the CAs. 
The nanostructures are made of biocompatible and natural polymers, like 
hyaluronic acid (HA) and chitosan (CS), also combined with lipids in the form of 
liposomes, and are formulated together with with FDA-approved and clinically used 
CAs for MRI without inducing chemical modifications to the CAs. 
Two different processes have been implemented to design the nanostructures: (1) 
High Pressure Homogenization; (2) Microfluidic Flow Focusing. 
Three main goals have been achieved: 
 Definition of the Hydrodenticity: the concept of Hydrodenticity has been 
proposed to describe the complex equilibrium formed by elastic stretches 
of polymer chains, water osmotic pressure and hydration degree of 
Gadolinium-based CAs able to boost the relaxivity of the CAs; 
 Application of the Hydrodenticity to nanostructures: three types of Gd-
loaded nanostructures with increased relaxivity have been obtained 
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without chemically modifying the CA’s structure and biocompatibility: 
(1) crosslinked HA nanohydrogels; (2) HA-CS coacervated 
nanoparticles; (3) hybrid polymer-lipid nanostructures; 
 Development of a preliminary predictive model to describe 
nanostructured CAs based on Hydrodenticity: a preliminary model has 
been implemented in Matlab to fit relaxometric data of different 
nanostructured CAs. 
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Chapter 3.  
 
IMPACT OF BIOPOLYMERS ON 
RELAXOMETRIC PROPERTIES OF 
CONTRAST AGENTS: DEFINITION OF 
HYDRODENTICITY 
 
 
 
 
3.1. SUMMARY OF THE CHAPTER 
Properties of water molecules at the interface between Contrast Agents (CAs) for 
Magnetic Resonance Imaging (MRI) and macromolecules could have a valuable 
impact on the effectiveness of metal chelates. Recent studies, indeed, demonstrated 
that polymer architectures could influence CAs’ relaxivity by modifying the 
correlation times of the metal chelate. 
However, an understanding of the physicochemical properties of polymer/CA 
systems is necessary to improve the efficiency of clinically used CAs, still exhibiting 
low relaxivity. 
In this context, we investigate the impact of Hyaluronic Acid (HA) hydrogels on 
the relaxometric properties of Gd-DTPA, a clinically-used CA, to understand better 
the determining role of the water, which is crucial for both the relaxation 
enhancement and the polymer conformation. To this aim, water self-diffusion 
coefficients, thermodynamic interactions and relaxometric properties of HA/Gd-
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DTPA solutions are studied through Time-Domain NMR Relaxometry and 
Isothermal Titration Calorimetry. 
We observed that the presence of Gd-DTPA could alter the polymer conformation 
and the behaviour of water molecules at the HA/Gd-DTPA interface, thus 
modulating the relaxivity of the system.The effect of the hydration of the hydrogel 
structure on the relaxometric properties of Gd-DTPA is explained for the first time 
and called Hydrodenticity. 
 
3.2. INTRODUCTION 
Investigation of water molecules at the interface between relevant clinical Contrast 
Agents (CAs) for Magnetic Resonance Imaging (MRI) and macromolecules can be 
of great interest to increase the performances of metal chelates. Indeed, most of the 
clinically-used CAs are characterized by poor effectiveness in the high magnetic 
fields region (3 T and above), which is clinically favored because of its higher signal-
to-noise ratio and high-resolution imaging. MRI CAs also lack of tissue specificity 
and can cause heavy allergic effects, serious nephrotoxicity 33–35 and intracranial 
deposition of metal ion after repeated intravenous administration 38. 
The extensive research on nano-engineered systems and polymer-based 
nanocomposites 54,55,66–74 has led to significant advances also in the field of MRI 
50,52,72,75–77. In particular, some recent studies have shown that nanoconstructs can 
improve CAs’ relaxivity and many efforts have been devoted to the development of 
polymer-based carriers for MRI CAs with particular reference to Gadolinium (Gd) 
chelates, which are the most commonly clinically used agents 49,75,78–82. 
In this chapter, we investigate the impact of and hydrogel-CA systems on the 
relaxometric properties of metal chelates to understand better the clear role of the 
water, which mediates interactions and could be responsible for their behaviour in 
solution. Indeed, water is crucial both in the relaxation process and in the polymer 
conformation. On one hand, the magnetic properties of the water protons 
surrounding the CA are fundamental to enhance the CA’s relaxivity. On the other, 
the presence of water molecules can induce changes in the polymer structure through 
polar interactions, hydrogen bonding and osmotic pressure. 
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Among different biopolymer, Hyaluronic Acid (HA) 88 is chosen as model polymer 
due to its hydrophilic nature and established biocompatibility and biodegradability. 
Commercially available Gd-DTPA is selected as the CA due to its widespread use 
in clinical practice 113. It is worth highlighting that both the selected polymer and CA 
are FDA approved and clinically used products 33,114,115. 
First experiments are focused on determining the water self-diffusion coefficients 
in polymer and CA solutions through Time-Domain NMR Relaxometry to observe 
changes in water mobility in the presence of both HA and Gd-DTPA. Self-diffusion 
measurements have already proved especially successful for probing interfacial 
water structure and dynamics near various biological and polymer surfaces 116. 
Intramolecular interactions, as well as entropy costs, can alter the mobility of solvent 
molecules within polymer matrices or in confined environments, with a slowing 
effect on the diffusion 117–119. Moreover, since the relaxation efficiency is mediated 
by translational and rotational diffusion 116, a variation of the water diffusion 
behaviour at the interface between polymer chains and MRI CAs could impact on 
the τD of the complex, thereby influencing the relaxometric properties of the metal 
chelate. 
Isothermal Titration Calorimetry (ITC) is employed after that to investigate 
thermodynamic interactions involved in the mixing of HA with Gd-DTPA. As 
already reported elsewhere 120, molecular interactions are accompanied by some 
level of heat exchange between the interacting system and its surrounding medium, 
which can be evaluated at a constant temperature through the ITC technique. 
Therefore, to investigate interactions between HA and Gd-DTPA, titration 
experiments were performed using a Nano ITC Low Volume calorimeter (TA 
Instruments). Basic principles of ITC measurements have been widely discussed 
elsewhere 120–122. 
Relaxometric properties of HA/Gd-DTPA solutions are investigated by means of 
time-domain NMR relaxometry. The characterization of these systems, obtained 
through the combination of commercial MRI CAs and hydrophilic biopolymers, 
could give an insight into the development of novel hydrogel-based CAs without 
modifying the chemical structure or altering the biocompatibility of the original CA. 
Chapter 3. Impact of biopolymers on relaxometric properties of contrast agents: definition of Hydrodenticity 
 
 
 
 
 
 
38 
In this theoretical framework, the peculiar effect of Hydrodenticity on the polymer 
conformation and the formation of the stable water compartments responsible for the 
enhancement of the MRI signal is introduced and discussed. 
 
3.3. MATERIALS AND METHODS 
3.3.1. MATERIALS 
HA (Bohus Biotech, Sweden) with an average molecular weight of 420000 Da is 
used for the polymer matrix because of its biocompatibility, biodegradability and 
swelling properties. Commercially available Gd-DTPA (Sigma-Aldrich) with a 
molecular weight of 547.57 Da is used since it is a well-known, low-risk CA. Divinyl 
Sulfone (DVS) (Sigma Aldrich) with a molecular weight of 118.15 Da is used as 
crosslinking agent. Milli-Q water is systematically used for sample preparation and 
analysis. 
 
3.3.2. SAMPLE PREPARATION 
Non-crosslinked hydrogel-CA solutions are prepared by dispersing both the HA 
and the Gd-DTPA powders in distilled deionized water and then mixing using 
magnetic stirrer. Different HA concentrations, ranging from 0.1 to 5 % w/v, is 
utilized for the experimentation. For each fixed concentration of HA, Gd-DTPA 
concentration is varied between 0 and 0.2 mM. 
Crosslinked hydrogel-CA solutions are prepared by adding Divinyl Sulfone (DVS) 
to the above-described solutions to crosslink the polymer network chemically. 
Hydrogels are prepared at different HA: DVS ratios (from 1:1 to 1:16). The 
biocompatibility of HA–DVS hydrogels is already confirmed in the literature 123. 
 
3.3.3. ISOTHERMAL TITRATION CALORIMETRY 
Isothermal Titration Calorimetry (ITC) measurements are conducted by filling the 
sample cell (0.7 mL in volume) with an aqueous solution of HA at different 
concentrations (from 0.1 to 0.7 % w/v) and the 50 μL syringe with an aqueous 
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solution of Gd-DTPA at 1.5 mM. Measurements are performed at 25 °C and fixed 
stirring rate of 200 rpm. Fifty injections, each of 1 μL of Gd-DTPA, are delivered in 
intervals of 500 s. Data analysis and processing to provide ITC and enthalpy change, 
ΔH, profiles are carried out using the NanoAnalyze (TA instruments) and the Origin 
Pro 9.1 SRO software (OriginLab Corporation, USA). 
 
3.3.4. RELAXOMETRIC MEASUREMENT 
Relaxation times are measured on a Bruker Minispec (mq 60) bench-top 
relaxometer operating at 60 MHz for protons (magnetic field strength: 1.41 T). The 
acquisitions are performed at 37°C, and before each measurement, the sample is 
placed into the NMR probe for about 15 min for thermal equilibration. Longitudinal 
relaxation times, T1, are determined by both saturation (SR) and inversion recovery 
(IR) pulse sequences. The relaxation recovery curves are fitted using a multi-
exponential model.The solid line represents the linear regression and relaxivity 
values, r1, are calculated from its slope. The longitudinal relaxation rate values, R1, 
defined as the inverse of the longitudinal relaxation time, R1 = 1/T1,s
-1, are plotted 
versus each concentration of CA, measured in mM. Data are treated by a least-
squares method using Origin Pro 9.1 SRO software (OriginLab Corporation, USA). 
Furthermore, the relaxation time distribution is obtained by CONTIN Algorithm. 
The relaxation spectrum is normalized with respect to the CONTIN processing 
parameters. Therefore, the integral of a peak corresponds to the contribution of the 
species exhibiting this peculiar relaxation to the relaxation time spectrum. 
 
3.3.1. NMR SPECTROSCOPY 
1H NMR spectra are recorded at 25 °C with Varian Agilent NMR spectrometer 
operating at 600 MHz to observe chemical interactions between polymer and 
chelating agent (DTPA). The NMR samples consisted of water solution of HA-
DTPA at different molar ratios (HA/DTPA ranging from 0 to 0.5), with 10% v/v 
D2O. 
Diffusion-ordered NMR Spectroscopy (DOSY) are also performed and the z-
gradient strengths (Gz) is varied in 20 steps from 500 to 32500 G/cm (maximum 
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strength). The gradient pulse duration (δ) and the diffusion delay (Δ) are kept costant, 
2 ms for δ and ranging from 7 to 1000 ms for Δ. After Fourier transformation and 
baseline correction, DOSY spectra are processed and analysed using Varian software 
VNMRJ (Varian by Agilent Technologies, Italy) in order to obtain the values of 
water self-diffusion coefficient. 
 
3.3.1. WATER SELF-DIFFUSION COEFFICIENT 
Diffusion measurements of water molecules are carried out on a Bruker Minispec 
(mq 20) bench-top relaxometer operating at 20 MHz for protons (magnetic field 
strength: 0.47 T). A pulsed field gradient spin echo (PFG-SE) sequence 124, with two 
magnetic field gradient pulses of length δ and strength g, and with a delay Δ between 
the leading edges of them, is used to measure water self-diffusion coefficients. The 
self-diffusion coefficient, D, is derived by linear regression of signal attenuation ratio 
curve, a semi-logarithmic plot of the echo attenuation as a function of the tunable 
parameter of the sequence, k = (γgδ)2 * (Δ - δ/3). 
 
3.3.2. DIFFERENTIAL SCANNING CALORIMETRY 
For all measurements the HA/water solution (Mw = 42 kDa) is used. The aqueous 
solutions are prepared in a concentration range of polymer 0.3–0.7% w/v. Next, Gd-
DTPA is added as CA at different molar ratio HA/Gd-DTPA (from 1:0.25 to 1:3) 
and stirred for 12 h. The hydrated polymer samples, with and without CA, are sealed 
at room temperature in a Tzero hermetic pans prior to analysis. DSC measurements 
are performed in a TA Instruments’ Q20TM calorimeter on samples between 5 and 
10 mg. The samples are cooled down from 25°C to -50°C followed by heating scan 
up to 25°C. The same heating and cooling rate are 10°C/min for all runs. Samples 
are tested in triplicate to ensure reproducibility. For DSC and ITC measurements, we 
used low molecular weight HA (42 kDa) to highlight better the energetic 
contributions of different components without exceeding the maximum scale of the 
instruments. 
 
Chapter 3. Impact of biopolymers on relaxometric properties of contrast agents: definition of Hydrodenticity 
 
 
 
 
 
 
41 
3.4. RESULTS 
3.4.1. CHANGES IN POLYMER CONFORMATION INDUCED BY A GD-BASED 
CONTRAST AGENT 
The polymer conformation can be modified by the affinity with the solvent solution 
125,126. Furthermore, the addition of a solute can still induce a change in the polymer 
conformation. In our previous work, we proved that the  relaxivity of CAs can be 
modulated combining them with macromolecules or polymers 91. Therefore, the 
understanding of the interaction between polymers and CAs in aqueous solution 
could be critical to tune the relaxometric properties of CAs. We aim to show how the 
presence of the Gd-DTPA in the aqueous solution can influence the behaviour of the 
polymer matrix and, on the other side, how these adjustments of the polymer 
conformation can govern the characteristic correlation times of the Gd-DTPA 91–93. 
To investigate thermodynamic interactions between polymer and contrast agent, 
HA and Gd-DTPA respectively, are selected to be tested by Isothermal Titration 
Calorimetry (ITC). We aim to take advantage of the molecular interactions that are 
accompanied by some level of heat exchange between the interacting system and its 
surrounding medium; indeed, these interactions can be evaluated, at constant 
temperature, through the ITC. Basic principles of this technique have been widely 
discussed elsewhere 120,121 
Titration experiments are conducted injecting a solution of Gd-DTPA in the ITC 
cell containing the polymer solution. Different HA concentrations, ranging from 0.3 
to 0.7% w/v, are tested and more representative results are reported in Figure 3.1 and 
3.2 (peaks above the baseline represent exothermic phenomena while peaks below 
the baseline represent endothermic phenomena). 
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Figure 3.1 Thermograms (heat flow versus time) of Gd-DTPA into aqueous solution of HA at 
0.6 % w/v. Temperature and stirring rate have been kept constant at 25 °C and 200 rpm, respectively, 
for each sample. 
In our experiment, a simple dilution of Gd-DTPA in water or water in HA exhibits 
only small constant exothermic peaks (see Supporting Information). On the contrary, 
when Gd-DTPA is injected as titrant into the cell containing HA solution a change 
from exothermic to endothermic behaviour is clearly observed. This change occurs 
at an HA/Gd-DTPA molar ratio of 0.5 (Figure 3.2), i.e. when the molar concentration 
of Gd-DTPA in solution is twice the HA molar concentration.  Starting from these 
observations, we hypothesize that at a certain HA/Gd-DTPA ratio, the enthalpy 
variations obtained in the binding experiment can be related to changes in the 
polymer structure, which in turn can be associated with the water-mediated 
interaction between the Gd-chelate and the polymer. The presence of Gd-DTPA, 
which has a high affinity for water molecules, may interfere with the polymer 
solution and induce peculiar arrangements in polymer chains’ conformation. 
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Figure 3.2 Titration curves of Gd-DTPA into aqueous polymer solutions at 25 °C. Calorimetric 
traces (heat flow against time) for (A) 0.3% w/v HA, (B) 0.5% w/v HA and (C) 0.7% w/v HA. In 
(D) it is reported the normalized enthalpy vs Gd-DTPA/HA molar ratio for Gd-DTPA in 0.3% w/v 
HA (red circles), in 0.5% w/v HA (blue triangles) and in 0.7% w/v HA (magenta diamonds). The 
curves were shifted vertically for clarity; y-offset were set at 2 (red circles), 0 (blue triangles) and -
10 (magenta diamonds). 
It is clear that significant enthalpy variations are obtained in the titration 
experiments (Figure 3.2A-C) and can be associated with the water-mediated 
interaction between the Gd-chelate and the polymer, which induces changes in 
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polymer chains’ conformation. Since Figure 3.2A-C show ITC thermograms varying 
the HA concentration in the sample cell, a wide range of Gd-DTPA/HA molar ratios 
is examined and the relative energetic contribution and enthalpy values are 
calculated by integrating peaks of the experimental curves and are reported in Figure 
3.2D. Simple dilution of Gd-DTPA in water exhibits only small constant exothermic 
peaks over the whole experiment. 
In Figure 3.2, it is worth noting that the energetic contribution decreases as the Gd-
DTPA/HA molar ratio increases; thus, the higher is the concentration of HA in the 
sample cell, the higher is the Gd-DTPA concentration needed to observe 
endothermic peaks. It can also be observed that the endothermic contribution exceeds 
the exothermic one at the recurrent Gd-DTPA/HA ratio approximatively equal to 0.5 
through all the experiments at different HA concentrations in the sample cell. It 
means that a specific energetic contribution is needed to induce the adjustment of the 
polymer conformation. Then, when the Gd-DTPA/HA molar ratio equals 0.5, the 
endothermic peaks start slightly increasing until reaching a plateau, which 
corresponds to the thermodynamic equilibrium established within the ternary system 
(polymer-CA-water). The measured energetic variation reflects the conformational 
changes of polymer chains due to the presence of the CA in solution and leads to the 
formation of stable sub-domains in which a balanced exchange of water molecules 
occurs between the polymer, the CA and the bulk. 
The attainment of this thermodynamic equilibrium derives from a water-mediated 
interaction occurring between HA and Gd-DTPA. As both hydrophilic components, 
HA and Gd-DTPA interact with the water by forming hydrogen bonds and by 
coordinating water molecules. This competitive behaviour generates a measurable 
heat that reflects the change in polymer chains conformation and the exchange of 
bound water molecules with the bulk, thereby, bringing the system to a more stable 
configuration. In our previous paper 92, we preliminary showed how this equilibrium 
is able to affect the relaxometric properties of the system, as an effect of the new 
concept of Hydrodenticity, which will be further explained in the following 
paragraphs. 
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3.4.2. NMR STUDY OF DTPA INTERACTIONS AND WATER MOBILITY IN 
POLYMER SOLUTION 
Since previous ITC measurements reported by Gouin et al. 122 have shown no 
binding energy between free Gd3+ ions and HA, we hypothesize that polymer 
conformational changes are mainly induced by the presence of the chelating 
macromolecule, DTPA. NMR spectroscopy is used to confirm this hypothesis. NMR 
spectra are calculated for HA and DTPA solutions. We use only the DTPA without 
the metal ion since we are mostly interested in examining interactions between the 
polymer and the chelating macromolecule. 
Considering the spectra of the only DTPA and HA (Figure 4.2A-B), whose 
characteristic peaks are circled in blue and red respectively, the observations of 
DTPA/HA solutions at different molar ratios are reported (Figure 4.2C-I). The molar 
ratio ranges from 2 to 100 and is obtained by decreasing the HA concentration from 
150 to 10 µM. 
In Figure 3.3, it can be observed that the characteristic DTPA peak at 3.50 ppm (s, 
2 H, CH2–COOH) is influenced by the presence of HA in solution. In fact, it seems 
to shift and reduce its intensity far more than the other peaks by increasing the HA 
concentration. As an example, the shift is evident by comparing Figure 3.3I, where 
the DTPA peak is highlighted in blue, with Figure 3.3C, where the signal is 
dramatically reduced. 
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Figure 3.3 (A) 1H NMR spectrum and chemical structure of DTPA; (B) 1H NMR spectrum and 
chemical structure of DTPA; (C–I) 1H NMR spectra of DTPA/HA solutions at different molar ratios, 
from DTPA/HA = 2 to DTPA/HA = 100. Characteristic peaks of DTPA and HA are highlighted in 
blue and red respectively. 
It results that an interaction between the two components of the system exists and 
generates changes in the NMR spectrum of the solution. 
Through NMR-DOSY, instead, we investigate how the presence of both HA and 
Gd-DTPA can affect the mobility of water molecules. 
Figure 3.4 shows the normalized time-dependent self-diffusion coefficient of water 
in both polymer solutions (Figure 3.4A) and polymer-CA solutions (Figure 3.4B). 
For short diffusion delays, the measured self-diffusion coefficient D is nearly equal 
to the free self-diffusion coefficient D0 of water at 25°C (2.5·10
-9 m2/s), since the 
molecules travel over a short distance and only few of them feel the surrounding 
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macromolecules. As the diffusion time increases, more water molecules go through 
these restrictions and the self-diffusion coefficient reaches a plateau value. 
 
Figure 3.4 (A) Normalized time dependent water self-diffusion coefficient in 0.1% w/v HA 
(squares), 1% w/v HA (triangles), 2% w/v HA (flipped triangles), 3% w/v HA (diamonds). (B) 
Normalized time dependent water self-diffusion coefficient in 1% w/v HA (triangles), 5 μM Gd-
DTPA in 1% w/v HA (flipped triangles) and 30 μM Gd-DTPA in 1% w/v HA (stars). 
We can hypothesize that the presence of Gd-DTPA compete with those HA-
molecular sites beared by water molecules and that are responsible for polymer 
hydration and hydrogel formation. As highlighted with ITC results, the polymer 
conformation can be modified by the presence of Gd-DTPA, which could interplay 
with the water molecules and with the formation of hydrogen bonding. NMR-DOSY 
measurements are carried out to assess these hypothesized changes in water mobility. 
It can be observed that, in the case of the ternary system, the diffusivity of water 
beyond decreases, suggesting that the polymer-CA combination affects the water 
mobility more than the polymer itself. 
Figure 3.4A clearly shows that the water diffusion behaviour is affected by the 
polymer concentration. In particular, the diffusion coefficient decreases at increasing 
polymer concentration. Besides, Figure 3.4B shows the additional contribution of 
the CA to the water mobility. In fact, the presence of Gd-DTPA, even at relatively 
low concentrations (5 - 30 µM), can further reduce the value of the water self-
diffusion coefficient for both short and long diffusion times. 
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It is worth noting that low Gd-DTPA concentrations are chosen (Figure 4.3B) 
because Gd-DTPA is highly paramagnetic and it can interfere with NMR 
measurements 127,128, while the HA concentrations (0.1 - 3% w/v) are slightly higher 
than those used in the ITC experiments to highlight and make more evident the 
differences in diffusion behaviour between samples. In particular, as illustrated in 
Figure 3.4B, a fixed polymer concentration of 1% w/v is selected to show the effect 
of CA on the diffusion of water molecules. 
A data comparison between ITC and NMR spectra confirms the hypothesized 
fundamental properties behind the concept of Hydrodenticity: the ability of Gd-
DTPA to induce changes in polymer conformation and in water mobility. 
To further confirm the NMR  results we also studied the diffusion in polymer 
matrices through time domain relaxometry. In our systems, we have observed that 
water mobility slightly changes with increasing network density induced by 
crosslinking reaction (Figure 3.5). 
 
Figure 3.5 Stejskal Tanner Plot is used for calculating water self-diffusion coefficient of: (1) 
distilled water; (2) 0.25 % w/v HA solution with 5 μL DVS 8 hours after the crosslinking reaction; 
(3) 5 % w/v HA solution with 40 μL DVS 8 hours after the crosslinking reaction. 
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Besides, a more significant decrease in the water diffusion is observed in the 
presence of increasing polymer concentration rather than increasing CA 
concentration (Table 3.1). 
Table 3.1 Range of water self-diffusion coefficients, D, measured for: (1) distilled water; (2) Gd-
DTPA solutions at different Gd-DTPA concentrations; (3) 0.25 and 5 % w/v HA hydrogel solutions 
at varying crosslinking degrees, i.e. different DVS concentrations. 
HA 
(% w/v) 
DVS 
(μL) 
Gd-DTPA 
(mM) 
Da 
(*10-9 m2s-1) 
0 0 0 3.19 
0 0 0.05 ÷ 1 3.18 ÷ 3.09 
0.25 0 ÷ 25 0 3.05 ÷ 2.90 
5 5 ÷ 40 0 2.88 ÷ 2.83 
a Values of the standard deviation for the measured diffusion coefficients are all below 0.4*10-12 m2s-1. 
 
However, the study of the diffusion coefficient as a function of the crosslinking 
degree requires further investigation to understand its influence on the relaxometric 
properties. Further details on diffusion data are reported in the Supporting 
Information. Furthermore, results show that water mobility starts decreasing even at 
very low polymer concentration (0.25 % w/v HA). This dynamic can be attributed 
to the high molecular weight and hydrophilicity of the HA, which allows the 
formation of several hydrogen bonds at the surface of the polymer, thereby 
stabilizing the polymer structure and reducing water self-diffusion. 
 
3.4.3. WATER DYNAMICS WITHIN HYDRATED POLYMER MATRIX 
CONTAINING GD-DTPA 
To analyse further the role of water mobility in the Hydrodenticity, a study of the 
dynamics and behaviour of water molecules is needed. Within hydrated polymer 
matrices (hydrogels), containing metal chelates, water molecules mediate polymer-
CA interactions and, therefore, play a dual role: on one hand, the amount of absorbed 
water 129,130 and its interaction with the hydrogel structure affects the chain motion 
of the hydrophilic polymer; on the other, the mobility of water molecules in the 
polymer matrix is responsible for the relaxometric properties of the CA. 
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We investigate the water dynamics in water-HA systems, with and without Gd-
DTPA, using the Differential Scanning Calorimetry (DSC). We focus on the thermal 
effects that the polymer (Figure 3.6A) and the CA (Figure 3.6B) have on the water 
dynamics. According to the literature, indeed, the crystallization of water changes 
with the polymer concentration and with the hydration degree 97. 
 
Figure 3.6 (A) DSC thermograms of HA at different concentrations (0.3, 0.5 and 0.7% w/v). (B) 
Melting (Tm) and crystallization (Tc) temperatures for free Gd-DTPA in water and HA solutions 
with and without CA. 
In Figure 3.6A, thermograms of water-polymer systems at different HA 
concentrations (0.3 - 0.7% w/v) are displayed. We can observe that, during the 
cooling phase, the crystallization peaks shift to lower temperatures and lower 
enthalpy values. As expected, the enthalpy, given as the peak area, reaches its 
maximum value at the highest HA concentration (0.7% w/v). 
Figure 3.6B shows a comparison of melting (Tm) and crystallization (Tc) 
temperatures between HA solutions with and without Gd-DTPA (concentration 
range: 60 - 200 µM). It can be noted that the transition properties remained 
unaffected in presence of the CA, suggesting that the influence of the polymer on the 
thermal behaviour of water is predominant with respect to the CA at the selected 
concentration. 
 
3.4.4. RELAXATION TIMES, RATES AND RELAXIVITY OF THE POLYMER 
MATRIX 
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Through Time-Domain Relaxometry, relationships between system formulation, 
polymer matrices and relaxivity enhancement are provided. Results show how the 
relaxivity could be varied by changing the structural parameters of the hydrogel, 
namely polymer concentration and crosslinking degree (DVS concentration). Figure 
3.7 a) and b) display the longitudinal relaxation rate, R1, and longitudinal relaxation 
time distribution for Gd-DTPA in distilled water and different crosslinked and non-
crosslinked HA/Gd-DTPA solutions. 
 
Figure 3.7 a) Longitudinal relaxation rate as a function of Gd-DTPA concentration and b) 
longitudinal relaxation time distribution for: (1) Gd-DTPA in distilled water; (2) Gd-DTPA in 0.3 
% w/v HA solution; (3) Gd-DTPA in 0.5 % w/v HA solution; (4) Gd-DTPA in 0.3 % w/v HA 
crosslinked with DVS (HA:DVS = 1:8); (5) Gd-DTPA in 0.5 % w/v HA crosslinked with DVS 
(HA:DVS = 1:8). Linear regression is applied to each set of data reported in a). 
 
In detail, Figure 3.7 a) demonstrates the variation of relaxation rates against the 
concentration of Gd-DTPA. As expected, R1 rises linearly as Gd-DTPA 
concentration increases and surprisingly, the relaxivity, r1, appears to be tuned 
mostly by the variation of hydrogel structure (polymer concentration and 
crosslinking degree). Therefore, we found out that could be possible to modulate the 
r1 by changing the DVS concentration and to induce corresponding changes in the 
relaxation rates through the hydrogel matrix. Slopes of the regression lines in Figure 
3.7 a), indicating each obtained relaxivity r1 value, are reported in Table 3.2. 
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Table 3.2 Relaxivity enhancement for the investigated polymer/CA systems. 
HA 
(% w/v) 
DVS 
(% w/v) 
r1 
(mM-1s-1) 
r1 increment 
(%) 
0 0 3.07 ± 0.04 0 
0.3 0 3.18 ± 0.05 3.6 
0.3 2.4 3,81 ± 0.16 24,1 
0.5 0 3,11 ± 0.06 1.3 
0.5 4 3,65 ± 0.23 18,9 
0.7 0 3,26 ± 0.06 6.2 
0.7 5.6 3,41 ± 0.21 11.1 
 
Figure 3.7 b) highlights through the relaxation time distribution the influence of 
hydrogel structure on the relaxation times as already discussed in Figure 3.7 a). In 
particular, it displays a narrower relaxation time distribution in the presence of 
crosslinking, thereby indicating an enhancement of the MRI signal. 
As shown in Table 3.2, a slight increase in the relaxivity (from 1% to 6%) on the 
reference solution (Gd-DTPA in water) is observed for the non-crosslinked samples. 
Besides, for crosslinked hydrogel-CA systems, in the presence of a crosslinked 
network, the relaxivity increases to an even greater extent, ranging from 11% up to 
25%. About this last result, it seems that the crosslinking degree is interfering more 
on the relaxivity of CAs than on the diffusivity of water, acting, therefore, more on 
the rigidification of the CAs than on the water mobility. However, this aspect is of 
crucial important and will require further investigations and comparison.  
Percentages of increment in the relaxivity are calculated by dividing the difference 
between the relaxivity of the polymer/CA system and the reference (Gd-DTPA in 
water) by that of the reference solution, as follows: 
 
For further details on relaxometric data, please refer to the Supporting Information. 
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The existence of a water-mediated interaction between Gd-DTPA and HA, 
observed through ITC, NMR and DSC, and the effect of the polymer conformation 
on the characteristic correlation time of the metal chelate could explain the boosting 
of the relaxivity in the studied systems. 
Relaxometric properties are investigated by means of time-domain relaxometry on 
two different systems: non-crosslinked and crosslinked polymer matrix (0.5% w/v 
HA) containing Gd-DTPA. 
In the latter case, rheological and chemical-physical properties of polysaccharide 
can be modulated by changing the crosslinker (DVS) concentration, as known as 
crosslinking density. In fact, thanks to the presence of hydrophilic groups in the 
skeleton of HA, hydrogel is able to uptake a large amount of water. Under these 
conditions, water is in an abnormal aggregate state that influences the relaxivity of 
hydrated Gd-DTPA. 
Figure 3.8 shows the results of relaxometric measurements for the hydrogel system 
(0.5% w/v HA) studied by loading different concentration of Gd-DTPA. 
 
Figure 3.8 Increment in longitudinal relaxation rate, R1, at different contrast agent concentrations 
(from 0 to 1 mM) for: free Gd-DTPA in water (black squares); Gd-DTPA in 0.5% w/v HA solution 
(blue filled triangles); Gd-DTPA in 0.5% w/v HA crosslinked with DVS (blue empty triangles). The 
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R1 increment is calculated in percentage with respect to the corresponding R1 of Gd-DTPA in 
water. A fast increment in R1 is observed until a Gd-DTPA concentration equal to 300 µM. For 
higher Gd-DTPA concentrations, the R1 increment reaches a plateau. 
The hydrogel system is analysed and compared to the free Gd-DTPA solution. In 
particular, we display the increment in percentage of the paramagnetic relaxation as 
a function of Gd-DTPA concentration. The increment in percentage of the relaxation 
enhancement has been calculated as follows (Equation 1): 
𝐸𝑛ℎ𝑎𝑛𝑐𝑒𝑚𝑒𝑛𝑡 𝑖𝑛𝑐𝑟𝑒𝑚𝑒𝑛𝑡 =
1
𝑇1
|
𝐺𝑑𝐷𝑇𝑃𝐴 𝑖𝑛 𝐻𝐴
−
1
𝑇1
|
𝐺𝑑𝐷𝑇𝑃𝐴
1
𝑇1
|
𝐺𝑑𝐷𝑇𝑃𝐴
∗ 100  (1) 
We find that the stronger the interaction is between Gd-DTPA and HA, the better 
is the MRI enhancement. Moreover, the crosslinked system is much more efficient 
than the non-crosslinked one. Indeed, in the crosslinked system, since the 
enhancement reaches a plateau at Gd-DTPA/HA molar ratio equal to 2.5 (i.e. at 300 
µM of Gd-DTPA in 0.5% w/v HA water solution), it is not necessary to overload the 
system with Gd-DTPA in order to achieve higher relaxation. It is worth noting that, 
for both studies, with and without crosslinker, the Gd-DTPA concentration of 200 
μM seems to represent a threshold for the maximum effect of the hydrogel on the 
Gd-DTPA relaxation mechanism. 
Figure 3.9 displays a schematic representation of the hydrogel network formation, 
even in presence of the crosslinking agent, and its influence on the polymer 
conformation. 
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Figure 3.9 Formation mechanism affects hydrogel network structure: schematic representation 
of: formation of a hydrogel of hyaluronic acid in water (top); complex HA-Gd-DTPA structure 
(middle); crosslinked hydrogel network containing the contrast agent (bottom). 
We hypothesize that the boosting of Gd-DTPA relaxivity in a hydrogel matrix is 
due to a proper complexation between the polymer and the CA in solution, mediated 
by the water and further amplified by the addition of a crosslinker. It is confirmed 
that the reached equilibrium among osmotic pressure and elastodynamic forces of 
the polymer meshes and hydration degree of the CA in the matrix are able to tune 
finely the relaxometric properties of the metal chelates in the ternary system. The 
overall ensemble of these phenomena is defined as Hydrodenticity 92. 
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3.5. THEORETICAL INTERPRETATION OF THE ENHANCED 
RELAXIVITY 
Starting from the Solomon–Bloembergen–Morgan (SBM) theory [36], the physics 
of CAs is described by a set of physicochemical parameters characterizing the 
fluctuating magnetic dipole created by the paramagnetic ion. In  detail, according to 
the SBM model, the metal complex can be viewed as having separate coordination 
spheres 31: the Inner Sphere (IS), which consists of water molecules directly 
coordinated to the metal ion, and the Outer Sphere (OS), which is a less organized 
structure consisting of bulk water molecules diffusing in the near environment of the 
metal complex. In some cases, a Second Sphere (SS) contribution is taken into 
account, which is related to water molecules hydrogen bonded to the metal complex 
32. Each of the coordination mentioned above spheres has its characteristic 
parameters. IS parameters include the number of labile water molecules coordinated 
to the metal ion (q), the residence time of the coordinated water molecule (τM), which 
in turn determines the rate of the coordinated water molecule exchanging with the 
bulk, and the rotational correlation time (τR), which is how quickly the contrast agent 
is tumbling in solution. Conversely, OS parameters include the translational 
diffusional time (τD), which represent the diffusion of water molecules in the bulk 
near to the Gd complex. 
It is already known that molecular motion, size, rigidity and possible binding 
between Gd-chelates and other macromolecules may induce changes in relaxivity 34. 
Furthermore, polymer architecture and properties can strongly affect the MRI 
enhancement 49–51.  
As previously reported in the SBM theory, characteristic parameters of the metal 
chelate can be physically or chemically tuned and are of primary importance in the 
design of new CAs 48. In particular, the Gd-chelator determines the number of 
coordinated water molecules (q) and the water exchange rate (kex), which is the 
inverse of the residence time τM. Moreover, decreased τD and τR, which can be 
obtained, for instance, through the binding of the metal chelate with large 
macromolecules, generally yield increased relaxation rates at low magnetic fields 
(<1.5 T) 35. 
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Our findings report that the presence of a polymer network can significantly affect 
the relaxation enhancement since it influences the hydration mechanism of the CA, 
i.e. the number of water molecules in either the IS, SS or OS, their diffusion 
behaviour and exchange rate with the water molecule coordinated to the metal ion. 
At first, as a result of the diffusion measurements, we can observe that thanks to 
the high hydrophilicity of the HA promoting the hydrogen bonds formation at the 
surface of the polymer, water mobility starts decreasing even at very low polymer 
concentrations. Secondly, ITC results suggest that the presence of Gd-DTPA induce 
considerable thermodynamic variations in the polymer/CA mixing process that can 
be related to changes in polymer conformation. Finally, taking into consideration the 
computed relaxivity values, we can hypothesize that the hydrogel structure, which is 
strictly dependent on the water content and its dynamics within the polymer matrix, 
can significantly impact on the relaxivity of the whole polymer/CA system. 
As schematically represented in Figure 3.10, the obtained results suggest that 
changes in polymer conformation, induced by varying polymer/CA molar ratio, 
could be further exploited to improve the relaxivity of the CA. 
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Figure 3.10 Relaxation enhancement induced by water-mediated HA/Gd-DTPA interactions. 
Indeed, the altered behaviour of the water molecules at the HA/Gd-DTPA interface, 
exhibiting reduced mobility and strong interactions with the highly hydrophilic 
polymer surface, may have a considerable impact on the correlation times, especially 
τM and τD. In fact, the presence of polymer hydrophilic groups can change the access 
of bulk water molecules to the coordinated water molecule and, thus, alter the water 
exchange rate (kex =1/τM). Moreover, polymer chains can slightly reduce the mobility 
of the OS water molecules, with a consequent decreasing of τD. A simultaneous 
reduction of the CA’s tumbling rate (τR) can also be hypothesized since the 
environment provided by the presence of the polymer chains as well as of the 
crosslinking degree may induce a slower rotation of the metal chelate. 
 
Chapter 3. Impact of biopolymers on relaxometric properties of contrast agents: definition of Hydrodenticity 
 
 
 
 
 
 
59 
3.6. THEORY OF THE GADO-MESH FORMATION 
This work reports the use of polymer hydrogels for boosting the relaxivity of 
clinical relevant CAs. 
Results show that a spontaneous complexation exists between HA and Gd-DTPA 
due to thermodynamic interactions as demonstrated by both calorimetric and NMR 
measurements. It is already known that, in an aqueous polymer solution, solvent 
affinity can alter polymer conformation by inducing a local solvation of the structure 
that influences the number of available conformations of the polymer chains. 
Moreover, the introduction of another soluble ionic component, such as Gd-DTPA, 
in the system can induce further changes in polymer conformation, detectable via 
diverse thermodynamic approaches 131–134. Based on our findings, we prove for the 
first time that these conformational changes, induced by the metal chelate, contribute 
to an increase in CA’s relaxivity. 
In order to tune the MRI enhancement, we exploit the versatile structural 
characteristics of HA. In fact, the high porosity of the hydrogel, which shows a mesh-
like structure, is controlled by varying the density of covalent crosslinking 135,136. 
Moreover, the presence of negatively charged groups and the degree of crosslinking 
influence water adsorption capacity and, thus, the relaxometric properties of the 
ternary system 53. 
Therefore, the presence of the hydrogel matrix can greatly amplify the magnetic 
properties of the encapsulated Gd-DTPA, suggesting a strong outer-sphere and 
second-sphere contribution to the relaxivity. 
Based on these observations, we hypothesize that increased relaxivity is mainly 
related to the creation of water domains or clusters (water compartments) around the 
CA within the polymer matrix. In fact, biopolymer systems contain intermolecular 
cavities that can be considered as molecular nano-domains in which various self-
assembly processes can be implemented in principle 137. The formation of peculiar 
structures within these cavities can be associated with thermodynamic transitions 
and it is a characteristic of many metallopolymeric systems 138,139. 
The sub-nanostructures, here defined “Gado-meshes”, are generated from a three-
way interaction between HA, Gd-DTPA and water. The entrapment of the CA inside 
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the hydrophilic matrix of HA results in a reduction of the rotational tumbling rate, 
due to an increase of the effective viscosity of the aqueous solution into the hydrogel 
matrix. At the same time, multiple CA-water interaction pathways occur between the 
exchangeable protons of the water molecules coordinated by the CA and the other 
water molecules freely moving within the hydrogel mesh or bonded to the polymer 
chains 27,81,140. 
Our “Gado-mesh” consists of highly relaxing Gd-water compartments 
spontaneously generated within the hydrogel matrix by the combination of these 
multiple physico-chemical interactions. The so created nanostructure is composed of 
different water layers departing from the polymer chains that surround the Gd-
molecules. It is known, in fact, that hydrated polysaccharides, such as HA, are 
characterized by the presence of multiple water layers, contiguous regions of variable 
water density within a polyelectrolyte solution 141, differing in their physical 
properties depending on the distance from the polysaccharide chain 142. The 
hydration process of HA generates: the “bound water layer”, which is the water 
fractions closely associated with the polymer matrix; the “unbound water layer”, 
made by the water molecules which are not directly interacting with the polymer; 
and the “free water layer”, which resembles dynamics of pure water. In addition, the 
developed polymer network can be dependent not only on the water layers 
organization but also on other solute species, such as Gd-DTPA, altering the bound 
water layer with non-negligible effect on the HA conformation and dynamic 143. In 
the “Gado-mesh”, Gd-DTPA has a competitive behaviour with the respect of HA, 
similar to the cation shielding of the HA due to the presence of salts 144, and 
interposes itself between the water molecules around the HA, altering the bound 
water layer and generating water compartments with high MRI enhancing properties. 
The “Gado-mesh” influences the τR, τD and τM times through the action of the 
Hydrodenticity, whose effect is magnified by the crosslinking. Hydrodenticity, 
hence, refers to the status of the hydrated Gd-DTPA with the coordination water 
subjected to osmotic pressure deriving from elastodynamics equilibrium of swollen 
gels 92,145–150. 
We hypothesize that the attainment of this equilibrium is reached when the normal 
energetic stability of the meshes is compromised by the presence of the Gd-DTPA 
and evolves to a new spontaneous equilibrium involving the formation of 
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nanocompartments, so called “Gado-Meshes”, in which water is in an abnormal 
aggregate state that influences the relaxivity. Water molecules in the hydrogel matrix 
that are subjected to the effect of Hydrodenticity, are able to change their water 
dynamics and can mediate the hydrogel conformation and the physical and 
relaxometric properties of the metal chelate. 
 
3.7. CONCLUSION 
Here, a study of the interactions involved in polymer- hydrogel-based CA solutions 
has been presented, aiming at understanding the key role of the water as a mediating 
agent that acts at the interface between the polymer and the metal chelate and 
determines both the polymer conformation and the relaxation enhancement.  
A multidisciplinary approach is used: changes in polymer conformation and 
thermodynamic interactions of CAs and polymers in aqueous solutions are detected 
by isothermal calorimetric (ITC) measurements and later, these interactions are 
investigated at molecular level using NMR to better understand the involved the 
phenomena. Water molecular dynamics of these systems is also studied by means of 
Differential Scanning Calorimetry (DSC). In order to observe relaxometric 
properties variations, we have monitored the MRI enhancement of the examined 
structures over all the experiments. 
The systems have been investigated by mixing crosslinked or non-crosslinked HA 
with Gd-DTPA at specific polymer/CA molar ratios in aqueous solution without 
introducing chemical modifications of the CA. Water self-diffusion coefficients, as 
well as proton longitudinal relaxation curves for different HA/Gd-DTPA solutions, 
have been measured. A thermodynamic investigation of the mixing process between 
HA and Gd-DTPA in water has also been conducted. 
We have observed that, in the presence of a crosslinked matrix, it is possible to 
modulate the water content of the system and, therefore, the hydration of the CA, by 
adjusting the crosslinking degree of the hydrogel structure. In these conditions, a 
more stable polymer network can be obtained, promoting more efficient water-
polymer and water-CA interactions that boost the relaxivity to higher values. The 
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crosslinking degree is proposed as an advanced tool to modulate the hydrogel 
network and its properties, enabling the tuning of the relaxometric properties. 
These findings could be useful to deepen the knowledge of hydrogel-CA systems 
and to achieve an advanced comprehension of the fundamental mechanisms that rule 
the interaction between MRI CAs and hydrogel matrices, and are responsible for the 
relaxation enhancement. Further characterization studies and computational 
simulations are necessary to insight the water behaviour within polymeric matrices 
in the presence of metal chelates and the potential impact that these structures can 
have on the relaxometric properties of clinically used CAs and, therefore, on the 
performance of MRI diagnosis. The knowledge of these complex systems could be 
scaled to nanoscale dimensions, inspiring the development of a new class of 
nanostructured MRI CAs with highly tunable relaxometric properties as well as the 
production of metallopolymer complexes or magnetic and conductive polymer-
based materials with applications in areas such as sensors, memory devices, 
nanolithography and controlled release. 
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Chapter 4.  
 
APPLICATION OF THE HYDRODENTICITY 
TO THE DESIGN OF NANOSTRUCTURES 
FOR ENHANCED MRI 
 
 
 
 
4.1. SUMMARY OF THE CHAPTER 
Recently, rational design of a new class of contrast agents (CAs), based on 
biopolymers (hydrogels), have received considerable attention in Magnetic 
Resonance Imaging (MRI) diagnostic field. Several strategies have been adopted to 
improve relaxivity without chemical modification of the commercial CAs, however, 
understanding the MRI enhancement mechanism remains a challenge. 
Here, the effect of the hydration of the hydrogel structure on the relaxometric 
properties, called Hydrodenticity, is used to develop Gadolinium-based polymer 
nanovectors with improved MRI relaxation time. 
The ability to tune the hydrogel structure is first proved through a high pressure 
homogenization technique. Then, a Microfluidic Flow-Focusing approach able to 
produce crosslinked Hyaluronic Acid Nanoparticles (cHANPs),analyzed regarding 
the crosslink density and mesh size, and connected to the characteristic correlation 
times of the Gd-DTPA. 
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Hydrodenticity explains the boosting (up to 12 times) of the Gd-DTPA relaxivity 
by tuning hydrogel structural parameters, potentially enabling the reduction of the 
administration dosage as approved for clinical use. 
The experimental results indicate that the entrapment of metal chelates in hydrogel 
nanostructures offers a versatile platform for developing different high performing 
CAs for diagnosis of diseases. 
 
4.2. INTRODUCTION 
We have recently published some works in this field explaining the impact of 
biopolymer matrices on relaxometric properties of CAs and showing a microfluidic 
approach to produce hydrogel nanoparticles loading clinical relevant Gd-based CAs, 
improving relaxometric properties of CAs without their chemical modification 93. 
Other authors also proposed some strategies to fabricate nanostructures based on the 
effect of rigidification and confinement of metal-chelates to boost relaxometric 
properties 27,51,80,151. 
Despite the valuable role of the CAs for MRI, this case history confirms the 
importance of developing systems able to enhance relaxivity of clinical relevant Gd-
based CAs and also to protect the chelate from transmetallation phenomena and 
control accumulation and clearance in a specific organ 152,153. 
In this scenario, we have proved that, by changing structural parameters of an 
hydrogel matrix containing a CA through a Microfluidic Flow-Focusing approach, 
it is possible to affect the dipolar coupling between the electronic magnetic moment 
of the metal ion and the nuclear magnetic moment of the water protons (relaxation 
rate). This effect results from the complex equilibrium established by the elastic 
stretches of polymer chains, water osmotic pressure and hydration degree of GdCAs, 
that we have called Hydrodenticity. 
Hydrodenticity, hence, refers to the status of the hydrated Gd-DTPA with the 
coordination water subjected to osmotic pressure deriving from elastodynamics 
equilibrium of swollen gels 148,149,154. We hypothesize that the attainment of this 
equilibrium is reached when the normal energetic stability of the meshes is 
compromised by the presence of the Gd-DTPA and evolves to a new spontaneous 
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equilibrium involving the formation of nanocompartments, called “Gado-Meshes”, 
in which water is in an abnormal aggregate state that influences the relaxivity. The 
capability to control the organization of these nanocompartments within the 
nanoparticles can be applied to define a new class of medical products useful to 
improve the properties of CAs for MRI. 
The tunability of the hydrogel properties is here achieved by two approaches: (1) 
high pressure homogenization; (2) microfluidic flow focusing approach. 
Within the nanostructures, the properties of Hydrodenticity can be modulated to 
obtain desired crosslink density, mesh size, hydrophilicity and loading capability, 
playing on the biodegradable behavior and relaxometric properties of the Gd-loaded 
nanostructures. 
 
4.3. HIGH PRESSURE HOMOGENIZATION TO PRODUCE POLYMER 
NANOPARTICLES BASED ON HYDRODENTICITY 
Recent recommendations from Food and Drug Administration (FDA) and 
European Medicine Agency (EMA) about the Gd deposition in the brain and other 
tissues have highlighted the importance to design polymer biocompatible NPs with 
enhanced relaxivity without chemical modification of the clinical relevant CAs 38,155. 
Thus, crosslinked NPs formed by HA, a biodegradable, biocompatible, non-toxic, 
non-immunogenic and non-inflammatory linear polysaccharide 156, could represent 
a successful candidate among nanovectors for MRI applications 157. Indeed, in the 
last decades, it is undisputed the growing research interest toward the therapeutic 
action of HA and in developing new diagnostic tools based on this polymer 157. In 
this work, starting from the above-presented results, we aim to apply the 
Hydrodencity in the design of biocompatible hydrogel nanostructures to obtain 
improved relaxometric properties. We propose a concrete example of the concept of 
Hydrodenticity applied to the production of crosslinked HA NPs for MRI, loaded 
with Gd-DTPA. An emulsion-based method is used to obtain stable W/O 
nanoemulsions as templates. 
 
4.3.1. STUDY OF EMULSION STABILITY 
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Stable W/O emulsions are prepared by stirring appropriate amounts of oil phase 
(Mineral oil) and aqueous phase containing different concentrations of Span-80 
(S80) or S80 with Tween-85 (S80/T85). The pH, ranging from 12 to 14 is adjusted 
by adding appropriate amounts of NaOH from a stock solution (0.2 M). Further 
details are reported in the Materials and Method Section. As expected, in the absence 
of any surfactant, W/O emulsions prepared in the same conditions split very rapidly 
in two phases due to their unfavourable thermo-dynamic state. Visual comparison, 
turbidimetry and backscattering are successfully used to study emulsion stability (see 
also Supporting Information) 158. Comparing emulsions obtained at different W/O 
ratio, 10:90 and 20:80, but at same concentration of surfactant, the stability is more 
extended for emulsions with lower water content. In particular, a formulation 10/90 
W/O volume ratio containing S80 (1% w/v) and T85 (0.5 % w/v) resulted the more 
stable. However, even though the stability of the emulsion is crucial to reduce 
polydispersity, an alkaline environment (addition of NaOH) is necessary for the 
crosslinking reaction to take place. Indeed, Balazs and Leshchiner 159 showed that 
the crosslinking reaction starts shortly after addition of DVS (5 - 10 min) and, that, 
1 hour is sufficient for the completion of the reaction 160,161. On the basis of these 
requirements, to conduct the experiments, we select the formulation with S80 (1% 
w/v) and NaOH (0.2 M) as the optimal trade-off to obtain an emulsion stable for at 
least 3 hours (see also Supporting Information), enough for the DVS to react. 
 
4.3.2. PREPARATION OF DVS-CROSSLINKED NANOPARTICLES WITH AND 
WITHOUT CA 
The exploitation of the best process conditions to design biocompatible 
nanostructures based on Hydrodenticity and control their relaxation parameters for 
MRI application is reported. In particular, the effect of the homogenization, HA 
concentration and the role of the crosslinking reaction is analysed. Different 
experimental parameters and conditions are tested and details are reported in the 
Materials and Methods section. A preliminary mixing is performed at 5000 or 7000 
rpm for 10 min, by keeping constant the temperature at 25 °C. A 5000 rpm speed is 
preferred to avoid and uncontrolled increasing of the temperature. 
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After the homogenization, a crosslinking reaction is performed at high pH values 
(12 - 14) and creates sulfonyl bis-ethyl linkages between the hydroxyl groups of HA 
162. This crosslinking method has the advantage of occurring at room temperature, 
which limits the degradation of HA in alkaline solutions. Even though the starting 
material DVS is highly reactive and toxic, the biocompatibility of the HA-DVS 
hydrogels are confirmed by histological analysis 123. 
In our protocol, a study of the modalities of injection of the crosslinking agent at 
different steps of the homogenization process has shown that only when DVS is 
added after the homogenization step spherical NPs are obtained. On the contrary, 
when the addition of the crosslinker is performed at any time point during the 
homogenization phase, a shear stress behaviour of the polymer phase, interfering 
with the formation of that particles, is observed (see Supporting Information). 
The best experimental condition for production of crosslinked NPs is reached at 
0.045% v/v DVS (see Supporting Information). 
Based on these results and using the same process conditions, loaded NPs are 
obtained by adding the CA in the water phase of the emulsion. Among several FDA 
approved CAs, we have chosen to encapsulate a Gd chelated, Gd-DTPA (9.13 mM). 
 
4.3.3. PURIFICATION AND CHARACTERIZATION OF HA-NPS 
Ultracentrifugation (UC) and dialysis are performed to purify HA NPs. Dynamic 
Light Scattering (DLS) measurements are made on aqueous dilute NP suspension 
(1:10). The smaller NPs’ size without CA (217.57 ± 34.65 nm) is obtained at 0.25% 
w/v of HA solution. At higher polymer concentration (0.5% w/v) particle size is 
higher (401.67± 77,65 nm), while the formulation with 0.1% w/v HA shows a reverse 
phenomenon with larger particles (760.15 ± 86 nm), probably due to less stability of 
the nuclei that tend to coalesce. When Gd-DTPA is added to the process, the particle 
size at HA 0.25% w/v is slightly increased (258.77 ± 15.65 nm) for the same process 
conditions. After purification, NPs are investigated by electron microscopy 
techniques (SEM and TEM). The morphology of the NPs observed revealed that the 
particles are spherical in shape and monodisperse (see Supporting Information). 
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Loading Capability (LC) and Encapsulation Efficiency (EE) is determined through 
ICP-MS by comparing the theoretical amount initially used to prepare the particles 
and the Gd encapsulated in the system after ultracentrifugation. The higher 
encapsulation results for 0.25 % w/v HA (1:2 w/w HA/Gd-DTPA ratio). Results 
show that probably ionic nature of Gd-DTPA impacts on its encapsulation. The zeta 
potential value of the 0.25% HA-NPs, with and without CA, indicate that they had a 
negatively charged surface (-37.4 ± 1.34 mV and -31.8 ± 0.88 mV, respectively), due 
to the carboxylic group of HA. 
 
4.3.4. RELAXIVITY STUDIES 
T1 and T2 measurements at 60 MHz (1.5 Tesla) and 120 MHz (3 Tesla): Relaxivity 
and relaxation times are measured for both unloaded and loaded NPs and compared 
with free Gd-DTPA solution. Measurements are performed on a 120 MHz (3 Tesla) 
MRI system and on a 60 MHz (1.5 T) benchtop relaxometer. 
Relaxivity results obtained at 120 MHz are presented on a per millimolar Gd basis 
in Figure 4.1 and show a maximum r1 of 33.3 s-1mM-1 (i.e. 10 times higher compared 
to free Gd-DTPA). Even though all the proposed formulations of Gd-DTPA-loaded 
HA nanostructures show an increase of the r1 signal, as reported in Figure 4.1A, the 
highest boosting of the relaxivity is provided by the NPs obtained using the 
formulation at 0.25% HA and 1:2 w/w HA/Gd-DTPA (Figure 4.1A-C). 
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Figure 4.1 (A) Relaxivity values r1 determined at magnetic field strengths of 3T for different set 
of HA-NPs with respect to free Gd-DTPA in water. (B) Longitudinal relaxation rate (1/T1) versus 
Gd-DTPA concentration for free Gd-DTPA in water and for HA-NPs at different polymer 
concentrations loaded with Gd-DTPA. (C) T1-weighted images of Gd-DTPA, unloaded (used as 
control) and HA-NPs at different polymer concentrations loaded with Gd-DTPA. All samples are 
imaged at 3T, 25°C, using standard spin echo (SE) sequence. (D) Distribution of longitudinal 
relaxation times of (T1) of 200 μM Gd-DTPA in water (squares), unloaded 0.25% HA-NPs (circles) 
and 0.25% HA-NPs loaded with 200 μM Gd-DTPA (triangles). 
T1 relaxation time distributions at 37°C and 60 MHz are investigated for loaded 
and unloaded NPs (HA at 0.25% w/v) as well as for free Gd-DTPA solution (Figure 
4.1D). Compared to the 200 µM free Gd-DTPA solution, which shows a broad 
distribution around 1000 ms, NPs loaded with 200 µM Gd-DTPA exhibit an 
excellent T1 distribution with a sharp peak centered below 500 ms. Gd concentration 
within loaded NPs was determined through Inductively Coupled Plasma Mass 
Spectrometry (ICP-MS). 
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Loaded NPs perform far better even compared to the unloaded ones, whose 
distribution appears to be broad and centered around 2800 ms. 
It is worth mentioning that, compared to T1 distribution for bulk water (3600 ms), 
unloaded NPs’ distribution shows that a slight contribution to the longitudinal 
relaxivity is ascribable to the crosslinked polymer nanostructure, which is able by 
itself to tune the water mobility for a non-nanostructured material. The contribution, 
therefore, to the overall relaxivity is further enhanced in the ternary system, thanks 
to the water-mediated interaction between the polymer and metal chelate. 
 
4.3.5. MODELLING OF NMR DISPERSION: NMRD PROFILE 
The NMRD profiles as function of the static magnetic field of the aqueous solutions 
of Gd-DTPA and loaded and unloaded NPs (Figure 4.2) are set up in order to 
establish the effects caused by Hydrodenticity functionalities on the parameters that 
determine the observed relaxivities. 
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Figure 4.2 NMRD profiles showing relaxivity of Gd-DTPA in water (squares), unloaded 0.25% 
HA-NPs (circles), Gd-loaded 0.25% HA-NPs at 25°C (triangles) and 37°C (flipped triangles). 
The longitudinal relaxation rates are recorded at 37°C as a function of resonance 
frequency and according to NP Gd-loading obtained by ICP-MS. The NMRD 
experimental curve for free Gd-DTPA shows a plateau in longitudinal relaxivity at 
low fields and significantly decreases as the applied magnetic field increases starting 
from 1 MHz. Conversely, longitudinal relaxivity (r1) for loaded NPs (HA at 0.25% 
w/v) is characterized by the presence of a low-field plateau and a gradual increase 
starting from 10 MHz, reaching a “dispersion peak” between 60 and 70 MHz. The 
same peak and trend in the high field region (20 – 70 MHz) is observed for both at 
25°C and 37°C. As a control, unloaded NPs do not exhibit increase in relaxivity in 
this field region, confirming that the nanohydrogel structure containing Gd-DTPA 
contributes to slowing the chelator's tumbling motion and allows water exchange 
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thanks to its hydrophilic properties, as hypothesized in the concept of 
Hydrodenticity. 
 
4.3.6. DISCUSSION 
The properties of Hydrodenticity and its application to the nanomedicine field is 
reported. The explanation of this concept take place through several key aspects 
underlying biopolymer-CA’s interactions mediated by the water. A multidisciplinary 
approach is used: changes in polymer conformation and thermodynamic interactions 
of CAs and polymers in aqueous solutions are detected by isothermal calorimetric 
(ITC) measurements and later, these interactions are investigated at molecular level 
using NMR to better understand the involved the phenomena. Water molecular 
dynamics of these systems is also studied by means of Differential Scanning 
Calorimetry (DSC). In order to observe relaxometric properties variations, we have 
monitored the MRI enhancement of the examined structures over all the experiments. 
The study of polymer-CA solutions reveals that thermodynamic interactions 
between biopolymers and CAs could be used to improve MRI Gd-based CA 
efficiency. For this reason, the optimal conditions to combine a CA with a 
hydrophilic biopolymer are identified and applied to the nanoscale in order to 
produce nanostructures of biomedical interest with high relaxivity. In particular, 
stable crosslinked HA NPs encapsulating Gd-DTPA are successfully prepared using 
a method that exploits the use of W/O nanoemulsions as templates. The aqueous 
emulsion droplets are shown to provide a good environment for the formation of the 
NPs and seemed to limit efficiently their size. NPs collected from the emulsion 
droplets using a purification procedure showed a size of about 200 nm and spherical 
shape. 
The conditions of the herein presented protocol to produce these biocompatible NPs 
offer advantages for the encapsulation of a broad-spectrum of biomolecules and 
provide a potential synthetic route to design a wide range of highly efficient 
nanostructured MRI CAs, letting the surface available for possible functionalization. 
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In conclusion, this work proves that a new generation of more efficient CAs can be 
developed by exploiting the affinity between CAs and biopolymers. It can be done 
using biocompatible and clinical relevant CAs without their chemical modification 
as approved in the clinical practice. Furthermore, the size of the resulting NPs is in 
a range that makes them suitable for delivery to cells and certain tissues and further 
increase in relaxivity can be potentially achieved by tuning the system to the most 
efficient structure by choosing the correct biopolymer-CA combination and 
optimizing concentration and crosslinking degree of the structure. From a biomedical 
point of view, the possibility to tune relaxometric properties of CAs by controlling 
hydrogel structural parameters can pave the way to new advancements in the design 
of nanovectors for diagnosis and therapy. Despite the promising achievements, 
further studies are needed to carry out a deeper investigation and a full validation our 
intriguing hypothesis. 
 
4.4. MICROFLUIDIC FLOW FOCUSING APPROACH TO PRODUCE 
POLYMER NANOPARTICLES BASED ON HYDRODENTICITY 
4.4.1. PREPARATION OF CROSSLINKED HYALURONIC ACID 
NANOPARTICLES (CHANPS) 
Microfluidic Flow-Focusing (MFF) systems have already been explored for the 
production of polymer micelles and nanoparticles 163,164. However, an investigation 
of the opportunity that this approach could bring to the MRI field, given the impact 
of the hydrogel behaviour on the relaxometric properties, is still missing. We have 
recently demonstrated that, through the microfluidics, it is possible to produce stable 
and hydrogel nanoparticles with improved relaxometric properties 93. Briefly, by 
changing the relative flow rates and the concentration of the species in the streams, 
we can control nanoprecipitation phenomena 164–166 and achieve the formation of 
small nanoparticles (see Supporting Information). In our system, starting from an 
HA 0.05% w/v solution, monodisperse and nanoparticles smaller than 40 nm are 
obtained (see Supporting Information). Subsequently, a crosslinking reaction is 
performed together with the formation of nanoparticles using DVS 161,167–170 as 
crosslinking agent at standard flow conditions. In the same work[35], we have also 
reported two effective crosslinking scenarios to explore and control the nature of the 
Chapter 4. Application of the Hydrodenticity to the design of nanostructures for enhanced MRI 
 
 
 
 
 
 
80 
interference (see Supporting Information) between the Gd-DTPA and the flow 
focused nanoprecipitation: (1) premixing of DVS into the middle channel at 
controlled temperature and surfactant concentration; (2) addition of DVS to the side 
channels by strictly controlling pH conditions. Both strategies, exploited through the 
Microfluidic Platform, have been already reported and further details in terms of 
crosslinking reaction and loading capability are reported in the Supporting 
Information. Results showing cHANPs with different concentration of NaOH and 
NaCl and different types of surfactants are already reported in our previous 
publication. Briefly, Spherical and stable nanoparticles are obtained for both strategy 
but the addition of DVS to the middle channel and the use of surfactants produce a 
smaller size down to 35 nm. 
 
4.4.2. SWELLING BEHAVIOUR AND HYDROGEL STRUCTURAL 
PARAMETERS OF CHANPS 
Here, starting from results in terms of the swelling ratio, crosslink density and mesh 
size of the cHANPs containing Gd-DTPA are discussed, aiming to evaluate the 
modulation of the hydrogel structure in the presence of Gd-DTPA. 
As far as the swelling behaviour of the nanoparticles, results at different DVS 
amounts are reported in Figure 4.3a and presented in terms of swelling ratio, as 
defined in the Method Section. 
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Figure 4.3 Swelling behaviour and hydrogel parameters of cHANPs. (a) Swelling ratio of of 
Gd-DTPA loaded cHANPs versus time at different DVS concentrations obtained according to the 
first (DVS in middle channel) or the second crosslinking scenario (DVS in side channels). (b) and 
(c) Swelling ratio (-●-) and mesh size (-■-) of Gd-DTPA loaded cHANPs versus crosslink density 
after 48 hours in water. d) and e) FE-SEM images of Gd-DTPA loaded cHANPs in water at 0.8% 
DVS (middle channel) and 4% DVS (side channels), respectively. (f) 15° C tilted FE-SEM image 
of Gd-DTPA loaded cHANPs at 4%. 
Results clearly show that, nanoparticles are stable and do not exhibit a significant 
swelling behaviour until 48 h at all explored DVS conditions (see also Supporting 
Information). In particular, smallest nanoparticles of about 70 nm and 50 nm 
measured in water are only produced at DVS of 0.8% v/v and 4% v/v, respectively. 
For these two conditions, an increase in size up to 125 nm for 0.8% DVS and 115 
nm for 4% DVS is detected only after 1 week (see Supporting Information). 
Then, according to Flory-Rehner calculations, we have determined the crosslink 
density (νe) and mesh size (ξ) of cHANPs in water after 48 h (see Supporting 
Information). It has been already reported that lower molecular weight films gave 
rise to decreased molecular weights between crosslinks as well as increased effective 
crosslink densities and decreased mesh size, thereby indicating a more stable 
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structure. Even our results show that a general increase of the crosslink density of 
the cHANPs corresponds to an increase in the nanostructure stability, i.e. lower 
swelling ratio (Figure 4.3b). Furthermore, as expected, by increasing the crosslink 
density, a reduction in mesh size is also obtained until to a certain extent (Figure 
4.3c). 
Field Emission Scanning Electron Microscopy (FE-SEM) images of cHANPs at 
0.8% DVS (middle channel) and 4% DVS (side channels) after 48 h in water are 
reported in Figure 4.3d, e and f. Higher DVS concentrations cause formation of large 
aggregates, as shown in the Supporting Information. It is important to highlight that 
cHANPs are potentially safe and biocompatible; indeed, even if DVS is highly 
reactive and toxic, HA-DVS biocompatibility has been confirmed by histological 
analysis, as previously reported by Oh et al. 123 
 
4.4.3. IN VITRO RELAXOMETRIC PROPERTIES 
The relationship between the measured structural parameters of the hydrogel and 
changes in CA’s relaxivity is also examined (Figure 4.4). 
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Figure 4.4 In vitro MRI and effect of the Hydrodenticity. (a) Longitudinal relaxation rate 
(1/T1) versus Gd-DTPA concentration for (-▲-) free Gd-DTPA in water and for Gd-DTPA loaded 
cHANPs at different crosslink densities (-●- 7.6*10-4 and -■- 4.6*10-4 mol/cm3), showing a 
relaxivity of 3.9 mM-1s-1, 14.09 mM-1s-1 and 48.97 mM-1s-1 respectively. (b) Longitudinal relaxation 
time distribution for cHANPs at different crosslink densities. (c) Bar chart of longitudinal relaxivity 
(gray columns) and mesh size (blue columns) values for cHANPs at different crosslink densities. 
(d) Mesh size versus crosslink density (-■-) and corresponding relaxivity values (-▲-) along with a 
graphical representation of cHANPs’ polymer network at different mesh size values. 
Given the versatility of the produced cHANPs, it is of particular interest to 
investigate how different reaction’s strategies and formulations could result in 
advanced and tailorable CAs-loading functionalities. In vitro relaxivity is studied for 
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loaded and unloaded cHANPs and the results are presented for Gd-DTPA in water 
at different concentrations. For all MR experiments, T1 values measured on loaded 
cHANPs show a higher relaxation rate compared to the relative “free” CA, 
confirming that active compounds are not only dispersed or encapsulated but even 
wrapped within the hydrogel polymer matrix of cHANPs. Besides, it is observed that 
the hydrogel structural parameters, i.e. crosslink density and mesh size, can affect 
not only the stability and degradation behaviour but also the MR functionality of the 
produced nanoparticles. Indeed, loaded cHANPs with different crosslink densities 
show a relaxivity (r1) of about 48.97 mM
-1s-1 and 14.09 mM-1s-1 respectively (Figure 
4.4a, squares and circles). Both values are considerably higher than the value of 3.9 
mM-1s-1 reported for commercial Magnevist (Figure 4.4a, triangles). 
Additionally, a change in the crosslink densities of cHANPs causes differences in 
longitudinal relaxation time distributions (Figure 4.4b). A narrow distribution is 
obtained at a crosslink density of about 4.62*10-4 mol/cm3, reflecting optimal 
equilibrium conditions able to boost the MRI signal. Contrary to expectations, 
further increase in the crosslink density does not allow a sharper relaxation time 
distribution, even at smaller mesh sizes. As shown in Figure 4.4c, in fact, even if the 
mesh sizes computed at two different crosslink densities are quite similar (1.5 nm 
and 2 nm for crosslink densities of 7.64*10-4 mol/cm3 and 4.62*10-4 mol/cm3, 
respectively), the highest relaxivity is not observed at the maximum crosslink 
density. This observation strengthens the hypothesis that an optimal equilibrium 
among the species should be achieved in order to boost the relaxometric properties 
and that the hydrogel structure plays a critical role in the relaxation enhancement 
(see Figure 4.4d). 
For completeness, we have also evaluated the relaxivity of unloaded cHANPs and 
cHANPs entrapping Gd-DTPA by sorption and compared with free Gd-DTPA in 
water (see Supporting Information). 
The comparison of MRI relaxivity values acquired for cHANPs and free Gd-DTPA 
supports our initial hypothesis made on Hydrodenticity, revealing the opportunity to 
select specifically the optimal range of conditions that promotes relaxation 
enhancement (Figure 4.4d). Hence, the high relaxivity is attributed to the equilibrium 
simultaneously achieved between the water content within the hydrogel structures, 
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expelled or retained during nanoprecipitation and crosslinking reaction, and the 
amount of Gd-DTPA entrapped in the formed matrix. 
 
4.4.4. DISCUSSION 
By the above-reported experiments, we have proved that a systematic and accurate 
tunability can be achieved by varying the crosslinking degree of the hydrogel 
nanoparticles in the presence of Gd-DTPA. A narrow or a broad distribution of 
relaxation rates on the crosslink density is shown with regards to changes in the water 
dynamics, hydrogel conformation and slow motion of the CAs. High control of these 
parameters is mainly reached through a MFF approach 93. 
Starting from the observation of a peculiar swelling behaviour (Figure 4.3a) and in 
vitro relaxometric properties of the cHANPs (Figure 4.4), we propose an 
explanation, through a modified Flory Rehner theory, of how the hydrogel structural 
parameters can be used to improve the relaxometric properties of CAs 161. 
Results show that Hydrodenticity can be proposed as a new concept to summarize 
the complex equilibrium formed by elastic stretches of polymer chains, water 
osmotic pressure and hydration degree of GdCAs able to boost the relaxivity. 
Indeed, at the achieved minimum mesh size, crosslink density is responsible for the 
elastodynamic of the hydrogel and is representative of the water amount within the 
polymer meshes, which in turn is related to the osmotic pressure. Our results also 
show that the reduction in the elasticity of the matrix by increasing the crosslink 
density does not correspond to a maximum enhancement of the relaxivity (see Figure 
4.4d). It is probably due to the expelled water from the hydrogel network that causes 
a reduction in the osmotic pressure within the water compartments of the meshes and 
a decrease of the hydrated status of Gd-DTPA, thus limiting the enhancement of the 
relaxometric properties in the nanostructures. These conditions promote the 
formation of water compartments containing Gd-DTPA called “Gado-Meshes”. 
It is also well-known that the crosslink density also acts on the water diffusion, 
which decreases when the crosslink density increases and its slowdown in diffusion 
is more severe at the polymer-water interface 117,171. Even in the Gd-loaded cHANPs, 
the water diffusion at various crosslink densities is correlated with the water 
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hydrogen bonding dynamics, and the variation of diffusion coefficient with crosslink 
density is related to the variation of water content in different crosslink densities. 
Therefore, by changing further the properties of the “Gado-Meshes” through the 
crosslinking reaction, relaxivity increases to an even greater extent due to the 
Hydrodenticity because of the tuning of the crosslink density and, consequently, of 
the aggregated water state and slow moving of the CAs. 
As the Hydrodenticity of CAs within the Gado-Mesh does not involve the chemical 
modification of the CAs, the observed enhancement in relaxivity is induced by the 
synergistic interaction of the aggregated water with the hydrogel matrix and Gd-
DTPA. Indeed, according to the Solomon- Bloembergen-Morgan theory, this effect 
promotes both (§) a further reduction of the water mobility and diffusion, inducing 
an increase of the residence lifetime (τM) and characteristic diffusion time (τD) of 
both IS and OS; and (§§) changes in hydrogel structures leading to the formation of 
nanocompartments enwrapping Gd-based CAs, causing a slow motion of the CAs 
and, therefore, an increase of the rotational correlation time (τR) of the chelate. 
Furthermore, it is reasonable that the conditions reached in the Gado-Mesh can 
control the water exchange and, therefore, the relaxivity. Indeed, relaxivity can be 
limited if the water exchange is too slow because the relaxation effect is poorly 
transmitted to the bulk. However, relaxivity can also be reduced if the water 
exchange is too fast because the water is not coordinated to the GdCAs long enough 
to be relaxed 172. 
In the proposed system, at some degree of Hydrodenticity, the hydrated status of 
Gd complexes, the elastodynamic response of HA and the osmotic pressure result 
probably in a much slower rotation. At this point, the importance of water exchange 
becomes significant, but the improved relaxivity of Gd-loaded cHANPs confirms 
that water diffusion is high enough, and the process for relaxing the water protons of 
aggregated water is in any case very efficient. Finally, the relaxation time 
measurements clearly demonstrate how cHANPs themselves do not contribute to the 
relaxivity of the system (see Supporting Information). Thus, the increase in the 
relaxivity of the loaded cHANPs can be attributed solely to the formation of the 
Gado-Mesh and to the Hydrodenticity achieved in their organization that influences 
the relaxivity through the characteristic correlation times above mentioned. 
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Modulation of the Hydrodenticity through the: (i) elastic stretching of the polymer 
meshes (ii) osmotic pressure and (iii) hydrated state of Gd-DTPA contributes to the 
changes of the Inner and Outer-Sphere mechanisms of the CAs. Therefore, through 
the hydrogel structural parameters, we can produce a library of functional 
nanostructures on the needs of a particular pathology, field and material properties. 
Results could lead to the identification of a personalized diagnostic window (Figure 
4.5) that can define the range of optimal properties between the hydrogel matrix and 
the CAs, being more efficient in treating a particular disease, avoiding toxic effects 
and increasing the performance of the MRI acquisitions. 
 
Figure 4.5 Hydrodenticity to enhance relaxivity. Schematic illustration of an improved 
diagnostic window in which it is possible to obtain a medical device for clinical use in the MRI field 
able to overcome the limitations related to the use of commercial CAs such as low relaxivity, limited 
acquisition time and reduced tissue specificity. 
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enables the increase of the relaxometric properties of the CA preserving the chemical 
structures as approved for the use in the clinical practice. The possibility to increase 
the sensitivity of the CAs represents an opportunity to reduce the administration 
dosage currently in use.  
Furthermore, Gd-loaded cHANPs based on the concept of Hydrodenticity are 
candidate to become an important nanomedicine tool to be tested in this direction, 
exhibiting a relaxivity value of ~ 48.9 mM−1s−1 and ~ 14.02 mM−1s−1. Additionally, 
cHANPs have an average diameter of about 35 nm, do not swell and degrade for at 
least 48 h under shaking. Further benefits can be found in the possibility to be 
decorated chemically, becoming suitable for a specific target, the direct clinical 
application, due to the utilization and improvement of biocompatible and FDA 
approved products without their chemical modifications, the ease of the synthesis, 
the nature of the materials, and the scalability of the proposed process. In the future, 
the concept of Hydrodenticity could inspire other applications and be extended to 
different molecules and field of knowledge. 
 
4.5. MICROFLUIDIC FLOW FOCUSING APPROACH TO PRODUCE 
COACERVATED CHITOSAN-HYALURONIC ACID NANOPARTICLES 
BASED ON HYDRODENTICITY 
Nanostructured materials, such as polymer nanoparticles (PNPs), have attracted 
considerable interest over the last years due to their multifunctional properties that 
can be modulated depending on the particular application173. Indeed, PNPs are 
widely used for the improvement of imaging techniques and treatments. Their 
peculiar features can potentially reduce limitations related to the fast clearance of 
drugs and diagnostic agents from the bloodstream and to the low detection and 
therapeutic efficacy. Advantages of PNPs as nanovectors also include controlled 
release, protection of active molecules, specific targeting and the ability to carry one 
or more therapeutic and/or imaging agents at the same time for theranostic 
purposes174. 
Several hydrophilic polymers, such as Hyaluronic Acid (HA), Chitosan (CS) and 
Dextran are widely used to manufacture PNPs for biomedical applications. Among 
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them, HA and its derivatives have been investigated for the development of several 
carrier systems for cancer diagnosis, staging and therapy157. HA has also been used 
in combination with CS and the usefulness of this combination is well documented 
for different bio-applications, like drug delivery and diagnostics157. 
For example, Chen and co-workers175 report a very interesting example of 
nanotheranostic system in which diagnosis and therapy are combined. This 
nanocarrier has a yolk-shell structure with a radioluminescent yolk based on Gd2O3: 
Eu nanospheres, an up conversion luminescent in a silica shell, and a coating 
constituted by HA/CS combination for pH-triggered drug release. 
Particularly remarkable results have been achieved by Courant et al.80, who develop 
a new and straightforward synthesis of high-relaxivity Gadolinium-PNPs for 
Magnetic Resonance Imaging (MRI) applications. For biocompatibility reasons, CS 
and HA are chosen as polymer matrix, which also enables a boost in the relaxivity 
of their Gadolinium-PNPs. 
Furthermore, recently, Russo et al.93 have produced core-shell polymer 
nanoparticles for multimodal imaging applications through a complex coacervation 
process driven by temperature. Nanovectors, made of a CS-core and a HA shell, are 
designed to entrap a contrast agents for MRI, boosting its performances, together 
with an additional optical tracer. 
As outlined so far, different protocols to combine CS and HA can be implemented 
to prepare hybrid nanovectors. Each method needs to take into account critical 
factors like the nature of the encapsulated drug/agent, the drug release mechanism, 
the administration route and the target site. The most used techiniques include: 
ionotropic gelation, complex coacervation, self-assembly and nano- and micro-
emulsion techniques. 
Among these, the ionotropic gelation proved to be the easiest and cleaner way to 
synthesize chitosan-based nanoparticles (NPs). It is based on the ability of 
polyelectrolytes to crosslink in the presence of oppositely charge to form hydrogels. 
Anions forms meshwork structure through their combination with the polyvalent 
cations and induce gelation by binding to the anion blocks. TPP bonds to the charged 
amino groups of chitosan and relies only on electrostatic interaction avoiding toxicity 
of reagents. Temperature, pH of crosslinking solution, mixing time, mass ratio of CS 
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to TPP, acetic acid concentration and chitosan molecular weight are factors that 
affect NPs size, shape and surface charge intensity176–180. 
However, a fine control over the final product’s features is difficult to achieve 
through the traditional preparation techniques. In these terms, microfluidic 
technology offers several advantages over batch processes in order to optimize 
quality process and produce material of required characteristics. Reactions in 
microfluidic devices are carried out with small amount of fluids within small 
channels. It enables fine control and manipulation of fluids and their interfaces, rapid 
and uniform heat and mass transfer thanks to the established laminar flow. 
In particular, microfluidics proved to be a promising and effective tool for the 
rational design of PNPs as imaging probes and drug delivery systems. As showed in 
recent studies conducted by Russo et al.90–94, microfluidics allows tuning 
nanohydrogels’ structural characteristics by changing process parameters, 
consequently improving contrast agent encapsulation and efficacy as a result of the 
Hydrodenticity concept, defined as the equilibrium between water osmotic pressure, 
elastodynamics of polymer chains and hydration degree of the contrast agent 
responsible for the enhancement in the relaxivity of MRI contrast agents. 
The aim of this work consists in the implementation of the ionotropic gelation in a 
microfluidic platform to produce CS-HA NPs, with the purpose to overcome some 
drawbacks of the traditional procedures, such as polydispersity and expensive and 
time-consuming purification/recovery steps. 
 
4.5.1. NANOPARTICLES’ PRODUCTION THROUGH HYDRODYNAMIC FLOW 
FOCUSING 
Production process used to generate NPs is a hydrodynamic flow focusing where 
fluids with different velocities flow side by side into microfluidic channels. More 
accurately, a central stream is squeezed between two adjacent streams at higher flow 
rate. The ratio between the flow rate of the middle channel (µL/min) and the flow 
rate used for both side channels (µL/min) has been called Flow Rate Ratio (FR2) and 
calculated as follows: 
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𝐹𝑅2 =
𝐹𝑙𝑜𝑤 𝑅𝑎𝑡𝑒|𝑚𝑖𝑑𝑑𝑙𝑒 𝑐ℎ𝑎𝑛𝑛𝑒𝑙
𝐹𝑙𝑜𝑤 𝑅𝑎𝑡𝑒|𝑠𝑖𝑑𝑒 𝑐ℎ𝑎𝑛𝑛𝑒𝑙
 
A higher FR2 leads to a narrow central stream and vice versa representing a direct 
way to control NPs characteristic. Hydrodynamic flow focusing and mixing process 
are strictly linked phenomena181–183. A schematic representation of the process to 
produce the nanoparticles is shown in Figure 4.6: 
 
Figure 4.6 Representation of hydrodynamic flow focusing within microfluidic chip. Middle and 
side streams include two different polymers that leads to NPs formation through an ionotropic 
gelation via CS-TPP crosslinking followed by HA-CS complex coacervation. 
 
4.5.2. COMPARISON BETWEEN BATCH AND MICROFLUIDIC SYSTEM: 
EFFECT OF CHITOSAN CONCENTRATION 
It has been decided to start from CS:HA weight ratio used in traditional batch 
system, as described by Callewaert et al.87, but using lower compounds 
concentrations (CS 2.5 mg/mL; HA 0.8 mg/mL; TPP 1.2 mg/mL) suitable for the 
microfluidic platform. SEM images reveals that, changing CS concentration at the 
same flow rate and CS:HA ratio, obtained coacervates show a considerable size and 
polydispersity reduction when CS concentration grows (Figure 4.7). 
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Figure 4.7 a) Tests carried out from Callawaert studies in batch with a 6 to 1 CS: HA ratio and 
flow rate ratio equal to 0.5 using compounds concentrations 1/400 compared to Callawaert ones 
(CS 2.5 mg/mL; HA 0.8 mg/mL; TPP 1.2 mg/mL). b) CS= 0.05 mg/mL. c) CS = 0.1 mg/mL. d) 
CS=0.2 mg/mL. SEM images reveal that, changing CS concentration but using the same flow rate 
and CS: HA ratio, obtained coacervate shows a considerable size and polydispersity reduction when 
CS concentration grows. 
 
4.5.3. CONCENTRATION EFFECT AT FR2 = 0.5 
Experiments at fixed FR2 = 0.5 have been carried out in two different conditions: 
(1) high flow rates, i.e. middle channel flow rate > 1 μL/min; (2) low flow rates, i.e. 
middle channel flow rates < 1 μL/min. In both conditions, two values of CS:HA ratio 
were tested. 
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Results show that, regardless the condition (high or low flow rates), size grows 
when CS: HA increases, although starting nuclei are different, and there is a double 
NPs population when CS: HA value is 3.125 (Figure 4.8). 
 
Figure 4.8 a) graphic trend of NPs size for different CS: HA ratio shows a higher standard 
deviation at 3.125 due to double NPs population development. Independently of high or low flow 
rates, size grows when CS: HA increase although starting nuclei are different. b) SEM images CS: 
HA = 1.56 c) SEM images CS: HA =3.125. 
 
4.5.4. FLOW RATE EFFECT AT TPP = 0.003% AND TPP = 0.012% 
Chapter 4. Application of the Hydrodenticity to the design of nanostructures for enhanced MRI 
 
 
 
 
 
 
94 
In this case, once HA and CS concentrations have been set (HA 0,002 %w/v and 
CS 0,00625 %w/v), two different crosslinker concentrations are tested using 
different flow rates. Therefore, varying CS:HA ratio through various tested flow rate 
ratios, working ranges more suitable to NPs heavy co-precipitation are identified. As 
in the previous case, a NPs size control through the change of process parameter is 
observed. 
 
Figure 4.9 a) NPs size trend evaluated at three different FR2 (0.05, 0.2 and 0.4) depending on 
TPP concentration (0.012 or 0.003%). b) Histogram that compare NPs size at both high and low 
flow rates at different TPP concentration with a flow rate ratio equal to 0.4. c) SEM images at 
different TPP concentration and flow rate. 
Size trend (Figure 4.9a) shows that TPP concentration interferes in coprecipitation 
process. When TPP = 0.003% size and polydispersity are very similar independently 
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of flow rate ratios. Instead, at TPP = 0.012% and FR2 = 0.2, NPs are more 
polydisperse, while, at FR2 = 0.4 and 0.05, they lead to coprecipitates with size and 
polydispersity comparable to the one obtained at TPP = 0.003%. Moreover, 
histograms in Figure 4.9b and SEM images in Figure 4c reveal that size and 
polydispersity are influenced by the flow rates. In fact, represented parameters grow 
proportionally with them. 
 
4.5.5. MORPHOLOGICAL TREND OF NPS 
Plots in Figure 5 show NPs morphology obtained by varying FR2 and CS:HA ratio 
into two flow rates regimes. 
 
Chapter 4. Application of the Hydrodenticity to the design of nanostructures for enhanced MRI 
 
 
 
 
 
 
96 
 
Figure 4.10 NPs morphological characterization at a) TEM and b) SEM for different CS: HA 
ratio, flow rate ratio and flow rate conditions. Low flow rates allow to modulate morphology and 
obtain different structure as full core, co-precipitates or core-shell. On the other hand, higher flow 
rates use leads to NPs with a mainly core-shell morphological structure. 
Low flow rate conditions promote different morphology like full core, co-
precipitates or core-shell NPs thanks to parameters modulation while higher flow 
rates use leads to NPs with a mainly core-shell morphological structure (Figure 
4.10a). Consequently, it is obvious that microfluidics can control morphology 
development thanks to flow rates management.  
 
4.5.6. GD-DTPA ENCAPSULATION 
The best process condition for NPs formation, selected in the previous tests (FR2= 
0,5), are used and Gadolinium is added in polycationic solutions with concentration 
equal to those of CS. 
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After dialysis in water or ethanol, 300 μL of the sample are collected in specific 
tube and brought at 22 °C to analyze relaxation time at MINISPEC at 1.5 T by use 
three different sequences to detect T1 and T2. The relaxation time distribution is 
obtained by CONTIN Algorithm. In Figure 4.11, two different cases are represented. 
 
Figure 4.11 Longitudinal relaxation time distribution. Comparison between water and Gd-loaded 
NPs. 
In both situations a reduction of the relaxation time can be observed compared to 
the solvent and so Gadolinium is encapsulated inside NPs allows to enhance 
relaxivity. 
 
4.5.1. FLUOROPHORE ENCAPSULATION 
Finally, in the last two tests, ATTO488 fluorophore has been introduced in the 
polyanionic solution (35 μg/mL) in order to demonstrate that NPs are able to 
encapsulate, at the same time, two diagnostic agents and so, theoretically, even a 
drug. ATTO488 amount has been evaluated through spectrofluorometric 
measurements and it shows an estimated concentration from fluorescence signal of 
7 pmol. 
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Figure 4.12 Calibration straight line for NPs in the range 0-200 pmol/mL 
 
4.5.2. DISCUSSION 
Microfluidic flow focusing is well-established and high-throughput technique to 
produce NPs. In this paper, we adopt the flow focusing approach to form NPs by 
ionotropic gelation between HA and CS and using TPP as crosslinker. 
We demonstrate that, by varying process parameters (flow rates, polymer 
concentration and crosslink density), it is possible modulate NPs’ size, morphology 
and structures. During the experiment design, a wide range of these parameters has 
been explored to investigate their influence on the ionotropic gelation reaction and 
on the final output of the process. 
The experiments we carried out show that the implemented microfluidic process 
does not need great compound concentrations as in the batch. Indeed, high polymer 
concentrations could be a limiting factor in the formation of hybrid NPs along 
microchannels, because the accumulation of materials at the chip junction results in 
a reduction of the process controllability and in the consequent increase in 
polydispersity or even in the formation of big aggregates rather than NPs, as shown 
in Figure 4.7. 
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The CS:HA ratio also affects the result of the process as shown in Figure 4.8. In fact, 
fixed the flow rate ratio and HA concentration, an increment of the CS concentration 
and so in the ratio with the polyanionic polymer cause a growth of the NPs standard 
deviation in size independently of flow rates condition as previously explained. 
The crosslink density, combined with variations in flow rates, proved to be another 
controllable parameter to modulate NPs’ size and morphology, as shown in Figure 
4.9. This is due to their influence on the binding process between anionic and cationic 
blocks. High TPP concentration, i.e. higher availability of crosslinker, does not 
always lead to the formation of more stable and smaller NPs if it is not balanced by 
appropriate flow rates. Indeed, an increase in the TPP should correspond to a change 
in the flow rates regime in order to allow proper mixing and avoid random 
aggregation. For this reason, flow rates lower than 10 μL/min, both side and middle 
streams, are optimal to make available TPP in a right amount to lead to NPs 
formation avoiding polymer macroaggregates. These low flow rates allow to have a 
mixing time at the chip junction that ensure uniform reaction condition and more 
homogeneous production. 
As result of these considerations, NPs morphological structure is the outcome of 
the modulation of different factors involved in the microfluidic ionotropic gelation 
process, as shown in Figure 4.10. 
 
Microfluidic flow focusing approach is able to lead to nanoparticles formation and, 
through the control of process parameters and using different components 
concentration, it is possible obtain different NPs size and morphological structures. 
However, the most important advantage consists in the opportunity to change 
structural parameter of hydrogel matrix to obtain a relaxivity boost using 
Hydrodenticity concept. This equilibrium between water osmotic pressure, polymer 
chains and hydration degree of the contrast agent can be obtained thanks to the 
hydrophilic behaviour of hyaluronic acid and chitosan together with sodium 
tripolyphosphate used as crosslinker. In this way, we are able to modulate crosslink 
density, mesh size, hydrophilicity and loading capability and therefore increase 
GdCAs relaxivity. Crosslink density is directly responsible of the water amount in 
the polymer meshes and, consequently, of the osmotic pressure. In fact, water content 
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increases when crosslink density decreases and this is related to a variation of 
diffusion coefficient and of the water hydrogen bonding. Therefore, the tunability of 
the crosslink density leads to an increment of the interaction of water with polymer 
chains of the hydrogel and Gd ions. Hydrodenticity is thus able to influence the 
characteristic correlation times of the Solomon-Bloembergen-Morgan theory and, 
consequently, it allows a relaxivity increment of GdCAs. The great amount of water, 
that can be contained in the polymeric matrix, allows to enhance each single 
contribution given by the three coordination spheres surrounding the metal complex. 
Therefore, Hydrodenticity not only influence directly the relaxation time but, through 
the organization of the Gd-DTPA surrounding area, is able to change spheres 
mechanism. The formation of nanomeshes entrapping GdCAs increases the 
rotational correlation time of the metal chelate and changes both the diffusion 
correlation time of the bulk water and the residence lifetime of the inner sphere water 
molecules. Obviously, water exchange must not be neither too slow since it is 
important to transmit the relaxation effect nor too fast because it means that water is 
not coordinated enough with Gd.  A higher number of hydrogen nuclei around Gd 
chelates in the inner sphere, where they have direct coordination, leads to an increase 
of the residence lifetime but, at the same time, a reduction of the relaxation time in 
this sphere and so an enhancement of the inner sphere relaxivity contribution. 
 
We obtained NPs made up of chitosan and hyaluronic acid with different 
morphological structures through ionotropic gelation followed by complex 
coacervation. They can be loaded with Gd-DTPA to improve relaxometric properties 
of the CAs without chemical modifications of the metal chelate but using a 
microfluidic approach as tools to obtain desired crosslink density, mesh size, 
hydrophilicity and loading capability of the NPs structure. Therefore, thanks to the 
Hydrodenticity, it is possible to obtain different structural characteristics of hydrogel 
nanoparticles that indirectly influence GdCAs relaxation. Through the definition of 
this new concept, we are able to overcome biological limits of current clinical CAs 
improving potentially the tissue specificity, stability of the chelates, imaging 
diagnostic window, reducing the administration dosage and, at the same time, 
increase the performance of the GdCAs for the MRI image acquisition. Finally, we 
demonstrated that our NPs are able to encapsulate another compound that could be 
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a drug or a diagnostic agent and so reduce the time taken up over treatments or clinic 
exams. 
 
4.6. MICROFLUIDIC FLOW FOCUSING APPROACH TO PRODUCE 
CHITOSAN-LOADED LIPOSOME NANOSTRUCTURES BASED ON 
HYDRODENTICITY 
Today, medical diagnostic methodologies have an enormous impact on the 
diagnosis and in the clinical management of the diseases. In this scenario, the 
integration of different imaging modalities enables to acquire information on specific 
biological processes. Among different diagnostic techniques, Magnetic Resonance 
Imaging (MRI) is a highly flexible, reproducible and non-invasive imaging modality. 
In contrast to the other medical imaging methods, which expose patients to ionizing 
radiation, MRI uses strong non-ionizing electromagnetic fields in the radio 
frequency range, offers excellent spatial resolution, is operator independent and 
provides 3D data 16,17. Compared to other imaging techniques (i.e., nuclear medicine 
techniques), it shows low sensitivity and long acquisition time. Furthermore, the use 
of contrast agents (CAs) is often required in MRI scans in order to improve the 
enhancement of MRI signals 27. The majority of these agents are paramagnetic ion 
complexes, which contain lanthanide elements such as Gadolinium (Gd), or 
superparamagnetic iron oxide (SPIO) conjugates 20. These compounds shorten the 
T1 (or longitudinal) and T2 (or transverse) relaxation time, thereby increasing signal 
intensity on T1-weighted images or reducing signal intensity on T2-weighted 
images. Their effectiveness remains limited owing to nephrotoxic effects, lack of 
tissue specificity, low relaxivity and short circulation half-lives. Moreover, 
McDonald et al. 38,184,185 have recently reported results about progressive Gd 
deposition in the brain after repeated intravenous administration of CAs. As a result, 
the Food and Drug Administration (FDA) has alarmed the medical community and 
has recommended healthcare professionals to limit the use of Gd-based CAs unless 
necessary and to report any possible related side effects. Despite the valuable role of 
the CAs for MRI, these latest results confirm the need to have a biocompatible 
system able to boost a clinical relevant Gd-chelate without its chemical modification. 
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According to these parameters and by exploiting the versatile properties of nano- 
and bio-materials several nanostructured CAs with enhanced relaxivity have been 
investigated. This chapter aims to describe and evaluate clinical aspects related to 
the use of biomaterials such as polymer nanoparticles and liposomes for MRI 
applications186. 
Liposomes are structures composed of hydrophobic head groups and hydrophilic 
tail groups. They can be prepared by adding lipids in organic solution, which is 
slowly evaporated to produce a thin film. The film is then hydrated with a desired 
aqueous buffer and sonicated. Liposomes are generally nano-scaled structures and 
can be further size refined by passage through physical membrane pores of known 
size (extrusion). Liposomes are typically characterised by their size, shape and 
lamellarity. They may be composed of a single bilayer (unilamellar), a few bilayers 
(oligolamellar), or multiple bilayers (multilamellar). Due to their aqueous cavity and 
“tunable” bilayer, liposomes have traditionally been used as drug delivery vehicles, 
encapsulating water-soluble drugs within the aqueous cavity in order to improve 
drug pharmacokinetics 187. 
 
4.6.1. LIPOSOMES AND MRI 
As far as the ability of liposomes to boost the MRI contrast, in order to make 
liposomes effective paramagnetic CAs for MRI, two main approach have been 
adopted: (a) encapsulation of Gd-chelates in the hydrophilic domain or (b) 
immobilization of the chelates on the bilayer membrane surface. On one hand, the 
former strategy permits to achieve higher Gd payload (theoretically, up to tens to 
hundreds of thousand Gd can be encapsulated within a single ~100 nm liposome1) 
and to leave the outer surface of the liposome unobstructed and available for the 
attachment of targeting ligands. Whereas, on the other hand, the latter strategy 
enables a better water accessibility than the encapsulated Gd since bulk water can 
easily reach Gd-chelates bound to the exterior surface of the liposome. 
The increase in the relaxivity, indeed, strongly depends on the access of water 
molecules to the metal-chelate coordination domain and on the fast exchange rates 
between bulk water and coordinated water. For this reason, some concerns have 
emerged since the permeability barrier imposed by the vesicle membrane decreases 
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the exchange between bulk water and the water complexed to encapsulated metal-
chelates, thereby preventing the relaxivity enhancement. As a result, the relaxivity 
of liposomes encapsulating CAs is generally lower than that of the corresponding 
small molecular CAs. 
To overcome the limitations of both immobilization and encapsulation strategies, 
dual-mode liposomal CAs have been developed, which contain both core-
encapsulated and surface-conjugated Gd-chelates and are able to combine large 
loading capability (Gd concentration per unit of liposomal particle) with high image 
contrast (see following figure) 33. 
 
Figure 4.13 Schemes of core-encapsulated gadolinium chelate (CE-Gd) liposomes, surface-
conjugated gadolinium chelate (SC-Gd) liposomes and liposomes containing both encapsulated and 
conjugated gadolinium chelates (Dual-Gd) and T1 relaxation rates (R1) of liposomal-Gd 
formulations for different lipid concentrations. [Adapted from 33: Zhou Z, Lu ZR. Gadolinium‐based 
contrast agents for magnetic resonance cancer imaging. Wiley Interdisciplinary Reviews: 
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Nanomedicine and Nanobiotechnology. 2013;5(1):1-18.] 
The improved structural stability of the polymersome bilayer architecture has made 
them an attractive alternative to liposome, which are often limited in clinical 
applications by their low stability in circulation 188. 
As far as the MRI CAs, the use of polymersomes has primarily focused on the 
loading of superparamagnetic iron oxide nanoparticles (SPIONs), showing a T2 
contrast equal or higher than commercially available CAs (e.g. Sinerem and 
Endorem) and providing a powerful tool that allies imaging to drug release. 
However, porous polymersomes have been also developed to encapsulate 
paramagnetic metal complexes 189. Indeed, the porosity of the polymersome 
membrane improves the water exchange rate so that the overall developed structure 
exhibits a relaxivity augmentation in comparison with normal Gd-chelates. This 
strategy has allowed to overcome one of the main limitation of liposomes, which are 
known to generally reduce the relaxivity of the encapsulated Gd-based CAs 189. 
 
4.6.2. LITERATURE REVIEW: LIPOSOMES AND POLYMERSOMES FOR 
ENHANCED MRI CONTRAST 
The interest in developing functionalized liposome and polymersome 
nanostructures has increased over the years. 
Just since the end of the 1980’s, Unger et al. 190 found that liposomal Gd-DTPA 
resulted in significant contrast enhancement between the liver and tumor in T1-
weighted MR images. They studied size effect with liposomes in a size range of 70 
to 400 nm and discovered that liposomal Gd-DTPA with a size of 70 nm created 
greater contrast enhancement thanks to the larger surface-area-to-volume ratio. By 
comparison, free Gd-DTPA without liposomes caused a statistically significant 
reduction in contrast between tumor and liver and reduced lesion detection. 
Liposomal Gd-DTPA also resulted in sustained vascular enhancement for 1 hour 
after administration. Their results suggest that paramagnetic liposomes may become 
a useful MRI CA permitting significant improvement in metastasis detection, which 
was assessed by five blinded radiologists. 
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This interest towards liposome applications to MRI and cancer detection remained 
alive even decades later. In 2008, indeed, Karathanasis et al. 191 evaluated 100 nm 
liposomes loaded with Gd(DTPA-BMA) for brain tumor MRI in a rat glioma model. 
The r1 and r2 relaxivities of the developed liposomal CAs were 0.65 and 20.7 
mM−1s−1 per Gd-chelate (measured at 25 °C and 9.4 T), respectively. Different from 
usual T1-shortening Gd-CAs, this liposomal encapsulated agent was used as a T2 
agent due to its high r2 relaxivity and produced negative signal enhancement. The 
tumor enhancement of the liposomal CA was visible for a period of three days. Using 
a 9.4 T MRI system, authors were able to track the intratumoral distribution of the 
Gd-loaded nanocarrier in a rat glioma model for a period of three days due to 
improved magnetic properties of the CA being packaged in a nanocarrier. Such a 
nanocarrier provides a tool for non-invasively assessing the suitability of tumors for 
nanocarrier mediated therapy and then optimizing the treatment protocol for each 
individual tumor. Additionally, the ability to image the tumor in high resolution can 
potentially constitutes a surgical planning tool for tumor resection. 
In the following year, Cheng et al. 188 synthesized a composite MR contrast 
platform, consisting of dendrimer conjugates encapsulated in porous polymersomes. 
The porous polymersomes, ~130 nm in diameter, were produced through the aqueous 
assembly of the polymers, polyethylene oxide-b-polybutadiene (PBdEO), and 
polyethylene oxide-bpolycaprolactone (PEOCL). Subsequent hydrolysis of the 
caprolactone (CL) block resulted in a highly permeable outer membrane. To prevent 
the leakage of small Gd-chelate through the pores, Gd was conjugated to PAMAM 
dendrimer via diethylenetriaminepentaacetic acid dianhydride (DTPA dianhydride) 
prior to encapsulation. The obtained nanoparticles exhibit improved permeability to 
water flux and a large capacity to store Gd-chelates within the aqueous lumen, 
resulting in enhanced longitudinal relaxivity. As a result of the slower rotational 
correlation time of Gd-labeled dendrimers, the porous outer membrane of the 
nanovesicle, and the high Gd payload, these functional nanoparticles were found to 
exhibit a relaxivity (R1) of 292, 109 mM−1s−1 per particle. The polymersomes were 
also found to exhibit unique pharmacokinetics with a circulation half-life of >3.5 hrs 
and predominantly renal clearance. When injected into living subjects, the gradual 
destabilization of the polymersomes allow the Gd-labeled dendrimers to be 
predominantly cleared by the kidneys, while still maintaining a relatively long 
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circulation time of >3.5 hrs. This could provide an important advantage over other 
long circulating MRI CAs, which generally require metabolism of the CA in the liver 
and exhibit prolonged retention in the body. In addition, with their work the authors 
showed also a way to prevent the leakage of encapsulated Gd through the membrane 
pores of the nanoconstruct. 
Zou et al. 192, for example, report an amphiphilic MRI-traceable liposome NPs 
encapsulating Gd-DOTA for in vivo inner ear visualization through MRI. They 
design these multifunctional NPs through the film hydration method that allows the 
encapsulation of Gd-DOTA inside the hydrophilic core of the NPs. They observe 
acceptable relaxivity values allowing visible signal characteristics for MRI. In vivo 
studies demonstrate that these systems are efficiently taken up by the inner ear after 
both transtympanic and intracochlear injection. The latter shows better NPs 
distribution throughout the inner ear, including the cochlea and vestibule, and 
induced stronger MRI signals on T1-weighted images. 
Bui et al. 193 produce lipid NPs containing phospholipids that express Gd-chelate 
or DTPA by incorporating DTPA-PE into the lipid core of the NPs and then adding 
Gd3+ to preformed NPs (for binding to Gd3+ as Gd-DTPA-PE chelate). They also add 
10-mole percentage of lipid conjugated to mPEG-PE to lipid nanoparticles in order 
to increase the bound water on the lipid nanoparticle surface, thereby increasing the 
MRI contrast. In this case, the following nanoparticle system shows an higher 
longitudinal relaxivity (33-fold) than the current FDA approved Gd-chelated CAs. 
In addition, intravenous administration of these Gd-LNP at only 3% of the 
recommended clinical Gd dose produce MRI signal-to-noise ratios of greater than 
300 times in all vasculatures. 
Kielar et al. (2010) 194 aimed to synthesize of a DOTA-like Gd complex 
functionalized with two hydrophobic chains on adjacent donor groups, endowing it 
with the ability to self-assemble into micelles and be incorporated into liposomes. 
The liposomes were prepared using a thin-layer deposition/extrusion technique, and 
their analysis using DLS showed that their diameters were in the range 45-60 nm. 
The r1 values of the two types of complexes embedded in liposomes were 17.0 and 
40.0 mM-1s-1 (measured at 298 K and 0.47 T), respectively. The remarkable 
relaxivity gain observed (135% at 0.47 T; 99% at 1.41 T) for GdDOTA(GAC12)2 
relative to the monosubstituted derivative results from the strong reduction in the 
Chapter 4. Application of the Hydrodenticity to the design of nanostructures for enhanced MRI 
 
 
 
 
 
 
107 
flexibility of the system associated with the hindered local rotation about the two 
aliphatic chains. These data were compared with related values for GdDMPE-DTPA, 
a neutral DTPA monoamide derivative carrying a fatty acid chain that exhibits slow 
water exchange (r1=12 at mM-1s-1 both 0.47 and 1.41 T). Next, authors noted that 
increasing the rate of water exchange resulted in an enhancement of r1 by 42%, 
whereas simultaneous optimization of water exchange and local rotation increased 
the relaxivity by ∼233%. Liposomes incorporating this paramagnetic building unit 
showed an unprecedented relaxivity enhancement relative to the derivative bearing 
only a single glutamic acid arm due to a favorable water exchange rate and optimized 
rotational rigidity. In addition, the used GdDOTA derivatives proved to be more 
stable and much more kinetically inert than other Gd chelates typically used in 
micelles and liposomes. 
Kamaly and collegues 187 synthesize a bimodal imaging liposome for cell labeling 
and tumour imaging. The lipid molecules are able to bear both fluorophore and CA 
on the same structure, thereby representing a useful probe for both MRI and 
fluorescence microscopy utility. Very briefly, they conjugate a rhodamine moiety 
onto a DOTA-bearing C-18 dialkyl lipid and complex Gd into the molecule to obtain 
the bimodal lipid Gd DOTA Rhoda DSA 1. The lipid is used to label IGROV-1 
human ovarian carcinoma cells and to image xenograft tumours in mice. The new 
paramagnetic and fluorescent lipid proved to be a valuable probe to obtain 
anatomical information, through MRI, and liposome biodistribution, through ex vivo 
fluorescence microscopy. 
Kono et al. 195 synthesize multi-functional pegylated liposomes having both highly 
thermosensitive polymers and newly synthesized Gd-chelate-attached dendron lipid 
(G3-DL-DOTA-Gd) with a compact conformation. The multifunctional liposomes 
show temperature-responsive drug release and MR imaging functions. In particular, 
authors load liposomes with Dox and tested the stability of the nanostructures, 
showing that liposomes are able to retain Dox below physiological temperature but 
release it immediately above 40°C. As far as the MRI properties, the developed 
liposomes exhibit the ability to shorten the longitudinal relaxation time with a 
relaxivity (5.5 mM-1s-1) higher than that of free Gd-DOTA (4.6 mM-1s-1). 
In addition, Na and co-worker 196 report dual functional liposomes co-encapsulating 
Dox and Gd as therapeutic and diagnostic carriers. They measure MR relaxivity and 
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cellular uptake showing that the liposomes can entrap 3.6 mM of Dox and 1.9 mM 
of Gd. Although the low relaxivity (5.5 mM-1s-1) compared to that of MRbester® due 
to limited water diffusion across the liposome membrane, the surface charge induced 
good cellular uptake, allowing a higher accumulation of Gd into cells than 
MRbester®. Additionally, Dox is more easily internalized to the nucleus compared 
to Doxil®. 
Li et al. 197, instead, prepare fluorescent and paramagnetic liposomes for early 
tumor diagnosis by incorporating a RGD-coupled-lipopeptide, synthesized using a 
cyclic RGD peptide headgroup coupled to palmitic acid anchors via a KGG 
tripeptide spacer, into lipid bilayers. As far as the paramagnetic liposomes, they 
adopted the thin film hydration method and hydrated the lipid film with commercial 
Gd-DTPA as MRI contrast agent. In vivo MRI scanning demonstrate that the signal 
enhancement in tumor after injection of RGD-targeted liposomes is significantly 
higher than non-targeted liposomes and pure Gd-DTPA. In addition, biodistribution 
study also show specific tumor targeting of RGD-targeted paramagnetic liposomes 
in vivo, proving them an effective means for noninvasive diagnosis of early tumor. 
Liao et al. 198 design a core-shell NPs system composed of a PLGA core and a 
paramagnetic liposome shell for simultaneous MRI and targeted therapeutics. They 
encapsulate Dox within biocompatible and FDA-approved PLGA NPs, and DTPA-
Gd is conjugated to the amphiphilic octadecyl-quaternized lysine-modified chitosan 
(OQLCS). The paramagnetic liposome shell is based on Gd-DTPA-conjugated 
OQLCS (Gd-DTPA-OQLCS), folate-conjugated OQLCS (FA-OQLCS), and 
PEGylated OQLCS (PEG-OQLCS). Briefly, the carboxyl groups of DTPA used as 
a chelating agent are combined with the amino groups of OQLCS. Then Gd is 
incorporated into the complex. As a result, the NPs show paramagnetic properties 
with an approximately 3-fold enhancement in the longitudinal relaxivity (r1 = 14.381 
mM−1s−1) compared to the commercial Gd-DTPA complex and exceptional 
antitumor effects without systemic toxicity. 
Another remarkable example as reported by Gianolio et al. 199. They prepare pH-
responsive Gd-DO3Asa-loaded liposomes which maintain the pH responsiveness of 
the unbound paramagnetic complex, and their relaxivities are markedly affected by 
the magnetic field strength, exhibiting a steep change in the relaxivity in the pH range 
5-7.5. Moreover, they provide a ratiometric method for measurement of the pH based 
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on a comparison of the relaxation effects at different magnetic fields, offering an 
alternative tool for accessing measurement of the pH without prior knowledge of the 
concentration of the paramagnetic agent. 
 
More recently, several liposomes and polymersomes have been developed to 
increase CAs’ relaxivity, improve cancer detection and for molecular imaging 
applications. 
Smith et al. (2013) 200 developed a simple process to load Gd exclusively on a 
liposome surface using a polymeric fastener. The fastener, so named for its ability to 
physically link two functional components together, consisted of chitosan substituted 
with diethylenetriaminepentaacetic acid (DTPA) to chelate gadolinium, as well as 
octadecyl chains to stabilize the modified chitosan on the liposome surface. The 
assembly strategy, mimicking the mechanisms by which viruses and proteins 
naturally anchor to a cell, provided greater T1 relaxivity than liposomes loaded with 
gadolinium in both the interior and outer leaflet. Liposomes were prepared by a film 
hydration method followed by sonication. The lipid film, formed as described above, 
was then hydrated with the aqueous mixture of gadolinium and DTPA-chitosan-g-
C18. The proposed process decouples particle assembly and functionalization and 
has considerable potential to enhance imaging quality while alleviating many of the 
difficulties associated with multifunctional particle fabrication. The average 
diameters of liposomes before and after one-hour incubation in serum-supplemented 
PBS were 4.3 ± 2 and 3.7 ± 2 µm respectively. Gadolinium loaded on the liposome 
modified by DTPA-chitosan-g-C18 significantly enhanced MR signal, compared to 
the liposome modified with DTPA-chitosan. At a given liposome concentration, R1 
of the suspension was increased with DTPA-chitosan-g-C18. However, the molar 
relaxivity of immobilized gadolinium was nearly the same across samples. 
Therefore, authors interpreted that the enhancement of R1 attained with 
DTPAchitosan-g-C18 is due solely to the higher loading of gadolinium on the 
liposome surface, noting that 30% of the DTPA-chitosan was desorbed upon 
exposure to GdCl3. Furthermore, the relaxivity was enhanced beyond that of the 
clinically used unconjugated DTPA-Gd complex with a molar relaxivity of 4.85 
mM−1s−1. Authors also evaluated Gadolinium-coated liposomes in vivo using murine 
ischemia models to highlight the diagnostic capability of the system. 
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Cittadino et al. (2013) 201 investigated the in vitro (relaxometry) and in vivo 
(melanoma tumour model on mice) MRI performance of liposomes incorporating 
either LIPO-GdDOTA-(GAC12)2 (LIPO=liposome, GA=glutaric acid) or an 
amphiphilic monoamide Gd agent conjugated with C18 chains 
LIPOGdDOTAMA(C18)2 as a reference. The liposomes were prepared using a thin-
layer deposition/extrusion technique. The mean hydrodynamic size of the liposomes 
was found to be around 140 nm with a polydispersity index value lower than 0.2. 
Through the NMRD profiles, authors showed a marked relaxivity difference over the 
entire frequency range investigated, and their shape is rather similar and typical of 
macromolecular systems characterised by a reduced rotational tumbling rate. They 
distinguished: 1) a region of constant relaxivity at low fields (0.01–0.5 MHz); 2) a 
dispersion around 1–3 MHz; 3) a peak centred about 20–30 MHz; and 4) a steep 
decrease of r1 at higher fields. However, although for LIPO-GdDOTAMA(C18)2 
the r1 peak (r1=11.4 mM-1s-1) is broad and centred at 30 MHz, for LIPO-
GdDOTA(GAC12)2 it is narrower and with a maximum at 20 MHz (r1=40.0 mM-
1s-1). As far as the in vivo studies, after about 7 h post-injection the contrast 
enhancement observed for the more efficient liposomes decreases rapidly and 
becomes lower than for LIPO-GdDOTAMA(C18)2. The relaxometric data and the 
quantification of the Gd complexes in the organs indicated that: 1) the differences in 
the contrast enhancement can be attributed to the different rate of water exchange 
and rotational dynamics of the Gd complexes; 2) the rapid contrast decrease is caused 
by a faster clearance of GdDOTA(GAC12)2 from the organs. The overall results 
highlighted clearly the superior relaxometric performance of the liposomes loaded 
with GdDOTA(GAC12)2 relative to the liposome formulation based on the 
GdDOTAMA(C18)2 complex. Therefore, GdDOTA(GAC12)2 complex may 
represent a good candidate for the development of improved MRI protocols based 
on paramagnetically labelled lipidic nanoparticles. 
Subsequently, Hossann et al. 202 investigate formulations of 6 clinically approved 
CAs encapsulated into thermosensitive liposomes (TLs): 
(1) Gd-DTPA (Magnograf®) from Marotrast GmbH, Jena, Germany; 
(2) Gd-BOPTA (Multihance®) from Bracco Imaging Deutschland GmbH 
(Konstanz, Germany); 
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(3) Gd-DOTA (Dotarem®) from Guerbet GmbH (Sulzbach/Taunus, Germany); 
(4) Gd-BT-DO3A (Gadovist™) from Bayer Vital GmbH (Leverkusen, 
Germany); 
(5) Gd-DTPA-BMA (Omniscan™) from GE Healthcare Buchler GmbH & Co. 
KG (Braunschweig, Germany); 
(6) Gd-HP-DO3A (Prohance®) from Bracco Imaging Deutschland GmbH 
(Konstanz, Germany). 
They observe that Omniscan™ and Prohance® are the most promising candidates 
to be encapsulated into DPPG2-TSL. In particular, Prohance® allows the highest 
loading capability (256 mM) due to the lowest osmolality and yields the highest 
relaxivity. Omniscan™ is the only formulation that could be stored at 4°C for weeks. 
The other CAs induce phospholipid hydrolysis, which results in unwanted CA 
leakage, and therefore reduce the shelf life of TSL. Nevertheless, Omniscan™ is 
associated with Nephrogenic Systemic Fibrosis (NSF) 105. The Human Serum 
Albumin (HSA) and Immunglobulin G (IgG) contribute to the increase of MRI signal 
at 30°C by increasing Pd. A high concentration of encapsulated CA is a prerequisite 
to achieve a sufficiently high Δr1 during heat triggered CA release combined with a 
low r1 at 37°C. Hence, the optimal CA is characterized by a non-ionic structure and 
a low contribution to osmolality. 
Cheng et al. (2014) 203 developed a highly efficient MRI CA based on stabilized 
porous phospholipid liposomes with encapsulated Gd-labeled dextran. Unilamellar 
liposomes were prepared using the film hydration method. To prevent small Gd-
chelates (i.e. Gd-DOTA) from leaking through the porous bilayer membranes, Gd-
DOTA was attached to large molecular weight dextran prior to encapsulation (this 
attachment increased proton relaxivity of GdDOTA by slowing the molecular 
rotation). In particular, 1 mL of Gd-DOTA-dextran (10 mg/mL) was added to the 
dried lipid film (2 mg of lipid) while non-entrapped Gd-DOTA-dextran was removed 
through repeated washing on centrifugal filter devices. The mean diameter of the 
liposomes was found to be about 100 nm. The highly porous membrane leads to a 
high relaxivity of the encapsulated Gd. Gd-DOTA-dextran encapsulated within the 
porous liposomes had an r1 of 9.9 mM−1s−1, which was similar to the r1 of Gd-
DOTA-dextran (9.4 mM−1s−1) in bulk water. This indicates that Gd-DOTA-dextran 
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encapsulated within the porous liposomes experiences a fast water exchange rate 
with surrounding bulk water. In contrast, Gd-DOTA-dextran encapsulated within the 
nonporous liposomes had an r1 of only 4 mM−1s−1, which is more than a 2.4-fold 
lower than the r1 for Gd-DOTA-dextran encapsulated into porous liposomes. 
Furthermore, the r1 measured from Gd-DOTA-dextran encapsulated into liposomes 
is 2.6-fold higher than the r1 of clinically used Gd-DOTA (3.9 mM−1s−1). By 
conjugating cancer-targeting ligands to their unobstructed outer surface, these CAs 
have the promise for use as targeted molecular imaging agents. 
Other authors report further interesting strategies for the development of new 
liposome-complexes. Kozlowska et al. 204, for example, synthesize liposomes loaded 
with Gd ions using different membrane-incorporated chelating lipids and 
functionalized with monoclonal anti-CD138 (syndecan-1) antibody for multiple 
myeloma and non-Hodgkin’s lymphoma diagnosis. In this case, the use of the 
polychelating amphiphilic polymer increases both the Gd content and the 
longitudinal relaxivity of the Gd-loaded liposomes as compared to Gd-DTPA-BSA 
equivalents. 
Then, Park and co-workers 205 develop nanohybrid liposomes coated with 
amphiphilic hyaluronic acid-ceramide for targeted delivery of anticancer drug and in 
vivo cancer imaging. Dox, an anticancer drug, and Magnevist, a Gd-based CA for 
MRI, are loaded into this nanohybrid liposomal formulation. They find that in vitro 
release and in vivo clearance of Dox as well as cellular uptake from the nanohybrid 
liposome is enhanced than that from conventional liposome, thanks to the prolonged 
circulation of the nanohybrid liposome in the blood stream and to the HA–CD44 
receptor interactions. 
Silva et al. (2015) 206 sinthesized complexes of Gd with N-octanoyl-N-
methylglucamine (L8) and N-decanoyl-N-methylglucamine (L10). These complexes 
were incorporated in liposomes as an attempt to further enhance the relaxivity. 
Liposomes were prepared by the thin-film method. Both the free and liposome-
incorporated gadolinium complexes showed high relaxation effectiveness, compared 
to commercial CA gadopentetate dimeglumine (Magnevist). The high relaxivity of 
these complexes was attributed to the molecular rotation that occurs more slowly, 
because of the elevated molecular weight and incorporation in liposomes. The results 
established that these paramagnetic complexes are highly potent CAs, making them 
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excellent candidates for various applications in molecular MR imaging. The fact that 
relaxivity of GdL8 complex was unaffected by incorporation into liposomes may be 
due to the reduced vesicle diameter (141 nm), resulting in elevated relaxation times, 
or to little restriction of the rotational flexibility of the complex. In addition to the 
greater diameter of the vesicle (169 nm) of Lipo-GdL10 sample, other factors may 
contribute to the significant increase of GdL10 relaxivity upon liposome 
incorporation. It is known that the incorporation of metal compound into 
nanoparticles can increase r1 due to the restriction of rotational flexibility of the 
compounds. Furthermore, the exposition of the metal at the external aqueous surface 
of the particle may facilitate the interaction of water molecules with the paramagnetic 
center. Incorporation into liposomes did not increase the relaxivity of Lipo-GdL8 
complex (r1 ∼ 11.92 mM−1s-1). However, an increase in relaxivity was observed for 
Lipo-GdL10 incorporated in liposomes. r1 and r2 relaxivities of the compound 
increase from approximately 12.3 to 15.5 and from 13.6 to 16.7 mM−1s-1. Moreover, 
the relaxivity values observed with complexes liposome incorporation are about 
three times higher than those of the commercial CAs used clinically (r1 ∼ 3.0–5.0 
mM−1s−1). 
Gu et al. (2015) 207 developed a novel gadolinium-loaded liposomes guided by 
GBI-10 aptamer to enhance magnetic resonance imaging (MRI) diagnosis of tumor. 
Nontargeted gadolinium-loaded liposomes were achieved by incorporating 
amphipathic material, Gd-(N,N-bis-stearylamidomethyl-N′-amidomethyl)-
diethylenetriamine tetraacetic acid, into the liposome membrane using lipid film 
hydration method. GBI-10, as the targeting ligand, was then conjugated onto the 
liposome surface to get GBI-10-targeted gadolinium-loaded liposomes (GTLs). Both 
nontargeted (NTLs) gadolinium-loaded liposomes and GTLs displayed good 
dispersion stability, optimal size, and zeta potential for tumor targeting, as well as 
favorable imaging properties with enhanced relaxivity compared with a commercial 
MRI CA, gadopentetate dimeglumine. Both NTLs and GTLs had average diameters 
at ~120 nm with a narrow particle size distribution index (0.30), implying their good 
dispersion stability, which may be an optimal size for tumor targeting. For NTLs and 
GTLs, the r1 values were 4.7±0.3 mM-1s-1 and 4.5±0.2 mM-1s-1, respectively, both 
significantly higher than that of Gd-DTPA solution. The increased r1 values suggest 
that Gd-loaded liposomal systems of NTLs and GTLs could act as an ideal T1 CA. 
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Increased cellular binding of GTLs to C6 cells was also confirmed by confocal 
microscopy, flow cytometry, and MRI, demonstrating the promise of this novel 
delivery system as a carrier of MRI CA for the diagnosis of tumor. These studies 
provide a new strategy furthering the development of nanomedicine for both 
diagnosis and therapy of tumor. 
Huang et al. (2015) 208 developed a dual-imaging diagnostic polymersome system 
featured with highly hydrated multilamellar wall structure capable of simultaneously 
embedding a hydrophobic near-infrared fluorophore, Cy5.5, and a paramagnetic 
probe, Gd cations. The polymersomes were obtained from the self-assembly of lipid-
containing copolymer, poly(acrylic acid-co-distearin acrylate), in aqueous solution. 
The Cy5.5 and Gd species were loaded into polymersomes via hydrophobic 
association (loading efficiency of Cy5.5 ca 74%) and electrostatic complexation (Gd 
ca 83%), respectively. Owing to the highly hydrated structure of vesicular 
membrane, the superior contrast enhancement of Gd-loaded liposomes in MRI was 
obtained as a result of prolonged rotational correlation time of Gd cations and fast 
water exchange from Gd to bulk solution. The system exhibits a 15-fold higher 
longitudinal relaxivity value (ca 60 mM-1s-1) than that (4 mM-1s-1) of the commercial 
CA, Magnevist, in phosphate buffered saline. The in vivo characterization 
demonstrates that liposomes exhibit a signal-to-noise ratio in T1-weighted MR 
image contrast similar to that of Magnevist, yet with a Gd dose 5-fold lower. Along 
with their non-toxicity at the dose used, these results demonstrate the great potential 
of the CGLPs as an advanced diagnostic nanodevice. An excellent contrast in NIR 
imaging at tumor site was attained following the intravenous injection of liposomes 
into Tramp-C1 tumor-bearing mice (C57BL/6). 
Xiao et al. 209 report liposomes loaded with Sorafenib (SF) and commercial Gd-
based CA (Gd-DTPA) for theranostic applications. Thin film hydration method is 
used to prepare liposomes exhibiting spherical shapes or ellipsoidal shapes, uniform 
particle size distribution (around 180 nm), negative zeta potential, high encapsulation 
efficiency and drug loading. As far as the longitudinal relaxivity, they achieve a value 
of 3.2 mM-1s-1, slightly lower than the commercial CA (4.5 mM-1s-1) and the MRI 
test show longer imaging time and higher signal enhancement at the tumor tissue. 
Furthermore, they demonstrate in vivo antitumor efficacy of the developed SF/Gd-
liposomes on hepatocellular carcinoma (HCC) in mice. To sum up, the authors show 
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that SF/Gd liposomes could be promising nano-carriers for MRI-guided in vivo 
visualization of the delivery and HCC treatment. 
Lorenzato et al. (2016) 210 showed that co-loading of a paramagnetic and a 
superparamagnetic MRI CA, affecting R1 and R2 respectively, in thermosensitive 
liposomes, allows for both monitoring liposomal biodistribution, as well as 
liposomal release. They developed three different thermosensitive liposomes (TSL) 
using the thin-film hydration technique, loaded either with a chelated gadolinium 
complex, citrated iron oxide nanoparticles or both. The first liposome formulation 
was hydrated with 250 mM of ProHance, the second formulation was hydrated with 
citrated-USPIO solution (50 mM iron content), the third formulation was hydrated 
with both 250 mM ProHance and citrated-USPIO solution (50 mM iron content), 
respectively. The authors measured and compared the MR properties before and after 
heating of these dual MRI CA formulations. They also investigated the utility of 
these formulations in an ex vivo renal vasculature system, showing that, when intact, 
the transverse relaxivity of the liposomes is high allowing detection of carriers in 
tissue. After heating the longitudinal relaxivity steeply increases indicating release 
of the small molecular contents. By choosing the appropriate MR sequences, 
availability and release have been evaluated without interference of one CA with the 
other. Regardless of the molecular cargo, these preparations showed a similar 
hydrodynamic radius (≈100 nm). Normalized to the phosphorus concentration, 
before release, Gd-loaded liposomes relaxivities r1, r2, and r2 * were found to be 0.1 
mM-1s-1, 1.6 mM-1s-1 and 3.8 mM-1s-1, respectively. For the two citrated-USPIO 
loaded liposomes, Gd-TSM and TSM, similarly low r1 values (r1 TSM = 0.1 mM-
1s-1 and r1 Gd-TSM = 0.3 mM-1s-1) were measured, whereas high r2 (r2 TSM = 8.8 
mM-1s-1, r2 Gd-TSM = 13.2 mM-1s-1) and r2* (r2* TSM = 11.9 mM-1s-1, r2* Gd-
TSM = 19.4 mM-1s-1) relaxivities were observed. After heating to 43 °C during 15 
min, no significant variations were measured for free Citrated-USPIOs or TSM 
whereas r1, r2, and r2* of Gd-TSM were found to increase by a factor 14.0, 1.1 and 
1.2. For Gd-TSL, finally, r1, r2, and r2* changed by a factor 27, 20 and 2.65, 
respectively. This concept allowed for MR monitoring of the drug delivery process, 
from the biodistribution of the carriers to the localized release of the contents. 
Liu et al. (2016) 211 encapsulated Magnevist (Gd-DTPA) into liposomes conjugated 
with IL-13 and characterized them by particle size distribution, cytotoxicity, and 
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MRI relaxivity. The average size of IL-13-liposome-Gd-DTPA was 137±43 nm with 
relaxivity of 4.0±0.4 mM-1s-1 at 7 Tesla. No significant cytotoxicity was observed 
with MTS assay and serum chemistry in mice. The MRI signal intensity was 
enhanced up to 15% post injection of IL-13-liposome-Gd-DTPA in normal brain 
tissue following a similar time course as that for the pituitary gland outside of the 
Blood-Brain-Barrier (BBB). IL-13-liposome-Gd-DTPA is able to pass through the 
uncompromised BBB and detect an early stage glioma that cannot be seen with 
conventional contrast-enhanced MRI. 
In the end, Tian et al. 212 synthesize Gd-DTPA-loaded mannosylated liposomes (M-
Gd-NL) and test their ability to target macrophages in Acute Pancreatitis (AP) and 
discriminate between mild and severe AP. Lipid film-based method is used to 
synthesize DSPE-PEG2000-Man liposomes encapsulating DPPE-DTPA-Gd, with 
size around 100 nm. In vitro tests show efficient bind and readily release of Gd-
DTPA into macrophages, resulting in enhanced MRI ability. Indeed, M-Gd-NL show 
a longitudinal relaxivity 1.8-1.9 higher than Gd-DTPA, as a consequence of the 
embedding of DPPE-DTPA-Gd into the bilayer of liposomes, which slowed down 
the tumbling motion of Gd complexes. As far as the safety profile, M-Gd-NL do not 
show any severe organ toxicity in rats, thus proving to be promising nanocarriers for 
clinical use and for the early detection of AP. 
 
Table 4.1 Literature review about liposomes for MRI 
Architecture Size 
Relaxivity 
(r1) mM-1s-1 
Tracer Application Year Ref 
Liposomes 
70 – 400 
nm 
- Gd-DTPA 
MRI 
Metastasis 
detection 
1989 190 
Liposomes 100 nm 0.65 – 20.7 Gd(DTPA-BMA) 
MRI 
Glioma 
detection 
2008 191 
Polymersomes 130 nm 
292 – 109 
per particle 
Gd-PAMAM-(DTPA 
dianhydrid) 
MRI 
Relaxivity 
enhancement 
Leakage 
prevention 
2009 188 
Liposomes 130 nm 0.033 – 2.2 GdDOTA 
MRI 
inner ear 
visualization 
2010 192 
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Liposomes 88 nm 13.6 GdDTPA 
MRI 
Relaxivity 
enhancement 
Vascular 
Contrast 
2010 193 
Liposomes 
45 – 60 
nm 
17.0 – 40.0 
GdDOTAGAC12 
GdDOTA(GAC12)2 
MRI 
Relaxivity 
enhancement 
Improve 
stability 
2010 194 
Liposomes 
48 – 110 
nm 
4.6 – 6.2 GdDOTA 
Temperature-
triggered 
release 
2011 195 
Liposomes 
95 – 120 
nm 
6.4 GdCl3 
Theranostic 
Doxorubicin 
delivery 
2011 196 
Liposomes 100 nm - GdDTPA 
Tumour 
targeting 
2011 197 
Polymersomes 430 nm 14.4 GdDTPA 
MRI 
and Targeted 
Therapeutics 
2011 198 
Liposomes 
120– 140 
nm 
11.2 – 17.7 Gd-DO3Asa 
MRI 
enhancement 
2012 199 
Liposomes 
4.3 – 3.7 
µm 
6.9 DTPA-chitosan-g-C18 
MRI 
Ischemia 
detection 
2013 200 
Liposomes 140 nm 11.0 – 40.0 
GdDOTAMA(C18)2 
GdDOTA(GAC12)2 
MRI 
Relaxivity 
enhancement 
Excretion 
efficiency 
2013 201 
Liposomes 150 0.1 – 6.0 
Gd-DTPA, Gd-BOPTA, 
Gd-DOTA, Gd-BT-
DO3A, Gd-DTPA-
BMA, and 
Gd-HP-DO3A 
Relaxivity 
enhancement 
Encapsulation 
efficiency 
2013 202 
Liposomes 100 nm 9.9 Gd-DOTA-dextran 
MRI 
Molecular 
imaging 
2014 203 
Polymeromes 170 nm 36 Gd–DTPA 
Detection of 
myeloma and 
non Hodgkin's 
lymphoma 
2014 204 
Polymeromes 130 nm 6 Gd–DTPA 
Cancer 
diagnosis and 
therapy 
2014 205 
Liposomes 
141 – 
196 nm 
11.9 – 15.5 
Gd-(N-octanoyl-N-
methylglucamine) 
Gd-(N-decanoyl-N-
methylglucamine) 
MRI 
Molecular 
imaging 
2015 206 
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Liposomes 120 nm 4.5 – 4.7 
Gd-(N,N-bis-
stearylamidomethyl-N′-
amidomethyl)-DTPA 
MRI 
Metastasis 
detection 
2015 207 
Polymersomes - 60.0 Gd3+ 
Mltimodal 
imaging (MRI 
+ optical) 
2015 208 
Liposomes 180 nm 3.2 Gd-DTPA 
Drug delivery 
and 
hepatocellular 
carcinoma 
treatment 
2016 209 
Liposomes 100 nm 0.2 – 4.9 
ProHance 
citrated-USPIO 
MRI 2016 210 
Liposomes 137 nm 4.0 Magnevist 
MRI 
Glioma 
detection 
BBB crosing 
2016 211 
Liposomes 100 nm 8.3 – 8.9 Gd-DTPA 
improved MRI 
in acute 
pancreatitis 
2017 212 
 
4.6.3. CHITOSAN-LOADED LIPOSOME NANOSTRUCTURES 
4.6.3.1. Effect of EtOH concentration 
In figure 4.14, the effect of two different EtOH volumetric fraction used in the 
solvent mixture to solubilize lipids (0.072 mg/ml) is shown. 
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Figure 4.14 a) TEM image and size distribution of chitosan-liposomes obtained at 65% EtOH + 
35% water in the side channels; b) TEM image and size distribution of chitosan-liposomes obtained 
at 80% + 20% water EtOH in the side channels. 
The optimal condition to make the self-assembly process effective can be observed 
in terms of liposomes production, morphology and size distribution. In particular, by 
solubilizing liposomes in a solvent mixture made of 65% EtOH and 35% MilliQ 
water, lower size and polydispersity can be achieved after the processing through the 
microfluidic platform. 
 
4.6.4. EFFECT OF CHITOSAN CONCENTRATION 
Figure 4.15 shows the effect of chitosan concentration on the liposomes formation 
and production. 
100 nm 100 nm
a) b)
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Figure 4.15 TEM image and size distribution of chitosan-liposomes obtained at 0 mg/ml (a), 0.1 
mg/ml (b) and 0.375 mg/ml (c) chitosan concentration. 
The best condition can be found at a chitosan concentration of 0.1 mg/ml. In fact, 
not only the size distribution is better, in terms of both size and polydispersity, than 
the trials with only acetic acid (Figure 4.15a) and the trial with 0.375 mg/ml (Figure 
4.15c), but also the structure of the liposomes seems to be able to encapsulate the 
polymer within the liposome core (darker liposome core in the TEM image). 
 
4.6.5. EFFECT OF ACETIC ACID CONCENTRATION 
Figure 4.16 shows the effect of increased acetic acid concentration on the liposome 
formation. 
a) b) c)
500 nm 500 nm500 nm
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Figure 4.16 a) TEM image and size distribution of chitosan-liposomes obtained at 1% acetic acid; 
b) TEM image and size distribution of chitosan-liposomes obtained at 10% acetic acid. 
In the case of 10% v/v acetic acid, the chitosan is no more entrapped into the 
liposome’s core. 
 
4.6.6. FLOW RATES OPTIMIZATION 
In figure 4.17, a comparison between two different flow rates used for the middle 
channel of the microfluidic platform is shown. 
In particular, Figure 7.5a shows chitosan-liposomes at 1 µL/min while Figure 7.5b 
shows the same liposomes obtained at 3 µL/min. 
a) b)
500 nm 200 nm
Chapter 4. Application of the Hydrodenticity to the design of nanostructures for enhanced MRI 
 
 
 
 
 
 
122 
 
Figure 4.17 a) TEM image and size distribution of chitosan-liposomes obtained with a flow rate 
in the middle channel equal to 1 µL/min; b) TEM image and size distribution of chitosan-liposomes 
obtained with a flow rate in the middle channel equal to 3 µL/min; 
The slightly higher flow rate in the middle channel represents not only an advantage 
in terms of higher throughput but also in terms of lower size and polydispersity. 
 
4.6.7. GD-DTPA ENCAPSULATION 
Figures 4.18 and 4.19 compare unloaded and Gd-loaded chitosan-liposomes at two 
different flow rate conditions (1 µL/min and 3 µL/min). As already highlighted in 
the previous paragraph, the value of 3 µL/min is the best flow rate condition even in 
the case of Gd-loaded liposomes. Smaller and less polydisperse chitosan-liposomes 
encapsulating Gd-DTPA can be obtained with a middle channel flow rate set at 3 
µL/min. 
a) b)
200 nm 200 nm
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Figure 4.18 a) TEM image and size distribution of chitosan-liposomes obtained with a flow rate 
in the middle channel equal to 1 µL/min; b) TEM image and size distribution of Gd-loaded chitosan-
liposomes obtained with a flow rate in the middle channel equal to 1 µL/min. 
 
 
Figure 4.19 a) TEM image and size distribution of chitosan-liposomes obtained with a flow rate 
in the middle channel equal to 3 µL/min; b) TEM image and size distribution of Gd-loaded chitosan-
a) b)
200 nm 100 nm
a) b)
200 nm 100 nm
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liposomes obtained with a flow rate in the middle channel equal to 3 µL/min. 
 
Moreover, in terms of longitudinal relaxation time (T1), the best process condition 
is obtained at 3 µL/min flow rate in the middle channel. As showed in Table 4.2 and 
4.3, the T1 of Gd-loaded chitosan-liposomes, is far lower than that of the unloaded 
chitosan-liposomes. Furthermore, after a dialysis to remove the excess of Gd-DTPA, 
the signal for the Gd-loaded chitosan-liposomes is still significant, meaning that the 
Gd-DTPA is encapsulated into the liposomes core. 
Table 4.2 Longitudinal relaxation time (T1). 
Flow rate middle 
channel 
(µL/min) 
Gd-DTPA 
T1 
(ms) 
1 unloaded 2350 ± 20 
1 loaded 1410 ± 20 
3 unloaded 2200 ± 20 
3 loaded 810 ± 10 
 
Table 4.3 Longitudinal relaxation time (T1) after dialysis. 
Flow rate middle 
channel 
(µL/min) 
Gd-DTPA 
T1 
(ms) 
3 unloaded 3360 ± 30 
3 loaded 1753 ± 8 
 
4.6.8. DISCUSSION 
Chitosan-loaded liposomes encapsulating a Gd-based CA are synthetized through 
an hydrodynamic flow focusing approach. On one hand, the chitosan gel structure 
entrapped within the core of the liposomes together enhances the relaxometric 
properties of the encapsulated CA; on the other, the lipid bilayer of the liposome 
prevents from leaking of the contrast agents, potentially favouring the 
biocompatibility of the nanostructure and its interactions with the surrounding bio-
environment. 
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Chapter 5.  
 
CONCLUSION AND FUTURE OUTLOOK 
 
 
 
 
5.1. CONTRIBUTION TO THE FUNDAMENTAL UNDERSTANDING AND 
APPLICATIONS 
Macromolecular Gadolinium Contrast Agents (GdCAs) offer high relaxivities and 
are thus promising GdCAs for Magnetic Resonance Imaging (MRI). In the last 
decades, indeed, several strategies have been developed to improve the relaxivity of 
GdCAs by using polymers and nanostructured materials and, more recently, the 
crucial role of polymer matrices in enhancing the relaxometric properties of GdCAs 
has been widely recognised. 
Unfortunately, despite these promising properties of macromolecular GdCAs, a 
comprehensive knowledge of the complex phenomena, which rule the interaction 
between polymers and GdCAs and are responsible for the relaxation enhancement, 
is still lacking. The fundamental understanding of those energetic and 
thermodynamic contributions, capable to boost the efficacy of commercial GdCAs 
by exploiting the properties of FDA approved biopolymers, is of crucial importance 
also because the relaxivity of clinically-used GdCAs is far below its theoretical limit 
and could be largely increased. The in-depth knowledge and the proper control of 
the behaviour of a library of different biopolymers combined with GdCAs could 
significantly contribute to the development of new advanced nanostructures for MRI. 
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We have observed that, in the presence of a crosslinked matrix, it is possible to 
modulate the water content of the system and, therefore, the hydration of the CA, by 
adjusting the crosslinking degree of the hydrogel structure. 
 
Figure 5.1 Graphical representation of the increased relaxivity obtained by tuning the hydrogel 
composition. 
This is due to the highly relaxing nano-scaled sinks forming around the GdCA, that 
we called Gado-Meshes. These nanocompartments create a favourable environment 
for the enhancement of the relaxivity due to the modulation of the characteristic 
correlation times (diffusion correlation time, residence lifetime, rotational 
correlation time) obtained through the polymer chain wrapping the GdCA as shown 
in Figure 5.2. 
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Figure 5.2 Schematic representation of the Gado-Mesh. 
In these conditions, a more stable polymer network can be obtained, promoting 
more efficient water-polymer and water-CA interactions that boost the relaxivity to 
higher values. The crosslinking degree is proposed as an advanced tool to modulate 
the hydrogel network and its properties, enabling the tuning of the relaxometric 
properties. We defined as Hydrodenticity the complex equilibrium between the water 
osmotic pressure, the elastodynamic forces of the polymer chains and the hydration 
degree of the CA which is able to increase the relaxivity of the CA itself. 
 
On the basis of the concept of Hydrodenticity, we produced different nanostructures 
for enhanced MRI, as summarized in the figure below (Figure 5.3): 
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Figure 5.3 Nanostructures for enhanced MRI developed starting from the concept of 
Hydrodenticity. 
 
Capitalizing on recent advances in nanotechnology together with a more 
fundamental insight in the behavior of these biopolymer systems could pave the way 
to the engineering of better and safer MRI CAs. Our findings about the interaction 
between biopolymer matrices and CAs could provide a flexible platform affording 
ample control over the physical attributes of the CAs and allow developing novel 
polymer-based CAs with increased relaxivity without inducing any chemical 
modification to the CA’s structure and biocompatibility. 
In addition, a better knowledge of the dynamics and properties of these systems 
could be scaled to nano-scale dimensions, inspiring the development of new 
nanostructured MRI CAs with tuneable relaxometric properties as well as the 
production of metallopolymer complexes or magnetic and conductive polymer-
based materials with applications in areas such as sensors, memory devices, 
nanolithography and controlled release. 
Hyaluronic acid-chitosan nanoparticles by coacervation in a microfluidic chip
- 50 nm-
--
Chitosan-liposomes by self-assembly in a microfluidic chip
Crosslinked hyaluronic acid nanoparticles by nanoprecipitation in a microfluidic chip
Crosslinked hyaluronic acid nanoparticles by high pressure homogenization
2 µm
100 nm
100 nm
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5.2. DRAFT OF A PRELIMINARY MODEL FOR THE STUDY OF POLYMER 
CONTRAST AGENTS 
The well-known Solomon-Bloembergen-Morgan (SBM) model has been theorized 
to describe the relaxation mechanisms and calculate the contrast agents’ relaxivity. 
As widely discussed in this thesis, the SBM model calculates the relaxivity as a 
function of multiple parameters characterizing the behaviour of the contrast agents 
and of the surrounding water molecules. 
We implemented this model using MatLab and we are now working to make it 
specific for the description of the relaxation enhancement in polymer-based contrast 
agents. The following figure is only an example of how the model simulates the 
behaviour of contrast agents with different rotational correlation times (τR). 
 
Figure 5.4 MatLab simulations of NMRD profiles for different types of contrast agents. 
Different Nuclear Magnetic Resonance Dispersion (NMRD) profiles are shown 
changing the value of τR and real relaxivity data from free Gd-DTPA and Gd-loaded 
polymer nanoparticles are also plotted. 
Further and in-depth studies are needed to complete and validate the drafted model. 
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5.3. FUTURE ACTIVITIES 
Future studies will be dedicated to: 
1. Test in vivo the efficacy of the obtained nanostructures; 
2. Decorate and functionalize the nanostructures with peptides and ligands to 
make them specific for certain biological targets; 
3. Develop and implement predictive models to describe the polymer-CA 
interactions and design new structures polymer-metal complexes with 
increased relaxivity; 
4. Design further nanostructures by using different biopolymers (e.g. PLGA, 
PLGA-PEG) and different MRI CAs; 
5. Build a library of biocompatible and clinically approved nanostructures that 
efficiently combines polymers and commercial MRI CAs for different 
diagnostic needs; 
6. Design nanostructures for multimodal imaging and theranostic applications 
as well as for precision medicine. 
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APPENDIX: 
SUPPORTING INFORMATION AND NANOSTRUCUTRES’ 
SYNTHESIS 
 
 
 
 
A.1. IMPACT OF BIOPOLYMERS ON RELAXOMETRIC 
PROPERTIES OF CONTRAST AGENTS: DEFINITION OF 
HYDRODENTICITY 
Supporting data, figures and tables. 
Table S1. Water self-diffusion coefficient measured at different Pulse Gradient Amplitudes for 
0.25 and 5 % w/v HA hydrogel solution at varying crosslinking degrees (different DVS 
concentrations). Diffusion coefficients have been measured 8 and 24 hours after crosslinking 
reaction. 
HA 
(% w/v) 
DVS (μL) 
D after 8h 
(*10-9 m2s-1) 
D after 24h 
(*10-9 m2s-1) 
0 0 3.19 ± 0.01 3.19 ± 0.01 
0.25 0 3.05 ± 0.01 3.06 ± 0.02 
0.25 5 3.01 ± 0.02 3.02 ± 0.01 
0.25 10 2.97 ± 0.03 2.98 ± 0.02 
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0.25 15 2.95 ± 0.03 2.96 ± 0.02 
0.25 20 2.92 ± 0.02 2.94 ± 0.02 
0.25 25 2.90 ± 0.02 2.92 ± 0.03 
5 10 2.88 ± 0.02 2.87 ± 0.01 
5 20 2.85 ± 0.01 2.85 ± 0.02 
5 30 2.83 ± 0.02 2.85 ± 0.01 
5 40 2.84 ± 0.01 2.84 ± 0.02 
 
Table S2. Range of water self-diffusion coefficient measured for Gd-DTPA solutions at different 
Gd-DTPA concentrations. 
Gd-DTPA 
(μM) 
D 
(*10-9 m2s-1) 
0 3.19 ± 0.01 
50 3.12 ± 0.02 
100 3.14 ± 0.02 
150 3.09 ± 0.02 
200 3.18 ± 0.01 
500 3.11 ± 0.02 
1000 3.13 ± 0.03 
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Figure S1. Titration curves of Gd-DTPA in water at 25 °C and 200 rpm. 
 
 
Figure S2. Titration curves of water into 0.2% w/v HA solutions at 25 °C and 200 rpm. 
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Table S3. Relaxation rates (1/T1) and relaxivity values for: (Sample 1) Gd-DTPA in water; 
(Sample 2) Gd-DTPA in 0.3% w/v HA solution; (Sample 3) Gd-DTPA in 0.3% w/v HA solution 
crosslinked with 2.4%  w/v DVS; (Sample 4) Gd-DTPA in 0.5% w/v HA solution; (Sample 5) Gd-
DTPA in 0.5% w/v HA solution crosslinked with 4%  w/v DVS; (Sample 6) Gd-DTPA in 0.7% w/v 
HA solution; (Sample 7) Gd-DTPA in 0.7% w/v HA solution crosslinked with 5.6%  w/v DVS 
Gd-
DTPA 
(mM) 
Sample 
1 
(s-1) 
Sample 
2 
(s-1) 
Sample 
3 
(s-1) 
Sample 
4 
(s-1) 
Sample 
5 
(s-1) 
Sample 
6 
(s-1) 
Sample 
7 
(s-1) 
0.000 
0.265 ± 
0.003 
0.264 ± 
0.001 
0.273 ± 
0.000 
0.273 ± 
0.001 
0.331 ± 
0.001 
0.265 ± 
0.003 
0.301 ± 
0.001 
0.010 
0.299 ± 
0.000 
0.309 ± 
0.000 
0.342 ± 
0.001 
0.315 ± 
0.001 
0.301 ± 
0.001 
0.309 ± 
0.001 
0.313 ± 
0.001 
0.020 
0.330 ± 
0.001 
0.347 ± 
0.001 
0.348 ± 
0.001 
0.339 ± 
0.001 
0.360 ± 
0.001 
0.345 ± 
0.000 
0.342 ± 
0.001 
0.025 - - 
0.351 ± 
0.001 
- - - - 
0.030 
0.361 ± 
0.000 
0.372 ± 
0.001 
0.381 ± 
0.001 
0.384 ± 
0.001 
0.382 ± 
0.001 
0.373 ± 
0.001 
0.403 ± 
0.007 
0.035 
0.379 ± 
0.001 
0.388 ± 
0.001 
- 
0.392 ± 
0.001 
- - - 
0.040 
0.397 ± 
0.002 
0.398 ± 
0.002 
0.449 ± 
0.001 
0.400 ± 
0.005 
0.445 ± 
0.001 
0.398 ± 
0.003 
0.402 ± 
0.006 
0.050 
0.441 ± 
0.003 
0.434 ± 
0.025 
0.436 ± 
0.001 
0.450 ± 
0.001 
0.510 ± 
0.002 
0.445 ± 
0.001 
0.468 ± 
0.001 
0.060 
0.450 ± 
0.001 
0.463 ± 
0.001 
0.510 ± 
0.001 
0.493 ± 
0.001 
0.485 ± 
0.001 
0.452 ± 
0.001 
0.549 ± 
0.003 
0.070 
0.485 ± 
0.001 
0.496 ± 
0.001 
0.512 ± 
0.001 
0.505 ± 
0.001 
- - - 
0.080 
0.528 ± 
0.001 
0.562 ± 
0.003 
0.599 ± 
0.004 
0.503 ± 
0.001 
0.610 ± 
0.015 
0.548 ± 
0.002 
0.547 ± 
0.001 
0.100 - 
0.588 ± 
0.069 
0.702 ± 
0.002 
0.599 ± 
0.004 
0.590 ± 
0.001 
0.594 ± 
0.002 
0.595 ± 
0.007 
0.130 - 
0.685 ± 
0.000 
0.722 ± 
0.002 
0.678 ± 
0.001 
0.701 ± 
0.001 
0.675 ± 
0.002 
0.699 ± 
0.001 
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0.150 - 
0.754 ± 
0.001 
0.805 ± 
0.002 
0.757 ± 
0.002 
0.797 ± 
0.001 
0.755 ± 
0.001 
0.786 ± 
0.002 
0.180 - - - - - 
0.845 ± 
0.002 
1.043 ± 
0.003 
0.200 
0.880 ± 
0.002 
0.909 ± 
0.003 
1.075 ± 
0.002 
0.904 ± 
0.008 
1.098 ± 
0.004 
0.971 ± 
0.002 
0.896 ± 
0.004 
0.250 - - - - - 
1.071 ± 
0.003 
1.126 ± 
0.004 
Relaxivity 
(mM-1s-1) 
3.067 ± 
0.044 
3.185 ± 
0.050 
3.805 ± 
0.164 
3.114 ± 
0.061 
3.655 ± 
0.225 
3.256 ± 
0.064 
3.410 ± 
0.205 
 
 
A.2. HIGH PRESSURE HOMOGENIZATION TO PRODUCE 
POLYMER NANOPARTICLES BASED ON HYDRODENTICITY 
Materials: All chemicals used are of analytical reagent grade quality and are 
employed as received. Sorbitan monooleate (Span® 80) (S80), 
Polyoxyethylenesorbitan trioleate (Tween® 85) (T85), Mineral oil (light oil, 0.8 
gr/cm at 25°C), Divinyl sulfone (DVS, 118.15 Da), Diethylenetriaminepentaacetic 
acid gadolinium(III) dihydrogen salt hydrate (Gd-DTPA, 547.57 Da), Sodium 
hydroxide pellets (NaOH), Acetone and Ethanol are purchased from Sigma Aldrich 
Chemical (Italy). Sodium Hyaluronate, with an average molecular weight of 850 kDa 
(purity 99%; Hyasis® 850P) and 42 kDa, is respectively supplied by Novozymes 
Biopharma and Bohus Biotech (Sweden) as dry powder and used without 
purification. 
Magnevist® (Bracco Imaging, Italy), a contrast agent commercially available, is 
used in this study. The water is purified by distillation, deionization, and reserve 
osmosis (Milli-Q Plus) and systematically used for sample preparation, purification 
and analysis. All experiments are repeated in triplicate and conducted at room 
temperature, 25°C. 
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Isothermal Titration Calorimetry: Titration experiments are performed by using a 
Nano ITC Low Volume calorimeter (TA Instruments). CA and polymer are prepared 
in double-distilled filtered water without any additives. The sample cell (700 µL) 
and the syringe (50 µL) are filled with aqueous solutions of HA and Gd-DTPA 
respectively. Syringe Gd-DTPA concentration is fixed at 1.5 mM, while different 
HA concentrations in the sample cell are tested, ranging from 0.3 to 0.7% w/v. The 
measurements are performed at 25 °C and at fixed stirring rate of 200 rpm. Fifty 
Injections, each of 1 μL of Gd-DTPA, are delivered in intervals of 500 s. The 
concentration of polymer is expressed as the mass of the repeat unit (unit mol/L). 
Data analysis and processing to provide ITC and enthalpy change (ΔH) profiles is 
carried out using the NanoAnalyze (TA instruments) and the OriginPro software. 
 
NMR Spectroscopy: 1H NMR spectra are recorded at 25 °C with Varian Agilent 
NMR spectrometer operating at 600 MHz to observe chemical interactions between 
polymer and chelating agent (DTPA). The NMR samples consisted of water solution 
of HA-DTPA at different molar ratios (HA/DTPA ranging from 0 to 0.5), with 10% 
v/v D2O. 
Diffusion-ordered NMR Spectroscopy (DOSY) are also performed and the z-
gradient strengths (Gz) is varied in 20 steps from 500 to 32500 G/cm (maximum 
strength). The gradient pulse duration (δ) and the diffusion delay (Δ) are kept costant, 
2 ms for δ and ranging from 7 to 1000 ms for Δ. After Fourier transformation and 
baseline correction, DOSY spectra are processed and analysed using Varian software 
VNMRJ (Varian by Agilent Technologies, Italy) in order to obtain the values of 
water self-diffusion coefficient. 
 
Differential Scanning Calorimetry: For all measurements the HA/water solution 
(Mw = 42 kDa) is used. The aqueous solutions are prepared in a concentration range 
of polymer 0.3–0.7% w/v. Next, Gd-DTPA is added as CA at different molar ratio 
HA/Gd-DTPA (from 1:0.25 to 1:3) and stirred for 12 h. The hydrated polymer 
samples, with and without CA, are sealed at room temperature in a Tzero hermetic 
pans prior to analysis. DSC measurements are performed in a TA Instruments’ 
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Q20TM calorimeter on samples between 5 and 10 mg. The samples are cooled down 
from 25°C to -50°C followed by heating scan up to 25°C. The same heating and 
cooling rate are 10°C/min for all runs. Samples are tested in triplicate to ensure 
reproducibility. For DSC and ITC measurements, we used low molecular weight HA 
(42 kDa) to highlight better the energetic contributions of different components 
without exceeding the maximum scale of the instruments. 
 
Time-Domain Relaxometry: The spin-lattice relaxation times (T1) are measured in 
a Bruker Minispec (mq 60) bench-top relaxometer operating at 60 MHz for protons 
(magnetic field strength: 1.41 T). Measurements are taken at 37°C, and before NMR 
measurements, the tube is placed into the NMR probe for about 15 min for thermal 
equilibration. Experiments are made using water solutions of Gd-DTPA (from 0 to 
0.1 mM) and HA (0.3, 0.5 and 0.7% w/v) crosslinked with DVS (DVS/HA weight 
percentage ratio equal to 1:8). T1 values are determined by both saturation (SR) and 
inversion recovery (IR) pulse sequences. The relaxation recovery curves are fitted 
using a multi-exponential model. Relaxivities, r1, are calculated from the slope of the 
regression line of 1/T1 [s-1] versus concentration with a least-squares method. 
 
Emulsion preparation: The emulsions are prepared at different water to oil (W/O) 
ratio (10/90 and 20/80 v/v). Mineral oil is used as oil phase (or continuous phase, PC) 
and W/O emulsions are made by varying the concentration of surfactants for the PC 
and water phase (or dispersed phase, PD) and the concentration of NaOH (from 0 to 
0.2 M) for the PD in order to obtain emulsion systems. In particular, a pair of non-
ionic surfactants, Span-80 (S80) and Tween-85 (T85), are used to prepare mixtures 
with a range from 4.3 to 7.65 of HLB values. Depending on the initial HLB to be 
used, mixtures of S80 and T85 are pre-dissolved in the appropriate S80/T85 mass 
ratios (from 50/50 to 75/25) in PC and PD, respectively. PD containing T85 and 
NaOH, is added dropwise to PC and W/O emulsions are prepared using a high-shear 
homogenizer (Silverson L5M-A, Silverson Machines Ltd, Waterside, UK). 
Homogenization of the Emulsion is performed from 5000 to 7000 rpm for 10 min at 
room temperature (25°C). 
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Temporal emulsion stability determination: The stability of emulsions is evaluated, 
at regular time intervals, by visual observation, measuring the height of the phase 
separated by creaming in centrimeters as a function of the time. In addition, an 
optical characterization of emulsion stability made is using a Turbiscan (Turbiscan 
LabThermo) by static multiple light scattering (MLS), sending a light beam from an 
electroluminescent diode (λ=880 nm) through a cylindrical glass cell containing the 
sample. The emulsion sample without dilution is placed in a cylindrical glass cell 
and two synchronous optical sensors receive the light transmitted through the sample 
(180° from the incident light) and the light backscattered by the droplets in the 
sample (45° from the incident light). The optical reading head scans the height of the 
sample in the cell (about 40 mm), by acquiring transmission and backscattering data 
every 40 μm. Transmitted and backscattered light are monitored as a function of time 
and cell height for a period of 24 hours at an interval of 30 min at 25°C. 
 
Preparation of DVS-crosslinked nanoparticles: Based on these preliminary results, 
PD/PC ratio in all samples is set at 10/90 v/v. In particular, for the preparation of 
cross-linked NPs, HA powder (Mw = 850 kDa) is dissolved at different 
concentrations (from 0.1 to 0.5% w/v) under alkalyn condition (NaOH ranging from 
0 to 0.2 M) by vigorous stirring at room temperature for 4 hours until a homogenous 
solution is obtained. Mineral oil and S80 (from 0.5 to 2% w/v) are separately mixed 
by stirring. PD is added drop-wise in the PC without stirring and all the components 
are completely mixed by homogenization at various times (5-15 minutes) and speeds 
(5000 - 7000 rpm). Then, the cross-linking agent (DVS) is added to the final 
emulsion (40 ml), which is kept in agitation on a laboratory tube rotator for 24 hours 
in order to obtain a homogeneous DVS distribution in the PD. To test DVS activity, 
various conditions of crosslinking reaction are explored: (1) at different DVS 
concentrations (from 0.01 to 0.5% v/v); (2) at three starting times of reaction 
(beginning, during and post homogenization) and (3) at different temperatures (4 and 
25°C). 
 
Loading of HA NPS with Contrast agents: After identifying the protocol to obtain 
NPs, Gd-DTPA is chosen as CA and mixed in the PD before homogenization. Gd-
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loaded HA NPs (HA-Gd NPs) are prepared using different HA/CA mass ratios (1:1, 
1:2 and 1:5). DVS are added post homogenization to the batch at room temperature 
using the same procedure reported above. 
 
Collection of the nanoparticles: Recovery of the NPs and their separation from 
W/O emulsion system is made using dialysis and/or ultracentrifugation. For dialysis 
method, the obtained emulsion is placed in a pre-washed cellulose membrane tubing 
(Spectra/Por® Dialysis Tubing, cut-off of 25 kDa). Organic impurities (Mineral oil 
and S80) are removed dialyzing first against solvents as acetone and/or ethanol, and 
gradually against water. Dialyzing solutions are changed at regular time intervals. In 
the case of ultracentrifugation, 1 ml of the emulsion is added to 5 ml of ethanol and 
mixed for 2 hours. Then, this mix is centrifuged with an ultracentrifuge (Beckman-
Coulter OPTIMA MAX-XP) at 55000 rpm for 20 min at 15°C. The resulting pellet 
is washed twice and resuspended in MilliQ water. The second step of 
ultracentrifugation (70000 rpm, 10 min, 15°C) is applied to the pellet in order to 
obtain purified NPs. 
 
Characterization of the nanoparticles: To determine size distribution of NPs, 
dynamic light scattering (DLS) are performed using a Zetasizer S-90 1000 HS 
(Malvern Instruments, UK). 
All samples are diluted (1:10) with deionized water to prevent the effects of 
multiple scattering. The measurement temperature is set at 25°C. The morphology 
and size of NPs are investigated using a ULTRA PLUS field emission Scanning 
Electron microscope (FE-SEM Carl Zeiss, Oberkochen, Germany) and a 
Transmission Electron microscopy (TEM, TECNAI). In the first case, the samples 
are coated with gold (7 nm). 
 
Determination of Gadolinium loading by ICP-MS: The quantitative determination 
of loaded Gd in HA NPs is assessed by ICP-MS (NexION 350, Perkin Elmer) 
without any previous digestion processes. For all examinations, purified NP 
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suspensions are used. The non-encapsulated Gd-complexes are separated from the 
NPs by high speed centrifugation (55000 rpm, 20 min, 15 °C). 
 
MRI Testing: To explore the potential of Gd-loaded HA NPs as MRI contrast agent, 
MRI in vitro test is performed at two different magnetic fields, 1.5 T and 3 T MR 
(Philips Achieva) using Sense Head 8 coil. The T1-weighted MR images of HA NPs, 
unloaded and loaded with Gd-DTPA at different concentrations using an inversion 
recovery sequence are measured with the following parameters: TR = 2500 ms; TE 
= 12 ms; TI = 50, 100, 200, 400, 800, 1100, 1800 ms; FOV= 180x146 mm; slice 
thickness = 4 mm, acquisition matrix = 360x292. 
The signal intensity of the samples is measured on the obtained T1-weighted MR 
images and compared to Gd-DTPA. 
 
NMR dispersion measurements: The proton 1/T1 NMRD profiles are measured 
using a fast-field-cycling Stelar SmarTracer relaxometer over a continuum of 
magnetic field strengths from 0.00024 to 0.25 T (which correspond to 0.01 - 10 MHz 
proton Larmor frequencies). The uncertainty of these measurements is less than 1%. 
Additional data points in the range 15 - 70 MHz are obtained using a Stelar 
Relaxometer and a Bruker WP80 NMR electromagnet adapted to variable-field 
measurements (15 - 80 MHz proton Larmor frequency). 
 
Supporting data, figures and tables. 
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Figure S3. Photografic image of the appearance of emulsions at 25 °C by the effect of increasing 
concentration of surfactants and NaOH [(a) 0 M; (b) 0.1 M; (c) 0.2 M] on stability of W/O (10/90 
and 20/80) emulsion after 12 h. 
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Figure S4. Trasmission and backscattering spectra of W/O (10/90) emulsion (total volume, 20 ml; 
5000 rpm, 10 min) with 1% w/v of S80 without (a) and with (b) 0.2 M NaOH. 
 
Table S4. Experimental conditions for production of HA-NPs. 
Pd / Pc a) 
HA b) 
[% w/v] 
NaOH 
[M] 
DVS c) 
[% v/v] 
Span-80 
[% w/v] 
10 / 90 
0.1 
0 
0.1 
0.2 
0.045 1 
0.25 
0 
0.1 
0.2 
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0.5 
0 
0.1 
0.2 
a) Pd is the volume of the disperse phase, Pc is the volume of the continuous phase; b) Hyaluronic 
Acid; c) Divinyl Sulfone 
 
 
Figure S5. Optimization of HA NPs synthesis. SEM images of crosslinked nanoparticles (0.5% 
w/v HA; 18 µL (0.045% v/v) of DVS; 40 mL of W/O (10/90) emulsion; 5000 rpm, 10 min, RT, 
using high-shear homogenizer) under various conditions: HA’s concentration, (a) 0,5% w/v; (b) 
0,25% w/v and (c) 0,1% w/v. Start of reaction, (d) during, (e) end and (f) after homogenization. 
DVS’s concentration: (g) 18 µL and (h) 200 µL (0.5% v/v). 
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Figure S6. SEM images of crosslinked HA nanoparticles (0.5% w/v of HA; 1% w/v of S80; 
0.045% v/v of DVS) without (a) and with (b) contrast agent. 
 
 
A.3. MICROFLUIDIC FLOW FOCUSING APPROACH TO PRODUCE 
POLYMER NANOPARTICLES BASED ON HYDRODENTICITY 
Materials. Sodium Hyaluronate (Mw = 42 kDa) is purchased from Bohus Biotech 
(Sweden). Diethylenetriaminepentaacetic acid gadolinium(III) dihydrogen salt 
hydrate Gd-DTPA (empirical formula: C14H2OGdN3O10xH2O; Mw = 547.57 
g/mol). Non ionic surfactant Span80 (formula C24H44O6 Formula Weight: 428.62 
g/mol). Divinyl Sulfone (or Vinyl Sulfone) contains < 650 ppm hydroquinone as 
inhibitor (purity 97%; density 1.117 g/ml at 25°C (lit.); molecular formula: 
C4H6O2S; Mw = 118.15 g/mol). Acetone (CHROMASOLV, for HPLC ≥ 99.8; 
molecular formula: CH3COCH3; Mw = 58.08 g/mol). Ethanol (ACS reagent, ≥ 99.5 
(200 proof), absolute; molecular formula: CH3CH2OH; Mw = 46.07 g/mol). Sodium 
Hydroxide NaOH (ACS reagent, ≥ 97.0%, Mw = 40.00 g/mol). Gadolinium Chloride 
Solution GdCl3 (Mw = 263.61 g/mol) and Sodium Chloride NaCl (ACS reagent, ≥ 
99.0%, Mw = 58.44 g/mol) are purchased from Sigma-Aldrich Co. The water, used 
for synthesis and characterization, is purified by distillation, deionization, and 
reserve osmosis (Milli-Q Plus). 
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Microfluidic set-up for Flow-Focusing approach. Our microfluidic device “Droplet 
Junction Chip”, (depth x width 190 µm x 390 µm) is purchased from Dolomite 
Centre Ltd. It is a glass microfluidic device designed for generating droplets. The 
internal surface of the channel is coated with the hydrophobic material. On the chip 
there are two separate droplet junctions, which can be used in combination. For our 
experiments, we used only X-junction with three inlet channels and a single outlet 
channel that can be used to mix and react three reagents. The device has a Flow-
Focusing geometry with 90° angle between the inlets to enhance the diffusion 
process. It is compatible with Chip Interface H for fluidic connections. Three-way 
isolation Ethylene tetrafluoroethylene (ETFE) valves, connected to the syringes and 
the microfluidic device, make the automatic fill-in of the syringes feasible, thus 
allowing a continuous dispensing of reagents. The linkage between Fluorinated 
ethylene propylene (FEP) tubes and device is carried out through a specially 
designed connection with Polytetrafluoroethylene (PTFE) connectors. The Flow 
Focusing behavior on the microchannel is observed using an Optical Fluorescence 
Microscope (Olympus IX71) with a 4x scanning objective. 
 
Microfluidic Route of production and characterization. Multiple factors 
influencing the production process of cHANPs through the microfluidic platform 
have been evaluated in a previous publication 93. Main steps of this protocol and 
furthers used in the present work are summarized here: 
 Flow Rate Ratio: ratio between Volume Flow Rate Solvent and Volume 
Flow Rate Non-Solvent (see paragraph 2.4 and Supporting Information); 
 Crosslinking strategy: (1) premix of DVS into the middle channel or (2) 
adding DVS into the side channels (see paragraph 2.5 and Supporting 
Information); 
 Effect of crosslinking agent’s concentration, process temperature, type of 
surfactant, NaOH and NaCl concentration and other parameters have been 
widely discussed in our previous work 93. 
After the nanoparticles’ synthesis, further properties of cHANPs are also evaluated: 
 Loading capability (see also Supporting Information); 
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 Stability in water (see also Supporting Information); 
 Longitudinal relaxation times, rates and  relaxivity (see paragraph 2.9 and 
Supporting Information); 
 Swelling ratio (see also Supporting Information). 
Finally, the following hydrogel structural parameters are theoretically computed 
and their relationships with relaxation parameters are evaluated: 
 Crosslink density (see also and Supporting Information); 
 Mesh size (see also and Supporting Information). 
 
Preparation of Nanoparticles. Different flow rates are tested and the influence of 
the Flow Rate Ratio (FR2), defined as the ratio between Volume Flow Rate Solvent 
and Volume Flow Rate Non-Solvent, is determined. For the feasibility study, a 5 mL 
aqueous solution containing HA concentrations ranging from 0.01 to 0.1% w/v is 
used to examine the effect of the nanoprecipitation by flow-focusing only due to the 
concentration of the polymer. Higher HA concentrations provide massive 
precipitation dealing to a strong interference on the Flow Focusing and consequently 
on the nanoparticle size. Among several tested molecular weights of HA, 42 kDa is 
selected as the optimal one because it can provide smaller nanoparticles . The initial 
solution is kept under continuous stirring for at least 4 h and, then, injected through 
the middle channel. The middle flow rate is ranged from 5 to 100 µL/min. A Non-
Solvent, i.e. acetone as suggested elsewhere[47], is injected through the side channels 
to induce nanoprecipitation by a Flow-Focusing approach. Side flow rates are 
changed from 50 µL/min to 300 µL/min, with a step of 10 µL/min. Precipitated 
nanoparticles are collected in a petri glass containing Non-Solvent and kept under 
continuous stirring. The stirring, conducted over 8 hours, is used to promote the 
diffusion of DVS and consequently to improve the crosslinking reaction. 
 
Crosslinking reaction by DVS. Crosslinking reaction by Divinyl Sulfone (DVS) is 
studied in the microfluidic system at a concentration of NaOH and NaCl ranging 
from 0.1 M to 0.3 M and from 0.02 to 0.2 M, respectively. Acetone, Ethanol and 
APPENDIX 
 
 
 
 
 
 
155 
Isopropanol are tested as Non-Solvent and are introduced in the side micro-channels, 
as already explained in our previous work 93. 
Two crosslinking scenarios are investigated: (1) premix of DVS into the middle 
channel or (2) adding DVS into the side channels. The crosslinking agent is injected, 
alternatively, into the side channels or in the middle channel at different 
concentrations, ranging from 0 to 8 v/v % and from 0 to 20 v/v %, respectively.  
Three different surfactants are tested at various reagent concentrations and flow 
rates. Tween 85 (ranging from 0.5 to 1% w/v), Tween 21 (ranging from 0.5 to 3% 
w/v), and Span 80 (ranging from 0.5 %w/v to 1.5 %w/v), are mixed to the Non-
Solvent or to the aqueous solution. In the first scenario (1), the solvent phase 
containing also DVS is kept at a constant T of 5 °C to avoid undesired crosslinking 
effects; the device is instead heated to 35 °C. 
 
Purification, recovery, characterization of nanoparticles. Purification is performed 
by a solvent gradient dialysis or by ultracentrifugation. Typically, two mL of the 
produced nanoparticles is collected and used for further analysis and size 
characterization. A Spectra Por Cellulose Membrane 6 (Molecular Weight Cut Off 
MWCO 50.000) is used for purification protocol. A typical procedure consists of 
loading collected samples into dialysis tube and keeping the buffer solution 
(Phosphate-Buffered Saline, pH 6.8, room temperature; final concentration of 10 
mM PO43−, 137 mM NaCl, and 2.7 mM KCl) under continuous stirring at 130 rpm 
to increase the diffusion rate. The first purification step is in Ethanol: 
- Purify the sample for 2 hours in 70% Acetone + 30% Ethanol; 2 hours in 50% 
Acetone + 50% Ethanol; 2 hours in 30% Acetone + 70% Ethanol; 2 hours in 
100% Ethanol. 
The second purification step is in water: 
- Purify the sample for 2 hours in 70% Ethanol + 30% MilliQ water; 2 hours in 
50% Ethanol + 50% MilliQ water; 2 hours in 30% Ethanol + 70% MilliQ water; 
2 hours in 100% MilliQ water. 
The concentration gradient of water is slowly added to the buffer solution to avoid 
aggregation and diffusion phenomena across the membrane. Dynamic light 
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scattering is used to determine nanoparticle size. Nanoparticles are concentrated by 
ultracentrifugation. The recovery is performed at 15°C, at 80000 rpm for 15 minutes. 
After these treatments, a hundred microliters of purified samples are deposited on a 
polycarbonate Isopore Membrane Filter (0.05, 0.1 and 0.2 µm) by ultrafiltration 
vacuum system. The precipitated or deposited particles are gold palladium coated, 
and a ULTRA PLUS Field Emission Scanning Electron Microscope (FE-SEM Carl 
Zeiss, Germany) is used to observe particles’ morphology. Transmission Electron 
Microscope (TEM) and Cryo-TEM is also used to characterize the samples. It is 
worth highlighting that all nanoparticles are purified in Ethanol to remove partially 
the unreacted reagents and to allow us the SEM characterization deposing the sample 
on a polycarbonate Isopore Membrane Filter (0.015, 0.05 and 0.1 µm) by 
ultrafiltration vacuum system. 
 
Loading Capability. Loading Capability is calculated collecting data by Induced 
Coupled Plasma (ICP-MS). NexION® 350, Perkin Elmer Spectrometer. 
Nanoparticles are suspended in a solution of deionized (DI) water at a concentration 
of 250,000 particles/mL. Nanoparticles Tracking Analysis is used to calculate the 
number of nanoparticles. An acid compound is not added to avoid dissolution of the 
nanoparticles. All data are collected and processed using the Syngistix Nano 
Application Module. Gd is measured at m/z 157 using a 100 µs dwell time with no 
settling time. 
The lyophilization of cHANPs is performed using a freeze-dryer Christ, 1-4LSC. 
Briefly, a Freezing step for 3 hours at -80 °C with a cooling profile of 1 °C/min is 
applied, sublimation at a shelf temperature of 6 °C and pressure of 0.85mbar for at 
least 24 h and finally, secondary drying at 25 °C and 0.03 mbar for 5-6 hours. 
Trehalose or sucrose ranging from 1 to 3% w/v is added as cryoprotector if necessary 
for re-suspension. Dried particles are also observed by Field Emission-SEM. 
 
Stability and release study of cHANPs. The Gd-DTPA loaded cHANPs are mixed 
with 150 μL of PBS. The nanoparticles are kept shaking at 100 rpm at 37 °C. The 
solution is divided into two equal parts at 4, 12, 24, 48, 96 and 172 h post incubation. 
One-half of the solution is assessed by ICP-MS for the total concentration of Gd3+ 
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ions loaded within the nanoparticles. The other half of the solution is filter-spun 
using 0.45 μm filter columns at 14,000 rpm for 5 min, and the filtrate is analyzed for 
Gd3+ ions. The two concentrations are compared, and the amount of Gd3+ ions 
released over time is determined. To assess the long stability of the nanoparticles, 
only conditions that do not produce a swelling behaviour are tested. The release 
profile of Gd-DTPA is measured at different time points, namely 12, 24, 48 h, both 
in water and under two physiologically relevant conditions, namely stationary and 
constant shaking in PBS (pH= 7.4, 37°C). 
 
In vitro relaxivity study. Empty nanoparticles and nanoparticles containing Gd-
DTPA at different concentrations are tested by in vitro MRI and results are compared 
with Magnevist, Gd-DTPA in water as a control. After vigorously stirring, changes 
in longitudinal relaxation time (T1) are evaluated at 1.5 T by Minispec Bench Top 
Relaxometer (Bruker Corporation), adding 300 μL of the sample to a specific tube. 
Only results about T1 will be reported. Finally, relaxivity r1 is calculated using 
weighted linear regression (R1=1/T1 s
-1 relaxation rate plotted against Gd 
concentration, mM, and r1, mM
-1 s-1, is the slope of the fitted curve). Estimation of 
measurement uncertainty is evaluated using weighted linear regression. 
Furthermore, the relaxation time distribution was obtained by CONTIN Algorithm. 
The relaxation spectrum was normalized with respect to the CONTIN processing 
parameters. The integral of a peak corresponds therefore to the contribution of the 
species exhibiting this peculiar relaxation to the relaxation time spectrum. 
 
Swelling Ratio and Hydrogel parameters. Swelling Ratio (SR) is calculated with: 
𝑆𝑅 =
𝑑𝐻2𝑂
𝑑𝑒𝑡ℎ
 
where 𝑑𝑒𝑡ℎ (in nm) 𝑑𝐻2𝑂 (in nm) are the nanoparticle’s diameters in Ethanol and 
in water respectively (for further details about the swelling ratio calculation please 
refer to the Supporting Information at the paragraph “Calculations of the hydrogel 
network parameters”), measured by Dynamic Light Scattering. A simplified version 
of the Flory-Rehner equations are used in order to compute the hydrogel structure 
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parameters (𝑀𝑐̅̅ ̅̅ : molecular weight between crosslinks (g/mol); 𝑣𝑒: effective 
crosslink density (mol/cm3); ξ: mesh size (nm). See Supporting Information for 
detailed calculations of the hydrogel network parameters. 
 
Supporting data, figures and tables. 
 
Figure S7. Microfluidic device. “Droplet Junction Chip 190 µm” with two configurations T- and 
X- junction, which can be used in combination. Droplet Junction Chip is compatible with Chip 
interface H for fluidic connections. 
 
Table S5. Dynamic Light Scattering. z-Average (nanoparticles diameters) and Standard 
Deviation (SD) in Ethanol at different Flow Rate Ratio FR2. 
Solvent (S) 
Flow Rate 
[μL/min] 
Non-Solvent 
(NS) Flow Rate 
[μL/min] 
Flow Rate 
Ratio 
S/NS 
z-Average 
[nm] 
Mean SD 
40 100 0.4 218.2 40.58 
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80 0.5 364.6 65.83 
60 0.67 480.8 70.99 
50 0.8 523.2 101.92 
30 1.3 1001.3 144.46 
30 
100 0.3 35 9 
80 0.37 86.5 19.30 
60 0.5 246 38.46 
50 0.6 341.8 67.74 
40 1 684.4 212.57 
30 1.5 890.1 377.78 
 
A feasibility study was done to obtain a narrow Flow-Focusing that induces 
Nanoprecipitation Reaction in a continuous flow within our microfluidic device. The 
presence of precipitate in the mixing channel and the width of hydrodynamic 
focusing are considered. Optimal conditions provide an absence of a precipitate in 
the mixing channel and a narrow focusing. 
Nanoparticles are formed via a two-stage process: (i) a Nucleation stage, in which 
seed particles spontaneously precipitate from solution; (ii) a more gradual Growth 
phase, in which diffusion of solutes from the solution to the seed surface proceeds 
until the final particles size is attained. As more widely explained in our previous 
work1, the increase of the non-solvent Flow Rate and, therefore, the reduction of FR2 
(from 0.5 to 0.3), causes a more stable and narrow hydrodynamic focusing (Figure 
S8 a). In this situation, the extraction is faster and, therefore, nucleation is favored to 
the detriment of the growth, obtaining nanoparticles smaller and monodisperse 
(Figure S8 b). Conversely, higher FR2 increases the width of the middle stream, 
requiring a longer time to perform the mixing by diffusion and the non-solvent 
extraction by means of the nearby streams. This effect results in a larger amount of 
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solvent in the final mixture possibly causing core swelling, hence the formation of 
large and polydisperse nanoparticles (Figure S8 c). For these reasons 0.3 is chosen 
as optimal FR2. 
 
Figure S8. Nanoprecipitation through Flow-Focusing. (a) Representation of microfluidic 
device consisting of three inlets. Nanoprecipitation is generated by hydrodynamic Flow Focusing 
with a central stream of polymer solution and two side streams of acetone at standard conditions: 
FR2=0.3, HA=0.05% w/v, NaOH=0.2 M, NaCl=0.05 M. FE-SEM images of nanoparticles in 
Ethanol at standard conditions when (b) FR2 is 0.3 and (c) FR2 is 0.5. 
Preferred optimal values are selected as “standard conditions”, providing the 
prolonged stability of the hydrodynamic flow focusing, the absence of massive 
precipitation (Figure S8 a) and a higher yield of nanoparticles collection and 
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monodispersity (Figure S8 b and c). These optimal microfluidic conditions are used 
for all experiments. 
 
Encapsulation of Gd-DTPA: Interference of Gd-DTPA on nanoprecipitation. Once 
selected the best FR2, the influence of the Gadolinium on nanoprecipitation is also 
evaluated. The entrapping of GdCl3 or Gd-DTPA by adding the metal complex to 
the aqueous solution is exploited. Different GdCAs concentrations are tested ranging 
from 0.005 to 0.1% w/v to investigate relaxometric properties, but a significant 
interference on Flow-Focusing pattern (Figure S9) and an increasing in size and 
polydispersity of the nanoparticles is suddenly measured (Table S6 a and b). 
Although a further lowering of the amount of Gd-DTPA in the process can reduce 
this strong instability, we keep Gd-DTPA at 0.1% w/v to maximize the final Gd 
concentration within the collected nanoparticles and, therefore, to perform a reliable 
study on the relaxometric properties. As far as the results shown in Table S6, it is 
worth commenting that, despite size distributions of GdCl3 are better compared to 
the ones of Gd-DTPA, GdCl3 is highly toxic and not approved for clinical 
development. Therefore, we chose Gd-DTPA as being one of the most clinically used 
and FDA approved GdCAs. 
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Figure S9. Gd-DTPA interference. Interference on Flow-Focusing pattern in the presence of Gd-
DTPA. 
 
Table S6. Nanoparticles size. Increasing in size and polydispersity of nanoparticles at different 
(a) Gd-DTPA and (b) GdCl3 concentrations. Modal values of the particle size distributions are 
reported for each Gd-DTPA and GdCl3 concentration. 
a)  
Gd-DTPA concentration 
[% w/v] 
Nanoparticles size 
[nm] 
Mean SD 
0.005 100 57 
0.01 150 60 
0.05 200 70 
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0.1 450 156 
   
b)   
GdCl3 concentration 
[% w/v] 
Nanoparticles size 
[nm] 
Mean SD 
0.005 105 40 
0.01 110 25 
0.05 125 45 
0.1 123 10 
 
The interference of Gd-DTPA during polymer precipitation is overcome by finely 
tuning process parameters and leveraging the use of hydrophilic-lipophilic balance 
(HLB) of surfactants and pH conditions as discussed in our previous work1. At the 
end, after the optimization, the sizes of all the nanoparticles with Gd-DTPA and DVS 
will be 35 nm. 
 
Crosslinking reaction by DVS. When DVS is added to the middle channels, optimal 
conditions regarding the stability of the MFF are only reached at DVS concentrations 
ranging between 0.6 and 1.2% v/v and by injecting Span80 at 0.5% v/v in the side 
phase. At higher concentration, spherical morphologies are not observed, and a 
massive precipitation is detected (Figure S10, a and b). Morphologies obtained for 
optimal conditions are already displayed in Figure 1 d and e of the main manuscript. 
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Figure S10. Crosslinking reaction. FE-SEM images of morphologies obtained by adding a high 
concentration of DVS (a) in middle channel and (b) in side channels. Images show that the massive 
precipitation along the main channel of the microfluidic device causes the formation of large 
aggregates. 
 
Loading Capability. We considered loading capability for both crosslinking 
strategies (Table S7) using the following equation: 
% 𝑳𝑪 = 𝑪𝒊𝑽𝒊 𝒎𝒏𝒑𝒔⁄  
Table S7. Loading Capability. Loading Capability (LC) of Gd-DTPA loaded cHANPs for both 
crosslinking reaction strategies at standard conditions. The table shows how the LC increases when 
DVS is added in the middle channel. 
 
DVS concentration 
[% v/v] 
Loading Capability 
[%] 
DVS middle channel from 0.6 to 1 from 22 to 59 
DVS side channels from 4 to 4.5 from 26 to 35 
 
The proposed formulations also affect the Gd-DTPA Loading Capability (LC), as 
reported in Table S7. Furthermore, release behavior under shaking conditions is also 
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evaluated with respect to the in vitro MRI signal. Even if more stable nanoparticles, 
obtained by adding DVS in the side channels, preserve their spherical shape beyond 
96 h under shaking conditions, the lowering of the MRI signal reveals a partially 
reduced payload of metal compounds after 96 h. The experimental evidence clearly 
reports that the nanoparticles size, morphology and swelling behavior are highly 
sensitive to the proposed strategies. Differences between nanoparticles stability 
obtained through both formulations can be attributed to the diverse reaction-diffusion 
pathways of DVS and the barrier effect of Span80. In the first strategy, the formation 
of the crosslinked hydrogel structures is probably favored by the premixing of DVS 
in the aqueous environment promoting the fastness of the reaction at the nozzle 
section. Additionally, Span80 reduces the water extraction delaying the precipitation 
and, at the same time, increasing the water and Gd content in the nanoparticles. We 
could hypothesize that this phenomenon preserves a high hydration level within the 
hydrogel structure responsible of the faster swelling and probably promoting a faster 
hydrolytic degradation of the cHANPs. Therefore, we have next investigated the 
impact of these findings on the relaxivity. 
 
Swelling Ratio. Swelling Ratio (SR) is calculated with Eq. 1: 
𝑆𝑅 =
𝑑𝐻2𝑂
𝑑𝑒𝑡ℎ
     (1) 
where 𝑑𝑒𝑡ℎ (in nm) 𝑑𝐻2𝑂 (in nm) are the nanoparticle’s diameters in Ethanol and 
in water respectively, measured by Dynamic Light Scattering. 
Results clearly show that nanoparticles do not exhibit a swelling behavior until 48 
h (Figure S11 a) when produced at the above-reported range of conditions, while a 
significant increase in size is reported for longer time. In particular, smaller 
nanoparticles of 70 nm measured in water are only produced at DVS of 0.8% v/v and 
an increase in size to 168 nm is detected starting from 96 h to 1 week. The second 
scenario (2) is performed without the support of temperature and surfactants. Indeed, 
results show that pH conditions play the key role in adjusting the stability. Stable 
MFF in the presence of Gd-DTPA is always obtained at strict pH conditions ranging 
from 11.7 to 12.6 and in a wider DVS concentration range (0-4.5% v/v). However, 
swelling in water is avoided at the above rep orted pH conditions and exclusively at 
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DVS concentrations varying from 4 to 4.5% v/v. Swelling behavior along the time 
for loaded-cHANPs obtained outside the optimal range is reported in Figure S11 b. 
A mean nanoparticle diameter of 40 nm is measured at pH of 12.3 and DVS of 4% 
v/v; swelling is observed after 96 h. As far as the pH conditions, it is worth 
highlighting that high pH values (from 11.7 to 12.6) are used to promote 
nanoprecipitation and crosslinking reaction only during the production process; after 
the purification phase, the final pH value of cHANPs in water ranges from 6 to 8. 
Nanoparticle sizes for all the proposed conditions in both scenarios are reported in 
Table S8 a and b. Furthermore, the amount of Gd3+-ions released over time is found 
to be below the detection limit (0.1 ppb) of ICP-MS, even after 48 h and for both 
strategies. 
 
Figure S11. Swelling behaviour. FE-SEM images of cHANPs at very low concentrations of DVS 
injected (a) in the middle channel and (b) in the side channels at different hours. 
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Table S8. Size evolution of the nanoparticles. Evolution of nanoparticles size at different hours 
from 4 to 172 hours with respect to their size in Ethanol by adding DVS (a) in the middle channel 
and (b) in the side channels. 
a)       
 
DVS 
0.4 % v/v 
DVS 
0.6 % v/v 
DVS 
0.8 % v/v 
DVS 
1 % v/v 
DVS 
1.2 % v/v 
DVS 
1.6 % v/v 
Ti
me 
[h] 
Si
ze 
[n
m] 
S
D 
[n
m] 
Si
ze 
[n
m] 
S
D 
[n
m] 
Si
ze 
[n
m] 
S
D 
[n
m] 
Si
ze 
[n
m] 
S
D 
[n
m] 
Si
ze 
[n
m] 
S
D 
[n
m] 
Si
ze 
[n
m] 
S
D 
[n
m] 
EtOH 35 2 35 2 35 2 35 2 35 2 35 2 
4 155 22 105 16 71 10 71 10 74 13 734 164 
12 178 35 128 23 72 12 72 3 75 14 767 183 
24 200 40 137 25 70 11 70 12 78 16 860 223 
48 210 47 140 24 71 12 71 13 77 14 900 206 
96 324 58 143 29 85 15 85 15 87 16 1256 344 
172 420 115 170 34 125 25 89 16 89 15 2420 685 
       
b)       
 
DVS 
1 % v/v 
DVS 
2 % v/v 
DVS 
2.5 % v/v 
DVS 
3 % v/v 
DVS 
4 % v/v 
DVS 
4.5 % v/v 
Ti
me 
[h] 
Si
ze 
[n
m] 
S
D 
[n
m] 
Si
ze 
[n
m] 
S
D 
[n
m] 
Si
ze 
[n
m] 
S
D 
[n
m] 
Si
ze 
[n
m] 
S
D 
[n
m] 
Si
ze 
[n
m] 
S
D 
[n
m] 
Si
ze 
[n
m] 
S
D 
[n
m] 
EtOH 35 2 35 2 35 2 35 2 35 2 35 2 
4 156 22 105 16 115 18 95 13 40 9 54 9 
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12 182 35 128 23 122 21 112 5 53 13 55 11 
24 239 48 147 26 143 23 123 20 51 14 51 10 
48 358 80 162 28 162 27 152 26 52 12 53 9 
96 450 82 273 55 273 53 273 47 54 15 75 14 
172 1234 338 680 136 630 126 610 110 115 33 201 35 
 
Stability and release study of cHANPs. Additionally, the stability of cHANPs in 
water under shaking conditions is reported and discussed with respect to release 
properties and degradation phenomena. These studies are performed to assess the 
ability of nanoparticles to carry and retain the CAs. Observations are made starting 
from previously reported optimal conditions for both strategies (0.8% v/v of DVS in 
the middle channel and 4 % v/v of DVS in the side channels). Indeed, it appears 
obvious that, even if swelling is not observed, the presence of Gd-DTPA within the 
nanoparticles is not predictable. 
For cHANPs kept on a rotary shaker operating at 100 rpm under simulated 
physiological conditions (PBS 9.5 mM, pH 7.4, 37 °C), a correlation between 
crosslinking strategy and release and degradation behaviors is also detected. Indeed, 
under shaking, cHANPs of 70 nm obtained when DVS is added to the middle channel 
show a noticeable change in shape or prominent hydrolytic degradation just after 72 
h (Figure S12 a and b). 
Furthermore, for 40 nm nanoparticles, obtained by adding DVS in the side channels 
at the conditions previously reported, degradation and release are not observed even 
up to 96 h. Figure S12 c shows a slight degradation of nanoparticles observed only 
after 172 hours under shaking conditions, when DVS is added in the side channels. 
As far as the release is concerned, relaxation time and ICP-MS measurements have 
been carried out and already reported in our previous work1. 
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Figure S12. Degradation of cHANPs. (a), (b) FE-SEM images of cHANPs prepared by adding 
0.8% v/v of DVS in the middle channel, showing a slight change in shape or hydrolytic degradation 
just after 72 hours under shaking conditions. (c) FE-SEM images of cHANPs prepared by adding 
4% v/v of DVS showing a slight degradation only after 172 hours under shaking conditions. 
 
Loading of Gd-DTPA by sorption: In vitro relaxivity study. Loaded cHANPs are 
also prepared by sorption of Gd-DTPA to compare the relaxometric effects obtained 
with both strategies (Figure S7). Relaxivity r1 is calculated using weighted linear 
regression (R1=1/T1 s
-1 relaxation rate plotted against Gd concentration, mM, and r1, 
mM-1 s-1, is the slope of the fitted curve). Estimation of measurement uncertainty is 
evaluated using weighted linear regression2. Briefly, a solution of Gd-DTPA 91 μM 
is dissolved in the same volume of cHANPs solution and the suspension is placed on 
a wheel for 48 h in order to get maximum sorption of Gd-DTPA on NPs mainly 
through diffusion. In detail, the groups of HA interact with the COO- groups of Gd-
DTPA, which could facilitate the sorption. The small Gd-DTPA molecules, which 
were not adsorbed, are removed by dialysis. 
Then, the sample is dialyzed against water in dialysis membrane tube of 50000 
MCWO for 12 h. The concentration of Gd-DTPA from the exterior medium of 
dialysis bag, treated by evaporator (Buchi® R-215 Rotavapor®), is calculated by T1 
value measured at 37°C on Bruker Minispec mq60 instrument using standard 
inversion-recovery pulse sequence. Later the content of gadolinium adsorbed on NPs 
is calculated by subtracting the amount of gadolinium in the external medium from 
the total amount of Gd-DTPA was previously added to the system. In this study, the 
release of Gd-DTPA is very fast and there is no enhancement in MRI signal at the 
same concentration of Gd-DTPA in water. Furthermore, the adding of GdDTPA 
alters the morphology of formed cHANPs. However, after the sorption, no enhanced 
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relaxivity is observed compared to the free Gd-DTPA, but partial release of the Gd3+ 
ions is observed even after 12 h. 
 
Figure S13. Sorption of Gd-DTPA. FE-SEM images of cHANPs treated by sorption of Gd-
DTPA after the production through nanoprecipitation in hydrodynamic Flow-Focusing. 
 
Contribution of the unloaded cHANPs to the relaxivity. 
 
Figure S14. Relaxometric properties of unloaded cHANPs. The relaxation time measurements 
versus Gd-DTPA concentration show that the unloaded cHANPs do not contribute to the 
enhancement of MRI signal. 
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Nanoparticles tracking analysis (NTA). NTA is a powerful characterization 
technique that complements DLS and is particularly valuable for analyzing 
polydisperse nanosized particles and their concentration. NTA measurements are 
performed with a NanoSight (NanoSight, Malvern), equipped with a sample chamber 
with a 640-nm laser and a Viton fluoroelastomer O-ring. The samples are injected in 
the sample chamber with a sterile syringe until the liquid reached the tip of the 
nozzle. All measurements are performed at room temperature. The samples are 
measured for 40s with manual shutter and gain adjustments. Three measurements of 
the same sample are performed for all samples. The mean size and SD values 
obtained by the NTA software correspond to the arithmetic values calculated with 
the size of the nanoparticles analyzed by the software (Figure S15 a), b), c)). 
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Figure S15. Nanoparticles Tracking Analysis. Size distribution of cHANPs obtained through 
Nanoparticles Tracking Analysis. (a), (b) Concentration (particles/mL) versus size; (c) intensity 
(arbitrary unit) versus size; (d) summarized results. 
 
Calculations of the hydrogel network parameters. As previously described, studies 
on the swelling behavior of the nanoparticles are conducted in water at room 
temperature and the obtained results, in terms of swelling ratio (see Eq. 1), are used 
to estimate the following hydrogel structural parameters of the cHANPs: 
 𝑀𝑐̅̅ ̅̅ : molecular weight between crosslinks (g/mol); 
 𝑣𝑒: effective crosslink density (mol/cm
3); 
 ξ: mesh size (nm). 
In order to compute the above mentioned parameters, a simplified version of the 
Flory-Rehner equations are used[2, 3]. 
Firstly, the average molecular weight between crosslinks (𝑀𝑐̅̅ ̅̅ ) are computed using 
the following equation: 
 𝑄𝑣
5/3 =  
𝑣 ̅ 𝑀𝑐̅̅ ̅̅
V1
 (
1
2
−  𝜒)               (2) 
where Qv is the volumetric swelling ratio, 𝑣 ̅is specific volume of polymer (0.814 
cm3/g for HA)3, V1 is molar volume of solvent (18 mol/cm
3 for water)4, χ is polymer-
solvent interaction parameter (0.473 for HA)5. The volumetric swelling ratio, Qv, is 
estimated based on the approximate diameter ratio (see Eq. 1), determined 
experimentally by comparing the diameters of the swelled cHANPs with the 
cHANPs’ diameters in Ethanol, i.e. before the hydration of the nanoparticles in 
water. 
Differently from the previous works4-6, in which the volumetric swelling ratio is 
estimated from the mass swelling ratio by dividing the sample mass after swelling 
by the dry sample mass, no dehydration of the nanoparticles is performed in order to 
keep unchanged the structure and the shape of the Gd-DTPA loaded cHANPs. 
Therefore, the nanoparticles’ diameter measured in Ethanol is used as the reference 
value to compute the volumetric swelling ratio. This allows us to avoid the alteration 
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of the Gado-Mesh network and the release of the entrapped Gd-DTPA caused by the 
dehydration process, making us able to properly investigate the relationship between 
the cHANPS’ hydrogel structure and the relaxivity values, which strictly rely on the 
encapsulation of the contrast agent and on the hydrogel parameters. 
After 𝑀𝑐̅̅ ̅̅  is estimated, the effective crosslink density, ve, is determined from the 
following equation: 
𝑣𝑒 =  
𝜌𝑝
𝑀𝑐̅̅ ̅̅
               (3) 
where ρp is the density of polymer (1.229 g/cm3 for HA)6. 
The water swollen hydrogels mesh size, ξ, is calculated by the following equation: 
𝜉 =  𝑄𝑣
1/3 √𝑟?̅?
2               (4) 
where √𝑟?̅?
2 is the root-mean square distance between crosslinks, specifically 
reported for HA by Collins et al. 5 as follows: 
√(
𝑟?̅?
2
2𝑛
)  ≅  2.4 (𝑛𝑚)               (5) 
where n is the number of monomer units for HA. For HA with a molecular weight 
(Mn) of ~ 4*10
5, n is ~100, which gives the following estimation of √𝑟?̅?
2: 
√𝑟𝑜2̅̅ ̅̅ = 0.035 √𝑀𝑛               (6) 
Finally, the mesh size can be calculated by combining equations (4) and (6) as 
follows: 
𝜉 = 0.035 √𝑀𝑐̅̅ ̅̅  𝑄𝑣
1/3               (7) 
Estimated values of all swelling study parameters, Qv, 𝑀𝑐̅̅ ̅̅ , ve and ξ should be 
considered as approximate values on account of certain assumptions considered in 
Flory-Rehner calculations and for our specific systems. However, these values can 
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be used for making comparisons between various network features of different 
hydrogel nanoparticles. 
The following tables report all the computed values for swelled cHANPs after 48h: 
Table S9. cHANPs network parameters. Hydrogel network parameters of cHANPs after 48 h of 
swelling, obtained by adding DVS a) in the side channel and b) in the middle channels. 
a)        
 
Volumetric 
swelling ratio 
Molecular mass 
between two 
crosslinked points 
[*103 g/mol] 
Effective 
crosslink density 
[*10-5 mol/cm3] 
Mesh size 
[nm] 
DVS 
[% v/v] 
QV M̅C νe ξ 
 mean SD mean SD mean SD mean SD 
0.00 9.00 0 31.9 0 3.85 0 13.00 0 
1.00 10.23 2.87 39.5 18.5 3.11 1.46 15.09 4.94 
2.00 4.63 1.06 10.5 4.04 11.7 4.47 5.99 1.61 
2.50 4.63 1.04 10.5 3.93 11.7 4.35 5.99 1.56 
3.00 4.34 0.99 9.47 3.60 13.0 4.94 5.56 1.48 
4.00 1.49 0.43 1.58 0.760 77.6 37.2 1.59 0.53 
4.50 1.51 0.34 1.64 0.619 75.1 28.4 1.63 0.43 
        
b)        
 
Volumetric 
swelling ratio 
Molecular mass 
between two 
crosslinked points 
[*103 g/mol] 
Effective 
crosslink density 
[*10-5 mol/cm3] 
Mesh size 
[nm] 
DVS 
[% v/v] 
QV M̅C νe ξ 
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 mean SD mean SD mean SD mean SD 
0.00 9.00 0 31.9 0 3.85 0 13.00 0 
0.40 6.00 1.69 16.2 7.60 7.57 3.55 8.10 2.66 
0.60 4.00 0.91 8.26 3.14 14.9 5.67 5.05 1.35 
0.80 2.03 0.46 2.66 1.00 46.2 17.4 2.29 0.60 
1.00 2.03 0.49 2.66 1.07 46.2 18.5 2.29 0.64 
1.20 2.20 0.53 3.05 1.21 40.3 16.1 2.51 0.70 
1.60 25.71 7.36 183 87.5 0.670 0.319 44.25 14.77 
 
 
A.4. MICROFLUIDIC FLOW FOCUSING APPROACH TO PRODUCE 
COACERVATED CHITOSAN-HYALURONIC ACID NANOPARTICLES 
BASED ON HYDRODENTICITY 
Materials. Hyaluronic acid (HA) with a molecular weight of 50000 Da is purchased 
from CreativePEGWorks (USA). Chitosan with a low molecular weight of 50000 
Da and sodium tripolyphosphate (TPP) with a MW of 367,86 Da produced by Sigma-
Aldrich are chosen in this study. Acetone (Sigma-Aldrich) is used for collection and 
dialysis while ethanol (Carlo Erba, Italy) is employed in the successive step to 
change sample collection from acetone to water. Milli-Q water is used to prepare 
solutions and dialysis. 
 
Microfluidic platform. Microfluidic platform is composed by a system of three 
syringes (SETonic, 5 mL PTFE PEEK tubing connector) pushes fluids within tubes. 
Each single syringe is controlled by a low-pressure syringe pump (Low Pressure 
Syringe Pump neMESYS 290N by CETONI) that doses with high precision emitted 
fluid unit. Syringe is connected, through a ferrule, to the first segment of PTFE tubing 
(Dolomite, 0,8 x 1,6 mm) that, on the other side, is joined with a 2-way in-line valve. 
Thereafter, there is a second segment of PTFE tubing (Dolomite, 0,8 x 0,25 mm) that 
leads fluid to chip. Connection between tubes and chip is easily allowed by a linear 
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connector 7- way. All reactions and processes are conducted in the main body of a 
custom-made chip, purchased from the Dolomite center ltd designed to obtain a 
meeting point such as to promote flow focusing generation, that is locked in a H 
interface 7 way between two linear connectors 7 way. It is made up of quartz and its 
dimensions are 22.5mm long x 15mm wide x 4mm thick. Chip consists of 5 parallel 
inlets converging at a junction, followed by a straight output channel to the opposite 
edge. All channels have the same cross-section of 160 x 150 μm. Finally, a tube of 
outlet, that starts from the second connector, is employed to collect fluid in a glass 
Petri containing water or acetone. 
 
Nanoparticles production. Middle and side streams include two different polymers 
that leads to NPs formation through an ionotropic gelation via CS-TPP crosslinking 
followed by HA-CS complex coacervation. The starting step consists in the 
preparation of polycationic and polyanionic solutions. Components are withdrawn 
from previously prepared stocks at 0,1 % w/v. The first one is obtained by mixing 
CS (concentration range from 0,00625 to 0,2 % w/v) at an acetic acid buffer (1%) 
while the second one is obtained dissolving HA (concentration range from 0,002 to 
0,008 w/v) and TPP (concentration range from 0,003 to 0,012 % w/v) in water. Both 
solutions are stirred at 300 rpm for 30 min. Each syringe is connected to ferrule 
according to chip pattern: polycationic solution will be pushed in the middle channel 
while polyanionic solution in the two side channels. Holders are used to lock each 
syringe with piston and support in order to avoid their movement during fluid push. 
Before experiment launch, flow rates are set on PC software. Start button is pressed 
and fluids begin to flow in tubes but valves remain closed for few minutes to allow 
first tubing segment total filler and promote the compression of the small air bubbles, 
if present. Therefore, middle valve is opened and, after about 30 seconds, even side 
valve. Flow focusing is established at chip junction and can be modified changing 
flow rate on PC. Sample is collected in Petri dishes with acetone inside covered by 
aluminium foil to limit solvent evaporation. Experiment stops when syringes have 
pushed all solution volume within them or when precipitation is so high that main 
channel is occluded or macroaggregates are formed and so flow focusing is not more 
stable. Sample is moved in a vial by using Gilson pipetman and chip is partially 
cleaned with MilliQ water charged into plastic syringe. Possible matter residual 
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within chip are removed by immersing chip in a piranha solution composed of ¼ 
nitric acid and ¾ sulfuric acid for one day. 
 
Nanoparticles characterization. NPs morphological and structural surface features 
are analyzed with a scanning electron microscope (Carl Zeiss UltraPlus Field 
Emission Scanning Electron Microscope). Examined samples are dropped on glass 
directly from microfluidic platform outlet or filtered, after collection and dialyses, 
on membrane of 50 nm pore size. Nanoparticles are coated with 5,5 nm Au or Pt/Pd 
prior observation. Another characterization is carried out with a TEM (Tecnai FEI® 
transmission electron microscope) that allow to examine NPs internal features. 
Samples are collected on Formvar/Carbon 200 mesh Cu Agar® small net from 
platform outlet or dropping off 20-50 μL of solution from collection on it, before or 
after various dialyses. 
 
Minispec benchtop relaxometer. Relaxation times are measured on a Bruker 
Minispec (mq 60) benchtop relaxometer operating at 60 MHz for protons (magnetic 
field strength: 1.41 T). The acquisitions are performed at 37°C and, before each 
measurement, the sample is placed into the NMR probe for about 15 min for thermal 
equilibration. Longitudinal relaxation times, T1, are determined by both saturation 
and inversion recovery pulse sequences while transversal relaxation time T2 is 
determined by Carr-Purcell pulse sequence. The relaxation recovery curves are fitted 
using a multi-exponential model and then they are represented using OriginPro 
software. Relaxivity is evaluated through eq (1) and it is the slope of the straight line. 
 
Supporting data, figures and tables. 
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Figure S16. Microfluidic chip within H interface 7 way and locked between two linear connectors 
7 way. 
 
Figure S2. Chip features 
 
Table S10. Dimensionless numbers in microfluidic device (ρ, fluid density; ν, average flow 
velocity; d, characteristic channel dimension; η, fluid viscosity; σ, interfacial force; g, gravity 
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acceleration constant; β, coefficient of expansion; ΔT, temperature difference; a, sound speed; λ, 
mean free path; 
Dimensionless numbers Definition Equations 
Reynolds number (Re) Inertial force/viscous force pνd/η 
Capillary number (Ca) 
Viscous force/interfacial 
force 
ην/σ 
Bond number (Gr) Gravity/interfacial force ρgd2/σ 
Grashof number (Gr) Buoyancy/viscous force d3ρ2gβ∆T/η2 
Mach number (Ma) Inertial force/elastic force ν/a 
Kn number (Kn) Free path/flow dimension λ/d 
 
 
Figure S17. Microfluidic platform photo 
 
Table S11. Investigated parameters during the experiments design 
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Test  # 
HA 
(%w/v) 
TPP 
(%w/v) 
CS 
(%w/v) 
Flow 
rate 
middle 
channel 
(μL/min
) 
Flow 
rate 
side 
channel 
(μL/min
) 
Flow 
Rate 
Ratio 
CS:HA 
(g/g) 
1 0.008 0.012 0.025 20 100 0.2 0.3125 
2 0.008 0.012 0.025 20 100 0.2 0.3125 
3 0.008 0.012 0.025 0.75 5 0.15 0.23437
5 
4 0.004 0.006 0.0125 0.75 5 0.15 0.23437
5 
5 0.004 0.006 0.0125 20 100 0.2 0.3125 
6 0.002 0.003 0.00625 20 100 0.2 0.3125 
7 0.002 0.003 0.00625 0.75 5 0.15 0.23437
5 
8 0.002 0.003 0.00625 20 100 0.2 0.3125 
9 0.002 0.003 0.00625 20 100 0.2 0.3125 
10 0.002 0.003 0.00625 20 100 0.2 0.3125 
11 0.002 0.003 0.00625 0.75 5 0.15 0.23437
5 
12 0.002 0.003 0.00625 20 100 0.2 0.3125 
13 0.002 0.003 0.00625 0.75 5 0.15 0.23437
5 
14 0.002 0.003 0.00625 3 (CH) - 
9 (HA) 
90     
15 0.002 0.003 0.00625 20 100 0.2 0.3125 
16 0.002 0.003 0.00625 3 (CH) - 
9 (HA) 
90     
17 0.002 0.003 0.00625 0.3 4 0.075 0.11718
8 
18 0.002 0.003 0.00625 0.2 4 0.05 0.07812
5 
19 0.002 0 0.00625 20 100 0.2 0.3125 
20 0.004 0.006 0.0125 0.15 2.5 0.06 0.09375 
21 0.002 0.003 0.00625 0.2 4 0.05 0.07812
5 
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22 0.002 0.003 0.00625 0.2 4 0.05 0.07812
5 
23 0.002 0.003 0.00625 0.2 4 0.05 0.07812
5 
24 0.002 0.003 0.00625 0.2 4 0.05 0.07812
5 
25 0.002 0.003 0.00625 0.2 1 0.2 0.3125 
26 0.002 0.003 0.00625 0.2 1 0.2 0.3125 
27 0.002 0.003 0.00625 0.2 1 0.2 0.3125 
28 0.002 0.003 0.00625 0.2 0.5 0.4 0.625 
29 0.002 0.012 0.00625 0.2 1 0.2 0.3125 
30 0.002 0.012 0.00625 10 25 0.4 0.625 
31 0.002 0.012 0.00625 0.2 4 0.05 0.07812
5 
32 0.002 0.012 0.00625 0.2 0.5 0.4 0.625 
33 0.002 0.003 0.00625 10 25 0.4 0.625 
34 0.002 0.012 0.00625 0.2 1 0.2 0.3125 
35 0.002 0.003 0.00625 0.2 0.5 0.4 0.625 
36 0.002 0.003 0.00625 0.2 1 0.2 0.3125 
37 0.002 0.012 0.00625 10 25 0.4 0.625 
38 0.002 0.012 0.00625 2 5 0.4 0.625 
39 0.008 0.012 0.2 0.3 0.6 0.5 6.25 
40 0.004 0.006 0.1 0.3 0.6 0.5 6.25 
41 0.002 0.003 0.05 0.3 0.6 0.5 6.25 
42 0.008 0.012 0.05 0.3 0.6 0.5 1.5625 
43 0.008 0.012 0.1 0.3 0.6 0.5 3.125 
44 0.002 0.003 0.0125 0.3 0.6 0.5 1.5625 
45 0.002 0.003 0.0125 3 6 0.5 1.5625 
46 0.008 0.012 0.1 3 6 0.5 3.125 
47 0.008 0.012 0.1 3 6 0.5 3.125 
48 0.008 0.012 0.1 0.3 0.6 0.5 3.125 
49 0.002 0.003 0.025 3 6 0.5 3.125 
 
Table S12. Summary of all the trials carried out with Gd-DTPA 
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Test #
HA
(%w/v)
TPP
(%w/v)
CS
(%w/v)
Gd
(mg)
Gd
(%w/v)
Flow rate
Middle 
channel
(μL/min)
Flow rate
Side 
channel
(μL/min)
Collection
(mL)
Flow 
Rate 
Ratio
CS:HA
(g/g)
total ug 
collecte
d
µg Gd 
collected  
Gd1 0,008 0,012 0,1 8 0,1 3 6 15 (acetone) 0,5 3,125 37,8 21
Gd2 0,008 0,012 0,1 8 0,1 3 6 15 (acetone) 0,5 3,125 37,8 21
Gd3 0,002 0,003 0,05 4 0,05 3 6 8 (acetone) 0,5 6,25 126 180
Gd4 0,002 0,003 0,05 4 0,05 3 6 8 (acetone) 0,5 6,25 73,5 105
Gd5 0,008 0,012 0,1 8 0,1 3 6 8 (water) 0,5 3,125 43,2 24
Gd6 0,008 0,012 0,1 8 0,1 3 6 8 (water) 0,5 3,125 43,2 24
Gd7 0,008 0,012 0,1 8 0,1 3 6 10 (acetone) 0,5 3,125 54 30
Gd8 0,008 0,012 0,1 8 0,1 3 6 1 (water in eppendorf) 0,5 3,125 54 30
Gd9 0,008 0,012 0,1 8 0,1 3 6 1 (etoh in eppendorf) 0,5 3,125 27 15
Gd10 0,008 0,012 0,1 8 0,1 3 6 1 (water in eppendorf) 0,5 3,125 32,4 18
Gd11 0,008 0,012 0,1 8 0,1 3 6 1 (etoh in eppendorf) 0,5 3,125 32,4 18
Gd12 0,008 0,012 0,1 8 0,1 3 6 1 (water in eppendorf) 0,5 3,125 37,8 21
Gd13 0,008 0,012 0,1 8 0,1 3 6 8 (acetone) 0,5 3,125 37,8 21
Gd14 0,008 0,012 0,1 8 0,1 3 6 8 (acetone) 0,5 3,125 37,8 21
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Figure S18. Graphic trend of Reynolds number within microfluidic channels, 
distinguished in high and low flow rate regime, based only on the chitosan 
concentration due to its high intrinsic viscosity 
 
 
 
Figure S19. Reynolds number trend at different chitosan concentrations depending 
on the total flow rate  
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Figure S20. Reynolds number value depending on chitosan and hyaluronic acid 
concentration calculated at low (0.6 – 0.3 – 0.6 μL/min) and high ( 6 – 3 – 6 
μL/min) flow rates 
 
 
A.5. MICROFLUIDIC FLOW FOCUSING APPROACH TO PRODUCE 
CHITOSAN-LOADED LIPOSOME NANOSTRUCTURES BASED ON 
HYDRODENTICITY 
Materials. As lipids, we used phosphatidylcholine get from soybean (lyophilized 
powder; storage temperature −20°C; average molecular weight of approximately 776 
g/mol) and cholesterol derived from sheep wool (Empirical Formula C27H46O; 
APPENDIX 
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molecular weight 386.65 g/mol; storage temperature  −20°C) that we bought both 
from Sigma Aldrich.  As polymer, we used chitosan (low molecular weight: 50,000-
190,000 Da; soluble in dilute aqueous acid) that we bought from Sigma Aldrich too. 
As solvents, we used acetic acid (absolute), ethanol (puriss. p.a., absolute, 
≥99.8%GC; MW: 46.07 g/mol) and filtered MilliQ water for all the experiments and 
purification steps (dialysis). 
 
Preparation of stock solution. Preparation of lipids stocks solutions (PC:Ch – 4:1): 
● PC: 80mg in 10 ml (8 mg/ml); 
● Ch: 10 mg in 10 ml (1 mg/ml). 
At each trial ratio of cholesterol to phosphatidylcholine was 1:4, respectively. 
 
Solubility tests. At first we prepared solution of lipids and ethanol, and then step by 
step we was adding 1% acetic acid in water (2.92ml water + 0.08 ml acetic acid), 
solution was stirring all time (300x) at temp. 25 oC. Starting concentration of lipids 
in ethanol was 2.25 mg/ml after addition 3 ml of 1% acetic acid precipitation occur 
(1.28 mg/ml lipids concentration). 
Solubility of lipids in ethanol and acetic acid was checked. Starting lipids 
concentration was 1,6 mg/ml in ethanol. Then step by step acetic acid was added 
until 7.41% of acetic acid when precipitation occur. Precipitation disappear after 
decreasing acid percentage to 6%. In this way we checked solubility of lipids in 
presence of acetic acid (final lipids concentration 1.2 mg/ml). With starting 
concentration of lipids 0.1125 mg/ml, 10% of acetic acid was obtained without 
precipitation. in the same solution solubility of chitosan was checked in 
concentration 0.25 mg/ml, 24h stirring, solution not transparent. Water was added 
(33.3%) to the solution step by step, after next 24h solution become transparent 
(lipids 0.00375 mg/ml; acetic acid 6.66%; ethanol 58.5 %; chitosan 0.166%; water 
33.33%). 
Next one test was solubility of chitosan in absolute acetic acid. Starting point was 
5 mg/ml of chitosan in acetic acid; final concentration was 1 mg/ml, but solution was 
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not transparent. For this reason water was added, after 24h solution was transparent 
(final concentrations: acetic acid 77%; chitosan 0.77 mg/ml; water 23%). 
The last one solubility test checked mixing of lipids solution (lipids: 0.072 mg/ml; 
ethanol 64.3%; water 35.7%) with chitosan solution (acetic acid 77 %; water 23%; 
0.77 mg/ml). Chitosan solution was adding step by step every 15 min to the lipids 
solution until following concentrations: lipids 0.05305mg/ml; chitosan 0.203 mg/ml; 
ethanol 45%; water 35%; acetic acid 20%. 
 
Experiments on microfluidic platform. Microfluidic devices enable the 
manipulation of microquantities of liquid solutions, where mixing and demixing 
processes can be controlled to improve the efficiency of chemical reactions. In 
particular, the mixing that occurs within these devices happens on the order of a few 
milliseconds and provides the needed control over efficient and homogeneous mass 
transfer to achieve monodisperse nanostructure formulations. This has been widely 
used for applications in pharmacy, biotechnology, and chemical industries for years. 
The control of morphology, surface texture, size and polydispersity as well as of the 
system complexity through the variation of process parameters make the 
microfluidics one of the most promising approach in the reproducible and reliable 
design of micro- and nano-structures. In addition, the recent advancements in the 
fabrication of microfluidic devices for large-scaled production and direct clinical 
applications will rapidly drive the microfluidics technology to the industrial and 
medical arena. 
Each trial on microfluidic platform was performed. Microfluidic platform is 
composed by various components that work simultaneously: computer, microscope, 
NeMESYS device. The last one is a system of three syringes (SETonic, 2.5 mL PTFE 
PEEK tubing connector) that pushes fluids within tubes. Each single syringe is 
controlled by a low-pressure syringe pump (Low Pressure Syringe Pump neMESYS 
290N by CETONI). NeMESYS device can be controlled by PC software, thanks to 
that flow rate and volume can be monitored and changed. Syringe is connected and 
holding by the neMESYS through a ferrule and on the other side, is joined with a 2-
way valve. Thereafter, there is a second segment of PTFE tubing that lead fluid to 
chip. Fluid from the chip can be collected thanks to the tubing on other site of the 
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chip. All reactions and processes are conducted in the proposed chip design is 
22.5mm long x 15mm wide x 4mm thick and fabricated in Quartz, designed to obtain 
a meeting point to promote flow focusing. Chip consists of 5 parallel inputs and one 
output. In ours experiments Chip A (the Dolomite center ltd.) was used. All channels 
have the same cross-section of 160 x 150 μm, approximately circular as shown 
below. 
Further details concerning the experiment design can be found in the Supporting 
Information. 
 
Characterizations of samples. Characterization was performed on transmission 
electron microscope by FEI® in DRY and CRYO modes and Field Emission 
Scanning Electron Microscope (FE-SEM) by Zeiss. Samples for TEM 
characterization was stained in some cases with phosphotungstic acid 
(phosphotungstic acid 2%) on formvar carbon film 300 mesh. Regular samples on 
TEM was collected on Carbon Films on 300 Mesh Grids Copper. SIze of 
nanoparticles and Z-potential was analyzed by dynamic light scattering (DLS). 
Relaxation times are measured on a Bruker Minispec (mq 60) benchtop relaxometer 
operating at 60 MHz for protons (magnetic field strength: 1.41 T). The acquisitions 
are performed at 37°C and, before each measurement, the sample is placed into the 
NMR probe for 15 min for thermal equilibration. 
 
Supporting data, figures and tables. 
Table S13. Summary of all the trials carried out 
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Trial
Lipids total 
(mg/ml)
Chitosan 
(mg/ml)
Acetic acid 
(%)
Etoh-lipids 
(%)
Water-lipids 
(%)
Gd-DTPA 
(mg/ml)
Middle/Side
Flow rate 
middle 
(uL/min)
Flow rate 
side 
(uL/min)
1 1,68 0 0 63,6 36,4 0 water/lipids 21 41
2 1,68 0 0 63,6 36,4 0 water/lipids 7 41
3 1,63 0 0 100 0 0 lipids/water 7 41
4 1,63 0 0 100 0 0 lipids/water 21 41
5 0,072 0,375 1 65 35 0 polymer/lipids 21 41
6 0,072 0 1 65 35 0 water+acid/lipids 21 41
7 0,05 0 0 65 35 0 lipids/water 21 41
8 0,05 0 20 50 30 0 lipids+acid/water 21 41
9 0,05 0,2 20 45 35 0 lipids+acid/water 21 41
10 0,072 0,1 1 65 35 0 polymer/lipids 21 41
11 0,072 0,1 20 45 35 0 polymer+lipids+acid/water21 41
12 0,072 0 0 65 35 0 water/lipids 21 41
13 0,072 0 10 65 35 0 water+acid/lipids 21 41
14 0,072 0,1 10 65 35 0 polymer/lipids 21 41
15 0,072 0 0 80 20 0 water/lipids 21 41
16 0,072 0 0 80 20 0 water/lipids 7 41
17 0,072 0 10 80 20 0 water+acid/lipids 21 41
18 0,072 0 10 80 20 0 water+acid/lipids 7 41
19 0,072 0,1 1 65 35 0 polymer/lipids 3 41
20 0,072 0,1 1 65 35 0 polymer/lipids 7 41
21 0,072 0,1 1 65 35 0 polymer/lipids 14 41
22 0,072 0,1 1 65 35 0 polymer/lipids 28 41
23 0,072 0,1 1 65 35 0 polymer/lipids 1 41
24 0,072 0,1 1 65 35 0 polymer/lipids 3 41
25 0,072 0,1 1 65 35 0 polymer/lipids 1 41
26 0,072 0,1 1 65 35 0 polymer/lipids 3 41
27 0 0,1 1 65 35 0 polymer/water+etoh 3 41
28 0,072 0,1 1 65 35 0 polymer/lipids 1 41
29 0,072 0,1 1 65 35 0 polymer/lipids 3 41
30 0,072 0,1 1 65 35 0 polymer/lipids 1 41
31 0,072 0,1 1 65 35 0 polymer/lipids 3 41
32 0,072 0,1 1 65 35 0 polymer/lipids 3 41
33 0,072 0,1 1 65 35 4 polymer/lipids 3 41
34 0,072 0,1 1 65 35 4 polymer/lipids 3 41
35 0,072 0,1 1 65 35 4 polymer/lipids 1 41
36 0,072 0,1 1 65 35 4 polymer/lipids 3 41
Trial
Lipids total 
(mg/ml)
Chitosan 
(mg/ml)
Acetic acid 
(%)
Etoh-lipids 
(%)
Water-lipids 
(%)
Gd-DTPA 
(mg/ml)
Middle/Side
Flow rate 
middle 
(uL/min)
Flow rate 
side 
(uL/min)
1 1,68 0 0 63,6 36,4 0 water/lipids 21 41
2 1,68 0 0 63,6 36,4 0 water/lipids 7 41
3 1,63 0 0 100 0 0 lipids/water 7 41
4 1,63 0 0 100 0 0 lipids/water 21 41
5 0,072 0,375 1 65 35 0 polymer/lipids 21 41
6 0,072 0 1 65 35 0 water+acid/lipids 21 41
7 0,05 0 0 65 35 0 lipids/water 21 41
8 0,05 0 20 50 30 0 lipids+acid/water 21 41
9 0,05 0,2 20 45 35 0 lipids+acid/water 21 41
10 0,072 0,1 1 65 35 0 polymer/lipids 21 41
11 0,072 0,1 20 45 35 0 polymer+lipids+acid/water21 41
12 0,072 0 0 65 35 0 water/lipids 21 41
13 0,072 0 10 65 35 0 water+acid/lipids 21 41
14 0,072 0,1 10 65 35 0 polymer/lipids 21 41
5 0,072 0 0 80 20 0 water/lipids 21 41
6 , 80 20 0 w ter/li i 7 41
7 , 10 80 20 0 water+acid/lipids 21 41
8 0 0 80 20 0 water+ac d/lipids 7 41
19 , 1 65 35 0 polymer/lipids 3 41
0 , 1 65 35 0 polymer/lipids 7 41
1 , , 1 65 35 0 polymer/lipids 14 41
2 , , 1 65 35 0 polymer/lipids 28 41
3 0,072 0,1 1 65 35 0 polymer/lipids 1 41
24 0,072 0,1 1 65 35 0 polymer/lipids 3 41
25 0,072 0,1 1 65 35 0 polymer/lipids 1 41
26 0,072 0,1 1 65 35 0 polymer/lipids 3 41
27 0 0,1 1 65 35 0 polymer/water+etoh 3 41
28 0,072 0,1 1 65 35 0 polymer/lipids 1 41
29 0,072 0,1 1 65 35 0 polymer/lipids 3 41
30 0,072 0,1 1 65 35 0 polymer/lipids 1 41
1 , 1 65 35 0 polymer/lipids 3 41
32 0,072 0,1 1 65 35 0 polymer/lipids 3 41
33 0,072 0,1 1 65 35 4 polymer/lipids 3 41
34 0,072 0,1 1 65 35 4 polymer/lipids 3 41
35 0,072 0,1 1 65 35 4 polymer/lipids 1 41
36 0,072 0,1 1 65 35 4 polymer/lipids 3 41
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